
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="../style.css">
    <title>Document</title>
</head>
<body>

<span class="table_title">False Negatives</span>

<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>generated</th>
      <th>gold</th>
      <th>text</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>33</th>
      <td>LDL<br>P-value for interaction effect of groups over time<br>HDL</td>
      <td>LDL (low density lipoprotein)<br>HDL (high density lipoprotein)</td>
      <td>Abbreviations: HDL (high density lipoprotein); LDL (low density lipoprotein) *P-value for interaction effect of groups over time.</td>
    </tr>
    <tr>
      <th>56</th>
      <td>potential for interactions with other drugs<br>efficacy<br>safety</td>
      <td>efficacy and safety</td>
      <td>Therefore, herbal products must be assessed for their efficacy and safety, including their potential for interactions with other drugs [14].</td>
    </tr>
    <tr>
      <th>75</th>
      <td>resting lactate level</td>
      <td>lactate level</td>
      <td>Resting lactate level was measured at baseline and after 12 weeks, and results are presented in Figure 2.</td>
    </tr>
    <tr>
      <th>74</th>
      <td>quadriceps muscle strength (QMS)<br>lactate at rest</td>
      <td>quadriceps muscle strength (QMS)<br>lactate</td>
      <td>The purpose of this study was to evaluate the effect of SC extract supplementation on quadriceps muscle strength (QMS) and lactate at rest in adult women.</td>
    </tr>
    <tr>
      <th>87</th>
      <td>warfarin<br>INR<br>1.7–2.5<br>1.875 mg</td>
      <td>INR<br>monitoring</td>
      <td>The patient was compliant regarding the attendance of appointments and in taking the medication, and maintained a therapeutic INR (1.7–2.5) on a maintenance daily dose of 1.875 mg warfarin with monthly INR monitoring.</td>
    </tr>
    <tr>
      <th>30</th>
      <td>quinine<br>trace metals<br>flavonoids</td>
      <td>Cmax<br>tmax</td>
      <td>[38]  Although, the exact mechanism responsible for the delayed and decreased absorption of quinine in the presence of G. kola in this current study is not known, it is possible that quinine may have interacted through complex formation with the trace metals or flavonoids usually found in G. kola [6, 11] as evidenced from a significant reduction in the Cmax and tmax of quinine but no significant change in parameters which are indicative of interference with elimination.</td>
    </tr>
    <tr>
      <th>3</th>
      <td>OATs<br>SLC22 family members</td>
      <td>OATs<br>SLC22</td>
      <td>Currently, there are 29 putative SLC22 family members, 18 of which are believed to be OATs.</td>
    </tr>
    <tr>
      <th>10</th>
      <td>AUC0–∞<br>maximum plasma concentration (Cmax)<br>elimination half-life (t1/2)</td>
      <td>maximum plasma concentration (Cmax)<br>area under the plasma concentration–time curve from time zero to infinity (AUC0–∞)<br>elimination half-life (t1/2)</td>
      <td>The following pharmacokinetic parameters of docetaxel were calculated: area under the plasma concentration–time curve from time zero to infinity (AUC0–∞), elimination half-life (t1/2) and maximum plasma concentration (Cmax).</td>
    </tr>
    <tr>
      <th>28</th>
      <td>phenotypic ratio<br>midazolam clearance</td>
      <td>clearance<br>area-under-the-curve</td>
      <td>[17] The single-time point phenotypic ratio approach confirmed what other investigators observed with St. John’s wort when more conventional “area-under-the-curve” methods were utilized to determine midazolam clearance.</td>
    </tr>
    <tr>
      <th>57</th>
      <td>SOD<br>GPx<br>CAT<br>MDA</td>
      <td>glutathione peroxidase (GPx)<br>catalase (CAT)<br>superoxide dismutase (SOD)<br>malondialdehyde (MDA)</td>
      <td>Oxidative stress is dramatically increased in PCOS patients, when oxidant/antioxidant status is measured by circulating serum markers, including catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) [3].</td>
    </tr>
    <tr>
      <th>4</th>
      <td>unique substrates</td>
      <td>Oat3<br>Oat1</td>
      <td>Further, unique substrates that interact with Oat1, but not with Oat3 (and vice-versa) have been identified [7].</td>
    </tr>
    <tr>
      <th>105</th>
      <td></td>
      <td>BIO<br>AUC</td>
      <td>As shown in Table 1, after co-administration with RS, BIO of OS increased by 62% without change in its absorption rate (k  The developed pop-PK model lets us have an interpretation on the contradictory phenomena that co-administration of RS would increase both the elimination rate and systemic exposure (AUC The pop-PK model could separately estimate the metabolic clearance (CL  A platform including a six-dimension in-vitro screening, an in-vivo pharmacokinetics in rats and an ex-vivo pharmacodynamic evaluation, has been developed and successfully applied to find RS as a potential herb that would influence the co-administrated OS in rats.</td>
    </tr>
    <tr>
      <th>62</th>
      <td>pharmacodynamic (PD) parameters<br>pharmacokinetic (PK) parameters</td>
      <td>pharmacokinetic (PK)-pharmacodynamic (PD) parameters</td>
      <td>The aim of this study was to systematically review data regarding pharmacokinetic (PK)-pharmacodynamic (PD) parameters from randomized controlled trials relating to interactions between herbal medicines and warfarin.</td>
    </tr>
    <tr>
      <th>27</th>
      <td>soluble extract<br>GI tract<br>bioavailable concentration</td>
      <td>bioavailability<br>bioavailable concentration</td>
      <td>Since the intestinal absorption and plasma concentrations of each test compound are not known, and with the knowledge that herbal extracts have different bioavailability [28], the estimated bioavailable concentration was calculated using the % yield to give the soluble extract available in the GI tract.</td>
    </tr>
    <tr>
      <th>67</th>
      <td>blood pressure<br>pulse<br>oxygen saturation</td>
      <td>Vital signs (blood pressure, pulse, oxygen saturation)</td>
      <td>Vital signs (blood pressure, pulse, oxygen saturation) were obtained on every study day.</td>
    </tr>
    <tr>
      <th>100</th>
      <td>Schisandra lignans</td>
      <td>CYP</td>
      <td>Another limitation of the current study is the reliance on the assumption that Schisandra lignans are solely responsible for the interactions with CYP substrates.</td>
    </tr>
    <tr>
      <th>102</th>
      <td>CYP2C19<br>CYP3A4<br>CYP1A2</td>
      <td>IC</td>
      <td>Gongronema latifolium and Alstonia boonei may produce in vivo inhibitory activity on CYP1A2, CYP2C19 and CYP3A4 since the converted in vitro IC One of the problems of studying herb–drug interactions is the difficulty in identifying or quantifying the inhibiting components of the complex mixtures of phytochemicals in the herb.</td>
    </tr>
    <tr>
      <th>49</th>
      <td>AUC of S-warfarin</td>
      <td>AUC</td>
      <td>(2007) also investigated the effect of pretreatment with cranberry juice for 5 days on warfarin pharmacokinetics and found no clinically significant change in the AUC of S-warfarin.</td>
    </tr>
    <tr>
      <th>71</th>
      <td>elimination half-life</td>
      <td>an elimination half-life</td>
      <td>After administration, aspirin is rapidly hydrolyzed in the body with an elimination half-life of approximatly 15 min [11,12].</td>
    </tr>
    <tr>
      <th>97</th>
      <td></td>
      <td>recombinant CYP2C8 enzyme (supersomes)<br>human liver microsomes (HLM)</td>
      <td>An extensive in vitro study showed that recombinant CYP2C8 enzyme (supersomes) was less sensitive than human liver microsomes (HLM) to identify potential mechanism‐based inhibitors and was characterised by a high lot‐to‐lot variability.</td>
    </tr>
    <tr>
      <th>18</th>
      <td>IC50 values<br>four-parameter sigmoid (Hill) model<br>concentration-response<br>percentage control value</td>
      <td>the concentration-response (percentage control value)<br>the IC50 values</td>
      <td>To determine the IC50 values, the concentration-response (percentage control value) curves were fitted to a four-parameter sigmoid (Hill) model, according to eq.</td>
    </tr>
    <tr>
      <th>9</th>
      <td>plasma cell rich interface hepatitis<br>portal tracts<br>periportal hepatocyte apoptosis<br>cholangiolar proliferation<br>chronic hepatitis</td>
      <td>periportal hepatocyte</td>
      <td>At this time, the liver histology demonstrated chronic hepatitis with fibroinflammatory expansion of portal tracts by moderate plasma cell rich interface hepatitis, rare periportal hepatocyte apoptosis, and mild cholangiolar proliferation (Figures 1(a) and 1(b)).</td>
    </tr>
    <tr>
      <th>50</th>
      <td>metabolism of extract components<br>in vivo bioavailability</td>
      <td>bioavailability</td>
      <td>Especially the open questions of in vivo bioavailability and of the metabolism of extract components relevant for in vitro effects often prevent reliable extrapolations from in vitro to in vivo data.</td>
    </tr>
    <tr>
      <th>25</th>
      <td>IC50 values<br>CAW-R61J compounds</td>
      <td>in vivo concentration<br>IC50</td>
      <td>Ultimately, the clinical relevance of the weak P450 inhibition seen in this study will depend on the IC50 values of the as yet unknown inhibitory CAW-R61J compounds and their in vivo concentration achieved in humans.</td>
    </tr>
    <tr>
      <th>101</th>
      <td>concentration of aqueous extract of herb<br>50% inhibitory concentration</td>
      <td>Fifty percent inhibitory concentration</td>
      <td>Fifty percent inhibitory concentration (IC   where A = log of concentration of aqueous extract of herb in the incubations.</td>
    </tr>
    <tr>
      <th>113</th>
      <td>polyethylene tubing<br>jugular vein</td>
      <td>anesthesia</td>
      <td>Rats were cannulated with polyethylene tubing (PE-50, Natsume Co, Tokyo, Japan) in the jugular vein for sampling under anesthesia with isoflurane.</td>
    </tr>
    <tr>
      <th>90</th>
      <td></td>
      <td>adipocyte differentiation<br>blood viscosity<br>myocardial mass<br>ERK<br>PI3-K/Akt<br>cyclooxygenase inhibitory activity<br>calcium influx</td>
      <td>Biological Mechanisms  In vitro and in vivo studies focused on mechanism of action have determined several potential mechanisms of the HS extracts that may explain the hypotensive activity, including (1) vasodilation mediated through endothelium-derived relaxant pathways and inhibition of calcium influx [9, 57], (2) ACE inhibition [9] by the stimulation of new vessel formation and a reduction of myocardial mass [52] or anthocyanins competing with the substrate for the active site [58], (3) decrease in blood viscosity through cyclooxygenase inhibitory activity [44], and (4) inhibition of adipocyte differentiation through the modulation of PI3-K/Akt and ERK pathway [59].</td>
    </tr>
    <tr>
      <th>69</th>
      <td>glucuronidation<br>silibinin<br>silibinin–raloxifene interaction</td>
      <td>intestinal glucuronidation</td>
      <td>Silibinin was selected as a model herbal product perpetrator based on well‐characterized composition, availability of human pharmacokinetic data, and in vitro inhibitory potency (K Because standard approaches to evaluate herb–drug interactions mediated via inhibition of intestinal glucuronidation in humans have not been described, two different modeling platforms were used to predict the likelihood and magnitude of the silibinin–raloxifene interaction.</td>
    </tr>
    <tr>
      <th>8</th>
      <td>Antinuclear antibody (ANA)<br>smooth muscle antibody</td>
      <td>Antinuclear antibody (ANA<br>smooth muscle antibody</td>
      <td>Antinuclear antibody (ANA) was 1 : 40 and smooth muscle antibody was modestly elevated at 1 : 80.</td>
    </tr>
    <tr>
      <th>107</th>
      <td>synergistic inhibitory effect</td>
      <td>MCF-7 and T-47D cell growth</td>
      <td>When combined with TAM, it exhibits a significant synergistic inhibitory effect on MCF-7 and T-47D cell growth (Cho et al., 2010).</td>
    </tr>
    <tr>
      <th>6</th>
      <td>Danshen components<br>clinical pharmacokinetic profile</td>
      <td>the OATs<br>transporter families</td>
      <td>For the most part these latter two transporter families and the OATs have fairly distinct substrate interactions; however, the possibility that they also may contribute to the overall clinical pharmacokinetic profile of Danshen components in vivo needs to be considered until investigated directly.</td>
    </tr>
    <tr>
      <th>51</th>
      <td>alanine aminotransferase (ALT)<br>Pap smears<br>mammographies<br>creatinine levels<br>aspartate aminotransferase (AST)</td>
      <td>alanine aminotransferase (ALT)<br>cholesterol<br>creatinine<br>aspartate aminotransferase (AST)<br>fasting blood sugar<br>triglyceride</td>
      <td>Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone–related cancers; 4) women with uncontrolled hypertension (160/100 mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180 mg/dL or higher, or cases of starting or changing medication due to diabetes within 3 mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1 yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4 wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4 wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4 wk; 12) women who were administered female hormone formulations within 6 mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10 h) within 3 mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1 mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study.</td>
    </tr>
    <tr>
      <th>32</th>
      <td>PR interval<br>corrected QT interval (QTc)<br>QRS duration</td>
      <td>the PR interval<br>corrected QT interval (QTc)<br>QRS duration</td>
      <td>On serial electrocardiograms the PR interval, QRS duration and corrected QT interval (QTc) were similar in both arms (S2 Table).</td>
    </tr>
    <tr>
      <th>73</th>
      <td>drug metabolizing enzymes<br>drug transporters</td>
      <td>bioavailability</td>
      <td>PXR activating drugs (e.g., rifampicin) or herbal preparations (e.g., St. John’s Wort) consequently induce drug metabolizing enzymes, and drug transporters can deteriorate drug efficacy by reducing the bioavailability or increasing the clearance of concomitantly used drugs, being substrates of such enzymes and/or transporters [16,17].</td>
    </tr>
    <tr>
      <th>0</th>
      <td>TPMT gene<br>hypoglycemic effect</td>
      <td>The rs1142345 (A>G) SNP in the thiopurine S-methyltransferase (TPMT) gene</td>
      <td>The rs1142345 (A>G) SNP in the thiopurine S-methyltransferase (TPMT) gene was significantly associated with the hypoglycemic effect of the drug (P = 0.001, FDR P = 0.043).</td>
    </tr>
    <tr>
      <th>13</th>
      <td>cytochrome P450</td>
      <td>cytochrome P450 (P450)<br>monooxygenase forms</td>
      <td>The most important class of enzymes involved in human drug metabolism is cytochrome P450 (P450), which occurs as a superfamily of related monooxygenase forms responsible for oxidative metabolism of xenobiotics and endogenous compounds (Nebert et al., 2013).</td>
    </tr>
    <tr>
      <th>114</th>
      <td>AUC data<br>herb-drug interaction</td>
      <td>AUC</td>
      <td>The AUC data showed statistically significant differences between group 1 and 2 and between groups 2 and 3 possibly suggest the herb-drug interaction between Epimedium sagittatum extract and sildenafil.</td>
    </tr>
    <tr>
      <th>22</th>
      <td>CYP3A4<br>CYP2C19<br>CYP2D6<br>human liver microsomes<br>CYP2C9<br>centelloids<br>human P450 forms</td>
      <td>CYP2C19, CYP3A4, CYP2D6, and CYP2C9<br>P450</td>
      <td>Purified centelloids are weak inhibitors in human liver microsomes and human P450 forms expressed by E. coli of CYP2C19, CYP3A4, CYP2D6, and CYP2C9.</td>
    </tr>
    <tr>
      <th>70</th>
      <td>nicotinamide<br>CBZ plasma level</td>
      <td>clearance</td>
      <td>As regards the dietary supplement-CBZ interactions, folinic acid did not alter the plasma level of CBZ in rats [61] while nicotinamide increased CBZ plasma level and decreased its clearance in two children with epilepsy [70].</td>
    </tr>
    <tr>
      <th>2</th>
      <td>% yield<br>bioavailable concentration</td>
      <td>bioavailability<br>bioavailable concentration</td>
      <td>Since the intestinal absorption and plasma concentration of each test compound are not known and with the knowledge that herbal extracts have different bioavailability [24], the bioavailable concentration was estimated using the % yield (weight extracted powdered material/weight of original starting material) to give the soluble extract available in the GIT tract.</td>
    </tr>
    <tr>
      <th>88</th>
      <td>HDL-C<br>triglycerides<br>total cholesterol<br>LDL-C</td>
      <td>HDL-C<br>total cholesterol<br>cholesterol<br>triglycerides<br>Cholesterol<br>LDL-C</td>
      <td>Table 5  Cholesterol RCT interventions and effects of cholesterol RCT interventions on total cholesterol, HDL-C, LDL-C, and triglycerides.</td>
    </tr>
    <tr>
      <th>55</th>
      <td>plasma concentration-time curve<br>dose<br>pharmacokinetic parameters<br>valsartan<br>AUC<br>Rc<br>intravenous injection<br>rats</td>
      <td>AUC: area under the plasma</td>
      <td>AUC: area under the plasma concentration-time curve from 0 to 48 h C Pharmacokinetic parameters of valsartan and Rc following intravenous injection of valsartan at a dose of 1 mg/kg in rats.</td>
    </tr>
    <tr>
      <th>112</th>
      <td>OCT1<br>OAT3<br>OATP1B1<br>OAT1<br>OATP1B3<br>OCT2</td>
      <td>OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters</td>
      <td>[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA).</td>
    </tr>
    <tr>
      <th>64</th>
      <td>activated partial thromboplastin time<br>prothrombin time<br>international normalized ratio</td>
      <td>international normalized ratio (INR)<br>prothrombin time (PT)<br>activated partial thromboplastin time (aPTT)</td>
      <td>At the time of admission to ED, she had a prothrombin time (PT) of more than 37 seconds, activated partial thromboplastin time (aPTT) more than 70 seconds, and international normalized ratio (INR) greater than seven.</td>
    </tr>
    <tr>
      <th>11</th>
      <td>docetaxel AUC0–∞</td>
      <td>AUC0–∞</td>
      <td>The individual differences in docetaxel AUC0–∞ are depicted in Figure 3.</td>
    </tr>
    <tr>
      <th>16</th>
      <td>IC50 values<br>P450 enzyme activity<br>NADPH</td>
      <td>Potential TDI of P450 enzyme activity<br>NADPH<br>IC50</td>
      <td>Potential TDI of P450 enzyme activity by CAW-R61J was determined using the shift in IC50 values between 30-minute preincubations in the presence and absence of NADPH.</td>
    </tr>
    <tr>
      <th>110</th>
      <td>total AUC</td>
      <td>CHO<br>AUC</td>
      <td>However, the total AUC for CHO was lower in YM than PLC (13.3 vs. 15.00, p < 0.001).</td>
    </tr>
    <tr>
      <th>99</th>
      <td>competitive inhibition<br>K m values<br>noncompetitive inhibition</td>
      <td>K m values<br>concentrations of substrates</td>
      <td>Theoretically, the discrimination between competitive and noncompetitive inhibitions is not critical when concentrations of substrates are much lower than their K m values, which is often the case in the clinical setting.</td>
    </tr>
    <tr>
      <th>77</th>
      <td>antibody production<br>platelets<br>cytotoxicity<br>delayed hypersensitivity<br>survival time<br>T cell apoptosis<br>metastasis<br>tumor inhibition effect<br>caspase 3 and 8 expression and activity<br>Bax expression<br>cell cycle arrest<br>appetite<br>caspase 3 activity<br>WBC (CD3+, CD4+ T cells, NK cells)<br>symptomatic relief<br>T cells count (CD4, CD4/CD8)<br>intestinal damage caused by 5-FU<br>phagocytic activity</td>
      <td>CD3+<br>WBC<br>platelets<br>antibody production<br>T cell apoptosis<br>CD4<br>cells count<br>CD8<br>Bax expression<br>CD4+ T cells<br>NK cells<br>caspase 3<br>caspase 3 activity<br>bone marrow cells<br>phagocytic activity</td>
      <td>Reduce T cell apoptosis and caspase 3 activity through downregulating Bax expression in T cells [170] Increase in efficacy and survival [20], better symptomatic relief [20] increase in T cells count (CD4, CD4/CD8) [20] Better symptomatic relief [141] and increase appetite [144] Less reduction in WBC (CD3+, CD4+ T cells, NK cells) [141, 144], platelets [144] Pharmacodynamic interactions between medicinal mushrooms and cytotoxic drugs in preclinical studies Increase in tumor inhibition effect [83, 84, 98] and survival time [63] Less decrease in WBC [83, 84, 145], platelets [83] and other bone marrow cells [84] Greater recovery rate from intestinal damage caused by 5-FU [173] Increase in survival [67], cytotoxicity and inhibit metastasis [111] Reduce immunosuppression (reduce the decrease in phagocytic activity, antibody production [111], delayed hypersensitivity [111, 112]) Increase in tumor inhibition and apoptotic rate (dose-related or time-dependent) [98–103], similar effect at lower dose of 5-FU [105] Induce cell cycle arrest at different phases [99, 101], increase caspase 3 and 8 expression and activity [100].</td>
    </tr>
    <tr>
      <th>63</th>
      <td>metabolism of drugs metabolized by CYP2C9</td>
      <td>CYP2C9</td>
      <td>However, an in vivo study indicated that echinacea did not significantly affect the metabolism of drugs metabolized by CYP2C9 [47].</td>
    </tr>
    <tr>
      <th>21</th>
      <td>CYP2B6<br>CYP2C9<br>CYP1A2</td>
      <td>IC50</td>
      <td>The strongest reversible inhibition was against CYP2C9 (IC50 330 µg/ml), and the least inhibition was against CYP1A2 and CYP2B6 (IC50 > 1000 µg/ml).</td>
    </tr>
    <tr>
      <th>12</th>
      <td>biliary excretion</td>
      <td>Biliary excretion<br>urinary excretion</td>
      <td>Biliary excretion, but not urinary excretion, of methotrexate decreased in the RGE repeated administration group, compared to that in the control group.</td>
    </tr>
    <tr>
      <th>15</th>
      <td>drug disposition<br>transporter function<br>nuclear receptor agonists</td>
      <td>nuclear receptor</td>
      <td>Hepatocytes cultured in this format are responsive to nuclear receptor agonists and maintain important transporter function necessary for proper drug disposition (Yang et al., 2016).</td>
    </tr>
    <tr>
      <th>1</th>
      <td>clinical effect of traditional hypoglycemic herbs</td>
      <td>rs1142345</td>
      <td>Therefore, rs1142345 was associated with the clinical effect of traditional hypoglycemic herbs.</td>
    </tr>
    <tr>
      <th>38</th>
      <td>prothrombin complex activity<br>INR data<br>S-warfarin concentration</td>
      <td>INR<br>prothrombin complex activity (PCA</td>
      <td>In brief, a two-compartment pharmacokinetic model was used to describe S-warfarin concentration–time data and an indirect pharmacodynamic model described the relationship between percentage of prothrombin complex activity (PCA; which was derived from the INR data in this study) and S-warfarin concentration.</td>
    </tr>
    <tr>
      <th>108</th>
      <td>glutathione<br>sGPT<br>TBARS<br>sGOT<br>liver transaminases<br>antioxidant enzymes</td>
      <td>glutathione concomitant<br>TBARS<br>liver transaminases<br>antioxidant enzymes<br>the activity of sGPT and sGOT</td>
      <td>DDB is found to alleviate the oxidative stress status of TAM-intoxicated liver injury in rats, with the study reporting a significant increase in antioxidant enzymes, a significant decrease in the activity of sGPT and sGOT, reduction of glutathione concomitant, and a significant reduction of TBARS and liver transaminases (El-Beshbishy, 2005b).</td>
    </tr>
    <tr>
      <th>61</th>
      <td>major CYP enzymes<br>metabolic drug–drug interactions</td>
      <td>CYP enzymes</td>
      <td>EGb 761® has no relevant effect on the in vivo activity of the major CYP enzymes in humans and therefore has no relevant potential to cause respective metabolic drug–drug interactions.</td>
    </tr>
    <tr>
      <th>86</th>
      <td>BUN levels</td>
      <td>BUN</td>
      <td>Treatment with EJE and EJE + SITA significantly (p < 0.001) reduced the elevated levels of BUN (Fig.</td>
    </tr>
    <tr>
      <th>116</th>
      <td>inter-individual variability<br>ASA<br>AUC +28%</td>
      <td>AUC</td>
      <td>With MTX doses between 7.5 and 15 mg weekly, this effect is moderate (AUC +28% with ASA, less for the others), and there is inter-individual variability.</td>
    </tr>
    <tr>
      <th>68</th>
      <td>volume used to aid swallowing<br>time of administration<br>Siliphos<br>adverse events<br>beverage<br>pill diary</td>
      <td>approximate volume used to aid swallowing</td>
      <td>Each subject received his/her Siliphos in a blister pack and was asked to complete a pill diary documenting the time of administration, beverage, and approximate volume used to aid swallowing, and adverse events, if applicable.</td>
    </tr>
    <tr>
      <th>76</th>
      <td>high lactate production<br>reduced oxidative metabolism</td>
      <td>lactate</td>
      <td>have shown the association between high lactate production and reduced oxidative metabolism [47].</td>
    </tr>
    <tr>
      <th>35</th>
      <td>apparent volume of distribution (V/F)<br>half-life<br>apparent clearance (CL/F)</td>
      <td>CL/F<br>half-life<br>AUC0−∞<br>CL/kel</td>
      <td>The half-life was calculated as ln 2/kel, the apparent clearance (CL/F) as dose/AUC0−∞ and the apparent volume of distribution (V/F) as CL/kel.</td>
    </tr>
    <tr>
      <th>20</th>
      <td>logEC50</td>
      <td>logIC50<br>logEC50</td>
      <td>2 above (substituting logEC50 for logIC50).</td>
    </tr>
    <tr>
      <th>24</th>
      <td>plasma concentrations</td>
      <td>plasma concentrations for these compounds</td>
      <td>Based on the centelloid content of CAW-R61J, we expect similar plasma concentrations for these compounds in our clinical studies using this extract.</td>
    </tr>
    <tr>
      <th>72</th>
      <td>PON influence test</td>
      <td>PON</td>
      <td>The influence test for PON was conducted by the method of Furlong et al.</td>
    </tr>
    <tr>
      <th>117</th>
      <td>blood sugar levels</td>
      <td>blood sugar</td>
      <td>These findings suggest further research in individuals with diabetes is required to determine the effect of the combination of gymnema tea and metformin on blood sugar levels.</td>
    </tr>
    <tr>
      <th>103</th>
      <td>planning to conceive within 30 days of treatment cessation<br>pregnant<br>breastfeeding</td>
      <td>serum human chorionic gonadotropin</td>
      <td>Female volunteers were excluded if they were pregnant (positive test for serum human chorionic gonadotropin at screening or check-in), breastfeeding, or planning to conceive a child within 30 days of treatment cessation.</td>
    </tr>
    <tr>
      <th>104</th>
      <td>Adenosine diphosphate<br>Open in a separate window<br>Arachidonic acid<br>Collagen<br>Mean (95% CI)<br>Platelet aggregation (Ohms)<br>Geometric mean ratio to control (90% CI)</td>
      <td>Platelet aggregation</td>
      <td>Table 3  Platelet aggregation (Ohms) after 2 weeks of echinacea and policosanol pre-treatment (n= 12) \tControl\tPolicosanol treatment\tEchinacea treatment Agonist\tMean (95% CI)\tMean (95% CI)\tGeometric mean ratio to control (90% CI)\tMean (95% CI)\tGeometric mean ratio to control (90% CI) ADP*\t7.8 (5.5, 10.0)\t6.8 (4.9, 8.8)\t0.92 (0.64, 1.30)\t7.5 (4.1, 10.8)\t0.84 (0.59, 1.19) Arachidonic acid\t11.0 (9.6, 12.5)\t11.2 (9.4, 12.9)\t1.00 (0.82, 1.23)\t12.1 (9.3, 15.0)\t1.06 (0.86, 1.30) Collagen\t13.0 (11.5, 14.6)\t14.9 (12.6, 17.2)\t1.13 (0.93, 1.37)\t15.8 (12.2, 19.5)\t1.17 (0.97, 1.42) Open in a separate window *Adenosine diphosphate.</td>
    </tr>
    <tr>
      <th>40</th>
      <td>CL/F<br>CL/Fs<br>fu<br>AUC</td>
      <td>Cmax<br>Cmax, maximum concentration<br>F, bioavailability<br>CL/F, apparent clearance<br>AUC<br>CL, clearance<br>t1/2<br>CL/F<br>tmax, time to Cmax<br>AUC, area under the plasma concentration–time curve<br>tmax</td>
      <td>Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin  tmax (h)\t1.4 (1.1–1.6)\t1.9 (1.1–2.7)\t1.3 (1.1–1.6)\tNA\tNA  Cmax (μg mL−1)\t1.8 (1.7–1.9)\t1.7 (1.5–2.0)\t1.9 (1.5–2.2)\t0.94 (0.67–1.29)\t1.06 (0.77–1.47)  t1/2 (h)\t38.6 (35.7–41.5)\t34.9 (31.0–38.8)\t41.2 (35.1–47.3)\t0.94 (0.79–1.12)\t0.99 (0.83–1.18)  AUC (μg mL−1 h)\t60.3 (54.5–66.1)\t63.0 (57.3–68.8)\t65.5 (55.3–75.6)\t1.04 (0.94–1.67)\t1.06 (0.95–1.19)  CL/F (mL h−1)\t213 (193–232)\t204 (183–224)\t202 (175–229)\t0.89 (0.80–0.99)\t1.05 (0.94–1.17)  Fraction unbound (fu)\t0.010 (0.007–0.013)\t0.010 (0.007–0.014)\t0.011 (0.008–0.014)\t1.00 (0.75–1.25)\t1.12 (0.39–1.84)  \t \t \t \t \t  R-warfarin  tmax (h)\t1.4 (1.1–1.6)\t1.9 (1.1–2.7)\t1.8 (0.7–2.9)\tNA\tNA  Cmax (μg mL−1)\t1.8 (1.7–2.0)\t1.7 (1.5–1.9)\t1.9 (1.5–2.2)\t0.90 (0.67–1.21)\t1.02 (0.8–1.4)  t1/2 (h)\t55.6 (46.2–65.0)\t47.7 (41.5–53.9)\t52.6 (47.4–57.9)\t0.93 (0.80–1.08)\t0.98 (0.84–1.14)  AUC (μg mL−1 h)\t108.7 (90.0–127.3)\t105.8 (91.7–119.9)\t105.0 (96.3–113.7)\t1.0 (0.9–1.1)\t0.99 (0.87–1.13)  CL/F (mL h−1)\t123 (106–140)\t124 (109–139)\t121 (112–131)\t0.87 (0.75–0.99)\t0.96 (0.84–1.11)  Fraction unbound (fu)\t0.006 (0.004–0.007)\t0.005 (0.004–0.007)\t0.006 (0.004–0.007)\t0.95 (0.72–1.18)\t1.04 (0.80–1.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration–time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax.</td>
    </tr>
    <tr>
      <th>115</th>
      <td>CYP susceptibility</td>
      <td>CYP</td>
      <td>They favor CYP, as the patient could be unusually susceptible due to the individual genotype [207].</td>
    </tr>
  </tbody>
</table>
<span class="table_title">False Positives</span>

<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>generated</th>
      <th>gold</th>
      <th>text</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>1492</th>
      <td>relative humidity<br>barometric pressure<br>air temperature</td>
      <td></td>
      <td>All tests were performed at similar laboratory environmental conditions controlling for air temperature, barometric pressure, and relative humidity.</td>
    </tr>
    <tr>
      <th>956</th>
      <td>drug-metabolizing enzymes (DME)<br>drug transporters</td>
      <td></td>
      <td>Inhibition and/or induction of drug-metabolizing enzymes (DME) and or drug transporters mediated by herbs is the most typical mechanism of herb-drug interactions, which in turn alters the pharmacokinetic disposition of the drug [24,25].</td>
    </tr>
    <tr>
      <th>909</th>
      <td>aqueous suspension<br>Korean Pharmaceutical Codex</td>
      <td></td>
      <td>It has been officially listed in the Korean Pharmaceutical Codex for a long time and an aqueous suspension has recently been developed for convenient administration [1].</td>
    </tr>
    <tr>
      <th>618</th>
      <td>menopausal symptoms<br>herb extract complex (RHC)<br>red ginseng<br>safety</td>
      <td></td>
      <td>This study aims to confirm the safety of red ginseng and herb extract complex (RHC), which are used to relieve menopausal symptoms.</td>
    </tr>
    <tr>
      <th>112</th>
      <td>PCR<br>human genomic DNA</td>
      <td></td>
      <td>Briefly, PCR was performed in a final reaction volume of 50 μl, which included 20 μl 2.5 × HotMasterMix (Eppendorf, Westbury, NY, USA), approximately 250 ng of human genomic DNA and the primer pairs (0.25 μM).</td>
    </tr>
    <tr>
      <th>1190</th>
      <td>log P<br>tissue composition<br>K p (tissue‐to‐plasma partition coefficients)</td>
      <td>log P<br>K p (tissue‐to‐plasma partition coefficients)</td>
      <td>Inter‐correlation between tissue composition and log P also had a significant impact on the estimation of K p (tissue‐to‐plasma partition coefficients).</td>
    </tr>
    <tr>
      <th>1660</th>
      <td>pharmacodynamic HDI</td>
      <td></td>
      <td>When these herbs and drugs are used together, pharmacodynamic HDI (either additive/synergistic) may occur.</td>
    </tr>
    <tr>
      <th>1420</th>
      <td>OSA/OS ratio</td>
      <td></td>
      <td>This can further be verified by the lowered OSA/OS ratio in rat urine samples after co-administration with RS (Fig.</td>
    </tr>
    <tr>
      <th>947</th>
      <td>pomegranate<br>grapefruit<br>statins</td>
      <td></td>
      <td>The herbal reaction toward different types of statins is varied so that grapefruit or pomegranate was interacted with only some types of statins, but not with all statin types.</td>
    </tr>
    <tr>
      <th>380</th>
      <td>jejunal segments<br>pre-warmed saline</td>
      <td></td>
      <td>The jejunal segments were then isolated and rinsed using pre-warmed saline.</td>
    </tr>
    <tr>
      <th>319</th>
      <td>TCM formulations</td>
      <td></td>
      <td>Although a lot of experience has been accumulated in the clinical application of digoxin over the years, limited research has been conducted on its possible interactions with TCM formulations.</td>
    </tr>
    <tr>
      <th>755</th>
      <td>clinical pharmacokinetic interactions</td>
      <td></td>
      <td>In spite of this, studies of clinical pharmacokinetic interactions between antiretroviral agents and botanicals are scarce in the literature.</td>
    </tr>
    <tr>
      <th>1261</th>
      <td>endogenous peaks</td>
      <td></td>
      <td>No endogenous peaks were identified in the extracted ion chromatograms that would cause interference with drug quantitation.</td>
    </tr>
    <tr>
      <th>625</th>
      <td>degree and result of the adverse reaction<br>causal relationship with the test substance<br>treatment of adverse reactions<br>date of disappearance<br>date of onset<br>name of the drug other than the test substance</td>
      <td></td>
      <td>During the investigation of adverse reactions, the date of onset and disappearance, the degree and result of the adverse reaction, the measures are taken in relation to the test substance and the causal relationship with the test substance, the name of the drug other than the test substance, and treatment of adverse reactions were included.</td>
    </tr>
    <tr>
      <th>495</th>
      <td>quinine sulphate tablets<br>600 mg</td>
      <td></td>
      <td>In the first phase, after an overnight fast, each subject in the respective groups received a single oral dose of 600 mg quinine sulphate tablets (Maderich Ltd, Surrey, England).</td>
    </tr>
    <tr>
      <th>1178</th>
      <td>physiologically‐based pharmacokinetic (PBPK)<br>herb–drug interactions<br>modelling and simulation<br>drug metabolism</td>
      <td></td>
      <td>Keywords: drug metabolism, herb–drug interactions, modelling and simulation, physiologically‐based pharmacokinetic (PBPK) What is already known about this subject      Physiologically‐based pharmacokinetic (PBPK) modelling approaches combined with in vitro to in vivo extrapolation techniques have been extensively used for predicting clinically meaningful pharmacokinetic drug interactions.</td>
    </tr>
    <tr>
      <th>1393</th>
      <td>symptoms</td>
      <td></td>
      <td>Five days after presentation, her symptoms had completely resolved.</td>
    </tr>
    <tr>
      <th>1361</th>
      <td>warfarin pharmacodynamics<br>pharmacokinetics</td>
      <td></td>
      <td>Interestingly, this effect on the pharmacokinetics of (S)-warfarin was not associated with a significant effect on warfarin pharmacodynamics.</td>
    </tr>
    <tr>
      <th>1029</th>
      <td>tumor recurrence<br>metastasis</td>
      <td></td>
      <td>Some Yunzhi–drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49].</td>
    </tr>
    <tr>
      <th>122</th>
      <td>Antinuclear antibody (ANA)<br>smooth muscle antibody</td>
      <td>Antinuclear antibody (ANA<br>smooth muscle antibody</td>
      <td>Antinuclear antibody (ANA) was 1 : 40 and smooth muscle antibody was modestly elevated at 1 : 80.</td>
    </tr>
    <tr>
      <th>175</th>
      <td>Cytochrome P450 enzymes<br>CYP2C9<br>CYP3A4<br>CYP2C8</td>
      <td></td>
      <td>Cytochrome P450 enzymes, CYP2C8, CYP2C9, and CYP3A4, are important in the metabolism of hypoglycemic drugs, such as thiazolidinediones (TZDs) and sulfonylureas, and hypocholesterolemic drugs, such as atorvastatin.</td>
    </tr>
    <tr>
      <th>727</th>
      <td>phenolic phytochemicals<br>spearmint</td>
      <td></td>
      <td>showed that phenolic phytochemicals of spearmint possessed hypoglycemic, and antioxidant attributes [57].</td>
    </tr>
    <tr>
      <th>1087</th>
      <td>Eng et al.</td>
      <td></td>
      <td>2016; Eng et al.</td>
    </tr>
    <tr>
      <th>752</th>
      <td>Cτ<br>darunavir pharmacokinetic parameters<br>AUCτ</td>
      <td>Cτ<br>AUCτ</td>
      <td>Coadministration of E. purpurea resulted in little change in darunavir pharmacokinetic parameters, with Cτ and AUCτ decreasing by averages of 16% and 10%, respectively.</td>
    </tr>
    <tr>
      <th>1496</th>
      <td>total AUC</td>
      <td>CHO<br>AUC</td>
      <td>However, the total AUC for CHO was lower in YM than PLC (13.3 vs. 15.00, p < 0.001).</td>
    </tr>
    <tr>
      <th>1286</th>
      <td>major human CYP isoenzymes</td>
      <td></td>
      <td>Three of the plants studied did not exhibit inhibitory potential on any of the eight major human CYP isoenzymes used even at the highest dose of the extract, that is, aqueous extracts of Musa sapientum unripe fruits, Tetracarpidium conophorum seeds, and Allium sativum bulbs.</td>
    </tr>
    <tr>
      <th>838</th>
      <td>pharmacokinetic parameters<br>oral bioavailability</td>
      <td>oral bioavailability</td>
      <td>Although honey was shown to decrease the oral bioavailability of CBZ in rabbits, it had no effect on the pharmacokinetic parameters of CBZ in human [63–65].</td>
    </tr>
    <tr>
      <th>1628</th>
      <td>pulverized dried bulbs<br>Allium sativum<br>0.45% allicin</td>
      <td></td>
      <td>The European pharmacopoeia monographs pulverized dried bulbs of Allium sativum containing at least 0.45% allicin [154].</td>
    </tr>
    <tr>
      <th>289</th>
      <td>acetonitrile</td>
      <td></td>
      <td>The highest recovery was obtained using acetonitrile as a protein precipitant.</td>
    </tr>
    <tr>
      <th>976</th>
      <td>average<br>SD</td>
      <td></td>
      <td>All results are presented as the average ± SD.</td>
    </tr>
    <tr>
      <th>444</th>
      <td>CYP2E1<br>CYP2D6<br>CYP3A4<br>CYP1A2</td>
      <td></td>
      <td>Single time-point, phenotypic metabolic ratios were used to determine whether long-term supplementation of St. John’s wort, garlic oil, Panax ginseng, and Ginkgo biloba affected CYP1A2, CYP2D6, CYP2E1, or CYP3A4 activity in elderly subjects.</td>
    </tr>
    <tr>
      <th>431</th>
      <td>drug interactions</td>
      <td></td>
      <td>GGT with five major ingredients also possesses chance of drug interactions when co-administering with other drugs.</td>
    </tr>
    <tr>
      <th>1410</th>
      <td>antiviral activity</td>
      <td></td>
      <td>At 30 min following the 8PM dose on Day 5, the rats were anesthetized and about 10 mL of blood were collected from rats’ inferior vena for determination of antiviral activity.</td>
    </tr>
    <tr>
      <th>736</th>
      <td>volatile compounds</td>
      <td></td>
      <td>Volatile compounds identified in the essential oil of herbal mixture.</td>
    </tr>
    <tr>
      <th>1456</th>
      <td>protective effect</td>
      <td></td>
      <td>The protective effect is dose-dependent (Rahate and Rajasekaran, 2015).</td>
    </tr>
    <tr>
      <th>729</th>
      <td>glucose levels<br>insulin tolerance</td>
      <td></td>
      <td>Polymethoxylated flavones (PMFs) of C. sinensis have hypolipidemic effects, resulting in a significant reduction of insulin tolerance and glucose levels [61].</td>
    </tr>
    <tr>
      <th>1438</th>
      <td>complementary and alternative medicine (CAM) treatment</td>
      <td></td>
      <td>Of all the cancer patients, breast cancer patients, in particular, are more likely to turn to complementary and alternative medicine (CAM) treatment (Wanchai et al., 2010).</td>
    </tr>
    <tr>
      <th>457</th>
      <td>serious adverse events</td>
      <td></td>
      <td>[45] Go to: RESULTS General Experimental Observations  All subjects completed the study and no serious adverse events occurred during the course of the investigation.</td>
    </tr>
    <tr>
      <th>1333</th>
      <td>SD<br>mean</td>
      <td></td>
      <td>Values are expressed as mean (SD).</td>
    </tr>
    <tr>
      <th>99</th>
      <td>pharmacodynamics<br>St John's wort<br>CYP2C9<br>gliclazide<br>genotype<br>pharmacokinetics</td>
      <td></td>
      <td>Keywords: pharmacokinetics, pharmacodynamics, gliclazide, St John's wort, CYP2C9, genotype Go to: Introduction  The incidence of type 2 diabetes is increasing in the community.</td>
    </tr>
    <tr>
      <th>711</th>
      <td>reference value<br>calibration curve<br>standard</td>
      <td></td>
      <td>A 1,1′,3,3′-tetramethoxypropane was used to construct the calibration curve as the standard [32] (reference value: 0.54–1.32 pg/mL).</td>
    </tr>
    <tr>
      <th>20</th>
      <td>medicinal cannabis<br>health risks</td>
      <td></td>
      <td>This case report highlights the complexity associated with medicinal cannabis and the health risks associated with its use.</td>
    </tr>
    <tr>
      <th>146</th>
      <td>42 mg·kg</td>
      <td></td>
      <td>Group one was administered 42 mg·kg Data are presented as mean ± standard deviation (SD).</td>
    </tr>
    <tr>
      <th>275</th>
      <td>total protein</td>
      <td></td>
      <td>Briefly, total protein was obtained by homogenizing 100 mg of liver samples with equal volume of a tissue lysis buffer.</td>
    </tr>
    <tr>
      <th>385</th>
      <td>mass transition from Q1 to Q3<br>ionization mode</td>
      <td></td>
      <td>The ionization mode and mass transition from Q1 to Q3 were selected based on the product ion scan results of authentic standards and previously published reports (Figure 1).</td>
    </tr>
    <tr>
      <th>1626</th>
      <td>cannabis preparations</td>
      <td></td>
      <td>Cannabis preparations are emerging as a promising option for co-treatment of inflammatory diseases.</td>
    </tr>
    <tr>
      <th>270</th>
      <td>rheumatoid arthritis symptoms</td>
      <td></td>
      <td>In particular, the beneficial effects of red ginseng products for reducing the symptoms of rheumatoid arthritis have been proven in animals and humans [24,25,26,27,36].</td>
    </tr>
    <tr>
      <th>1569</th>
      <td>manic psychosis</td>
      <td></td>
      <td>Chronic use of ginseng on its own has been associated with manic psychosis [90].</td>
    </tr>
    <tr>
      <th>1475</th>
      <td>gradient elution program</td>
      <td></td>
      <td>The gradient elution program was as follows: 0–8.5 min, 97% A; 8.7–11 min, 60% A; 11.5–13.5 min, 10% A; 14–15 min, 97% A.</td>
    </tr>
    <tr>
      <th>633</th>
      <td>p-value</td>
      <td></td>
      <td>p-value by Fisher's exact test.</td>
    </tr>
    <tr>
      <th>964</th>
      <td>DAS (25 mg/kg)<br>Group I<br>Group II</td>
      <td></td>
      <td>Group I and II were orally administered with normal saline for 7 days and Group II was orally administered DAS (25 mg/kg) on the 7th day.</td>
    </tr>
    <tr>
      <th>434</th>
      <td>1000 mg<br>AAP dose<br>maximum dose<br>8 tablets</td>
      <td></td>
      <td>To mimic the recommended dose based on the status of patients, AAP dose is suggested from 1000 mg to the maximum dose of 1000 mg × 4 times (8 tablets) per day for treatment of the common cold [22,23].</td>
    </tr>
    <tr>
      <th>1700</th>
      <td>abemaciclib-related diarrhea</td>
      <td></td>
      <td>These may favor the occurrence of abemaciclib-related diarrhea, causing dose reductions and poor adherence and eventually negatively influencing patients' outcomes and quality of life.</td>
    </tr>
    <tr>
      <th>1303</th>
      <td>sexual dysfunction<br>cognitive declines<br>mood disorders<br>weight gain<br>night sweats<br>hot flashes<br>sleep disturbances</td>
      <td></td>
      <td>2020; 81:XXX–XXX) Transition to menopause is associated with a period of increased risk for problematic symptoms, including hot flashes, night sweats, sleep disturbances, sexual dysfunction, mood disorders, weight gain, and cognitive declines.</td>
    </tr>
    <tr>
      <th>1453</th>
      <td>Jaeumkanghwa soup<br>12 traditional herbs</td>
      <td></td>
      <td>Jaeumkanghwa soup (JEKHT) is a compound composed of 12 traditional herbs (Jung et al., 2010).</td>
    </tr>
    <tr>
      <th>637</th>
      <td>severe adverse reactions</td>
      <td></td>
      <td>It is noteworthy that no severe adverse reactions were observed in this study.</td>
    </tr>
    <tr>
      <th>413</th>
      <td>CYP2B6</td>
      <td></td>
      <td>Genetic polymorphism in CYP2B6 have been implicated in variations in the activity of the enzyme in metabolizing xenobiotics [26].</td>
    </tr>
    <tr>
      <th>1497</th>
      <td>exercise time<br>Total Energy Expenditure (TEE)<br>treatment (YM vs. PLC)</td>
      <td>Total Energy Expenditure (TEE)</td>
      <td>Total Energy Expenditure (TEE) was neither significantly affected by the treatment (YM vs. PLC) nor the exercise time (Figure 3).</td>
    </tr>
    <tr>
      <th>1464</th>
      <td>GBD Diseases and Injuries, 2020<br>lead causes of death and disability<br>WHO’s Global Health Estimates 2000–2019<br>Communicable diseases</td>
      <td></td>
      <td>Communicable diseases are still leading causes of death and disability globally, according to WHO’s Global Health Estimates 2000–2019 (GBD Diseases and Injuries, 2020).</td>
    </tr>
    <tr>
      <th>873</th>
      <td>p-values</td>
      <td></td>
      <td>** and *** denoted result significantly different from that of the control group (p < 0.01 and p < 0.001, respectively).</td>
    </tr>
    <tr>
      <th>153</th>
      <td>pharmacodynamic interactions<br>pharmacokinetic interactions</td>
      <td></td>
      <td>However, drug interactions can be divided into pharmacokinetic interactions and pharmacodynamic interactions.</td>
    </tr>
    <tr>
      <th>579</th>
      <td>two drugs</td>
      <td></td>
      <td>The results were not presented in detail but indicated that the two drugs act independently from each other.</td>
    </tr>
    <tr>
      <th>306</th>
      <td>heart rhythm<br>QRS interval prolongation<br>digoxin-induced arrhythmias<br>cardiovascular system<br>ventricular tachycardia<br>ventricular precontraction<br>vascular dilation<br>blood pressure<br>ventricular fibrillation<br>flavane polymers<br>flavonoid glycoside</td>
      <td>blood pressure<br>heart rhythm</td>
      <td>used the duration of QRS interval prolongation, ventricular precontraction, ventricular tachycardia, and ventricular fibrillation as markers of arrhythmia to study the effects of C. pinnatifida Bunge (Shanzha) extract on digoxin-induced arrhythmias, and the results showed that the ventricular arrhythmias in the digoxin-induced experimental group of rats all decreased after the administration of C. pinnatifida Bunge (Shanzha) extract, indicating that the flavonoid glycoside and flavane polymers in C. pinnatifida Bunge (Shanzha) extract can antagonize digoxin-induced arrhythmias (Li and Huang, 2016), which may be related to their ability to dilate blood vessels, lower blood pressure, slow down the heart rhythm, and improve the cardiovascular system (Zhang et al., 2021).</td>
    </tr>
    <tr>
      <th>1632</th>
      <td>bleeding risk<br>anticoagulant<br>platelet inhibiting co-medication</td>
      <td></td>
      <td>Based on cases of severe bleeding events associated with ginkgo [169,170], the plant has been suspected to increase bleeding risk of patients with anticoagulant or platelet inhibiting co-medication.</td>
    </tr>
    <tr>
      <th>433</th>
      <td>GGT</td>
      <td></td>
      <td>Therefore, we applied this dose of GGT in our study.</td>
    </tr>
    <tr>
      <th>1102</th>
      <td>filtrate</td>
      <td></td>
      <td>After seven days, the extract was filtered and the filtrate was stored in refrigerator until next processing.</td>
    </tr>
    <tr>
      <th>1127</th>
      <td>4–5 h<br>0–1 h<br>3–4 h<br>6–7 h<br>1–2 h<br>5–6 h<br>2–3 h</td>
      <td></td>
      <td>The bile was collected during 0–1 h, 1–2 h, 2–3 h, 3–4 h, 4–5 h, 5–6 h and 6–7 h after dosing.</td>
    </tr>
    <tr>
      <th>1096</th>
      <td>efficacy<br>safety</td>
      <td></td>
      <td>The present work was carried out to check the safety and efficacy of one of the probable concomitant treatments that a diabetic patient is likely to undertake during the course of his treatment.</td>
    </tr>
    <tr>
      <th>52</th>
      <td>therapeutic indices</td>
      <td></td>
      <td>An important fact is that most of these affected drugs have very narrow therapeutic indices.</td>
    </tr>
    <tr>
      <th>972</th>
      <td>APG–DAS interaction</td>
      <td></td>
      <td>Further thorough in vivo studies of the APG–DAS interaction in humans are warranted to support these findings.</td>
    </tr>
    <tr>
      <th>214</th>
      <td>plasma</td>
      <td></td>
      <td>Subsequently, plasma was separated and stored at −20°C until analysis.</td>
    </tr>
    <tr>
      <th>1514</th>
      <td>psychomotor effects<br>mood state<br>satiety</td>
      <td></td>
      <td>Favorable psychomotor effects on mood state and satiety are often expected outcomes of fat and weight-loss supplementation protocols.</td>
    </tr>
    <tr>
      <th>659</th>
      <td>OATP<br>RGE<br>Oatp<br>ginsenosides</td>
      <td></td>
      <td>The results suggest that valsartan could be used as a model drug for investigating OATP (in human) or Oatp (in rats)-mediated herb–drug interaction between valsartan and RGE or ginsenosides.</td>
    </tr>
    <tr>
      <th>1277</th>
      <td>freeze‐dried</td>
      <td></td>
      <td>Each mixture was filtered, concentrated, and freeze‐dried.</td>
    </tr>
    <tr>
      <th>1298</th>
      <td>CYP2C19<br>CYP3A4<br>CYP1A2</td>
      <td>IC</td>
      <td>Gongronema latifolium and Alstonia boonei may produce in vivo inhibitory activity on CYP1A2, CYP2C19 and CYP3A4 since the converted in vitro IC One of the problems of studying herb–drug interactions is the difficulty in identifying or quantifying the inhibiting components of the complex mixtures of phytochemicals in the herb.</td>
    </tr>
    <tr>
      <th>1321</th>
      <td>planning to conceive within 30 days of treatment cessation<br>pregnant<br>breastfeeding</td>
      <td>serum human chorionic gonadotropin</td>
      <td>Female volunteers were excluded if they were pregnant (positive test for serum human chorionic gonadotropin at screening or check-in), breastfeeding, or planning to conceive a child within 30 days of treatment cessation.</td>
    </tr>
    <tr>
      <th>1084</th>
      <td>formic acid</td>
      <td></td>
      <td>The reaction was then stopped by adding formic acid [17].</td>
    </tr>
    <tr>
      <th>363</th>
      <td>chronic kidney disease<br>hypertension</td>
      <td></td>
      <td>Based on these clinical outcomes, fimasartan can be recommended for patients with hypertension and chronic kidney disease [4,14].</td>
    </tr>
    <tr>
      <th>1589</th>
      <td>narrow therapeutic window</td>
      <td></td>
      <td>This is especially important for drugs with a narrow therapeutic window.</td>
    </tr>
    <tr>
      <th>1582</th>
      <td>oral administration</td>
      <td></td>
      <td>This is important because the vast majority of herbal products are orally administered.</td>
    </tr>
    <tr>
      <th>1007</th>
      <td>hyperforin<br>OATP2B1</td>
      <td></td>
      <td>For OATP2B1, we have recently shown that this transporter is not only inhibited by hyperforin but also transports this constituent of SJW (Schäfer, Bock, & Meyer Zu Schwabedissen, 2018), thus influencing the intracellular transactivation of PXR by hyperforin (Schäfer et al., 2019).</td>
    </tr>
    <tr>
      <th>881</th>
      <td>omeprazole<br>aryl hydrocarbon receptor (AhR)<br>Samento</td>
      <td></td>
      <td>To demonstrate possible influences on aryl hydrocarbon receptor (AhR), another important transcription factor regulating e.g., CYP1A, we also tested whether Samento can activate AhR and found only a minor effect compared to the positive control omeprazole (Figure 4B).</td>
    </tr>
    <tr>
      <th>783</th>
      <td>data extraction<br>study selection</td>
      <td></td>
      <td>The study selection and data extraction used standard eligibility inclusion criteria as determined by two reviewers.</td>
    </tr>
    <tr>
      <th>106</th>
      <td>7α<br>6β<br>7β<br>6α</td>
      <td></td>
      <td>Four of these metabolites (6α, 6β, 7α and 7β positions) have been identified in urine, which represented 1, 20, 6 and 14% of urinary recovered dose 96 h after dose, respectively (Oida et al., 1985).</td>
    </tr>
    <tr>
      <th>81</th>
      <td>vacuum degasser<br>serial dilutions<br>binary pump<br>column oven<br>ESI probe<br>Micromass Xevo tandem quadrupole mass spectrometric detector<br>regeneration system<br>autosampler<br>NADP Phytofingerprinting<br>UPLC system<br>Acquity BEH C18 column</td>
      <td></td>
      <td>Briefly, serial dilutions of the extracts were added to a mixture of regeneration system, NADP Phytofingerprinting was performed on the extracts using a Waters Acquity UPLC system (Waters Corporation, Milford, MA, USA) with an Acquity BEH C18 column (2.1 mm × 100 mm, 1.7 µm particle size) incorporating a binary pump, vacuum degasser, autosampler, column oven, and Micromass Xevo tandem quadrupole mass spectrometric detector (QTOF xevo G2; Waters micromass, Manchester, UK) equipped with ESI probe.</td>
    </tr>
    <tr>
      <th>1210</th>
      <td>thin layer chromatography<br>morphological authentication<br>Chinese Pharmacopoeia 2005</td>
      <td></td>
      <td>The raw herbs were morphologically authenticated by an in-house herbalist and chemically by the thin layer chromatography in accordance with the Chinese Pharmacopoeia 2005 [36].</td>
    </tr>
    <tr>
      <th>1563</th>
      <td>subtherapeutic serum levels<br>seizure<br>toxicological autopsy</td>
      <td></td>
      <td>He was reported to have experienced a seizure before his death, and the toxicological autopsy results revealed subtherapeutic serum levels for both drugs.</td>
    </tr>
    <tr>
      <th>1615</th>
      <td>species used<br>geographical area of this review</td>
      <td></td>
      <td>Most surveys on complementary and alternative therapy or supplement use by those patients did not ask for the species used [4,19,29] or were conducted outside of the geographical area of this review [30,31,32], or both [33,34].</td>
    </tr>
    <tr>
      <th>262</th>
      <td>plasma concentrations of ginsenosides</td>
      <td></td>
      <td>After RGE was orally administered to rats at single or multiple doses for 1 or 2 weeks, the plasma concentrations of ginsenosides were also monitored.</td>
    </tr>
    <tr>
      <th>207</th>
      <td>statistically significant</td>
      <td></td>
      <td>This result was statistically not significant.</td>
    </tr>
    <tr>
      <th>1701</th>
      <td>fatigue<br>loose stools</td>
      <td></td>
      <td>Moreover, the reckless pieces of information about possible effects of diet, such as fatigue and loose stools, elicited confusion in the patient.</td>
    </tr>
    <tr>
      <th>539</th>
      <td>whole blood<br>normal saline<br>incubation</td>
      <td></td>
      <td>Briefly, whole blood (0.5 mL) was diluted twofold with freshly prepared normal saline and incubated at 37 °C for at least 6 min.</td>
    </tr>
    <tr>
      <th>288</th>
      <td>half-life</td>
      <td></td>
      <td>The half-life (t Experimental values are expressed as mean ± SD.</td>
    </tr>
    <tr>
      <th>1624</th>
      <td>liver injury</td>
      <td></td>
      <td>Another patient experienced liver injury after taking 500 mg leaf powder every 2–3 days as a laxative [117].</td>
    </tr>
    <tr>
      <th>1035</th>
      <td>lipid peroxide levels<br>cytotoxic and tumor-infiltrating lymphocytes<br>superoxide dismutase (SOD)<br>suppressor T cells</td>
      <td>lipid peroxide levels<br>superoxide dismutase (SOD)<br>suppressor T cells</td>
      <td>Yunzhi could also enhance the cytotoxicity of anticancer drugs via other mechanisms, such as direct increase in the activity of cytotoxic and tumor-infiltrating lymphocytes, decrease in the activity of suppressor T cells [38, 70], and decrease and increase in superoxide dismutase (SOD) and lipid peroxide levels, respectively, in cancer cells [131].</td>
    </tr>
    <tr>
      <th>1198</th>
      <td>MBI</td>
      <td></td>
      <td>MBI, mechanism‐based inhibition Go to: 4.</td>
    </tr>
    <tr>
      <th>580</th>
      <td>pharmacodynamic interaction</td>
      <td></td>
      <td>A possible pharmacodynamic interaction of valerian preparations with other drugs is supported only by two case reports.</td>
    </tr>
    <tr>
      <th>144</th>
      <td>puerarin<br>rat tissue homogenate</td>
      <td></td>
      <td>Thereafter, 50 μL of the IS solution (puerarin, 20 ng/mL in methanol) and 50 μL of 2% formic acid were added to 100 μL of the rat tissue homogenate.</td>
    </tr>
    <tr>
      <th>598</th>
      <td>radiological abnormalities<br>LVEF</td>
      <td>LVEF</td>
      <td>After venlafaxine discontinuation, there was rapid improvement, with regression of the radiological abnormalities and normalization of the LVEF.</td>
    </tr>
    <tr>
      <th>1594</th>
      <td>author contributions</td>
      <td></td>
      <td>Author contributions: MK drafted the initial and final versions of the manuscript.</td>
    </tr>
    <tr>
      <th>373</th>
      <td>6 °C<br>post-preparative stability<br>QC samples<br>autosampler</td>
      <td></td>
      <td>Post-preparative stability was evaluated by comparing the extracted QC samples maintained in the autosampler at 6 °C for 24 h (compared with the untreated QC samples).</td>
    </tr>
    <tr>
      <th>1208</th>
      <td>VKOR<br>TM</td>
      <td></td>
      <td>We also monitored the effects of Danshen/Gegen on the activities and mRNA and protein expression levels of VKOR and TM (for pharmacodynamic analysis).</td>
    </tr>
    <tr>
      <th>344</th>
      <td>dmd.120.090860f1</td>
      <td></td>
      <td>Object name is dmd.120.090860f1.jpg Fig.</td>
    </tr>
    <tr>
      <th>114</th>
      <td>grapefruit<br>caffeine-containing beverages</td>
      <td></td>
      <td>All participants were asked not to drink caffeine-containing beverages and to refrain from grapefruit from the day before until 2 days after taking gliclazide.</td>
    </tr>
    <tr>
      <th>273</th>
      <td>Mrp2 regulation changes</td>
      <td></td>
      <td>Therefore, in conclusion, this study showed that the herb–drug interactions between red ginseng and MTX occurred via Mrp2 regulation changes in rats, but clinical significance thereof should be determined with follow-up studies.</td>
    </tr>
    <tr>
      <th>260</th>
      <td>systemic exposure</td>
      <td></td>
      <td>Surprisingly, the coadministration of GTC reduced the systemic exposure of digoxin in this study.</td>
    </tr>
    <tr>
      <th>571</th>
      <td>500 mg valerian extract</td>
      <td></td>
      <td>Daily before going to bed, participants took two tablets, with 500 mg valerian extract each (extraction solvent ethanol 70%, valerenic acid content 5.51 mg/tablet), for 14 subsequent days.</td>
    </tr>
    <tr>
      <th>263</th>
      <td>biliary excretion<br>Mrp2 substrate drug</td>
      <td></td>
      <td>Next, we investigated the effects of RGE on the biliary excretion of Mrp2 substrate drug in rats.</td>
    </tr>
    <tr>
      <th>859</th>
      <td>traditional use in diabetes management<br>pharmacological evidence</td>
      <td></td>
      <td>For all of the 12 identified plants, pharmacological evidence validating their traditional use in diabetes management have been published.</td>
    </tr>
    <tr>
      <th>1573</th>
      <td>circulation<br>diabetes<br>diarrhea<br>concentration<br>alertness<br>libido</td>
      <td></td>
      <td>Kratom is also used as complementary medicine to manage diabetes, diarrhea, improve circulation, enhance alertness and concentration, and increase libido [111-114].</td>
    </tr>
    <tr>
      <th>542</th>
      <td>factor activity<br>clotting time</td>
      <td>clotting time</td>
      <td>Percentage factor activity for each sample was obtained from a standard curve constructed using different dilutions of standard human plasma of known factor activity and clotting time.</td>
    </tr>
    <tr>
      <th>803</th>
      <td>blood pressure<br>pulse<br>oxygen saturation</td>
      <td>Vital signs (blood pressure, pulse, oxygen saturation)</td>
      <td>Vital signs (blood pressure, pulse, oxygen saturation) were obtained on every study day.</td>
    </tr>
    <tr>
      <th>610</th>
      <td>renais<br>sedimento urinário<br>hepáticos<br>proteínas do complemento</td>
      <td></td>
      <td>Os parâmetros renais e hepáticos, as proteínas do complemento e o sedimento urinário estavam todos normais.</td>
    </tr>
    <tr>
      <th>2</th>
      <td>rhabdomyolysis<br>alternative herbal medicine<br>trabectedin<br>heavy toxicity</td>
      <td></td>
      <td>We describe here the unexpected onset of heavy toxicity including rhabdomyolysis after the fourth course of trabectedin in a patient with retroperitoneal liposarcoma who at the same time was taking an alternative herbal medicine suspected of triggering this adverse event.</td>
    </tr>
    <tr>
      <th>639</th>
      <td>UGT1A1-mediated 4-MU glucuronidation<br>UGT2B7-catalyzed 4-MU glucuronidation</td>
      <td></td>
      <td>Furthermore, inhibition kinetic study (Dixon plot and Lineweaver-Burk plot) demonstrated that celastrol noncompetitively inhibited the UGT1A1-mediated 4-MU glucuronidation, and competitively inhibited UGT2B7-catalyzed 4-MU glucuronidation.</td>
    </tr>
    <tr>
      <th>1639</th>
      <td>water<br>green tea</td>
      <td></td>
      <td>applied atorvastatin in rats after 3 weeks of drinking green tea or water.</td>
    </tr>
    <tr>
      <th>6</th>
      <td>complete margin negative (R0) resection<br>abdominal mass</td>
      <td></td>
      <td>In May 2009 he underwent surgical removal of the abdominal mass achieving a complete margin negative (R0) resection.</td>
    </tr>
    <tr>
      <th>933</th>
      <td>CYP2B6 genotyping</td>
      <td></td>
      <td>CYP2B6 genotyping  CYP2B6 genotyping was performed by pyrosequencing of polymerase chain reaction (PCR) products as described previously [13].</td>
    </tr>
    <tr>
      <th>1239</th>
      <td>genetic factors<br>physical factors<br>predictive models<br>warfarin dose</td>
      <td></td>
      <td>Algorithms that integrate the relevant genetic and physical factors into comprehensive, individualized predictive models were used to predict warfarin dose [54].</td>
    </tr>
    <tr>
      <th>597</th>
      <td>serotonin-norepinephrine reuptake inhibitor</td>
      <td></td>
      <td>Venlafaxine is a serotonin-norepinephrine reuptake inhibitor used as an antidepressant.</td>
    </tr>
    <tr>
      <th>128</th>
      <td>clinicopathological features</td>
      <td></td>
      <td>The clinicopathological features of Case 1 are illustrated in Tables 1, 2, and 3.</td>
    </tr>
    <tr>
      <th>1474</th>
      <td>ATP-binding cassette transporters</td>
      <td></td>
      <td>CIP is a known substrate of the ATP-binding cassette transporters, which have been implicated in its intestinal secretion, biliary excretion and secretion into breast milk (Vance-Bryan et al., 1990; Merino et al., 2006; Ando et al., 2007; Mulgaonkar et al., 2012).</td>
    </tr>
    <tr>
      <th>1631</th>
      <td>ginkgolic acid content</td>
      <td></td>
      <td>For the refined quantified dry extract, the ginkgolic acid content is limited to 5 ppm [154].</td>
    </tr>
    <tr>
      <th>1104</th>
      <td>3a<br>3b</td>
      <td></td>
      <td>3a and b).</td>
    </tr>
    <tr>
      <th>1248</th>
      <td>discrepancies observed between the in vitro and in vivo results</td>
      <td></td>
      <td>All of these factors could therefore be considered as potential explanations for the discrepancies observed between the in vitro and in vivo results.</td>
    </tr>
    <tr>
      <th>1604</th>
      <td>AUC data<br>herb-drug interaction</td>
      <td>AUC</td>
      <td>The AUC data showed statistically significant differences between group 1 and 2 and between groups 2 and 3 possibly suggest the herb-drug interaction between Epimedium sagittatum extract and sildenafil.</td>
    </tr>
    <tr>
      <th>160</th>
      <td>Penicillin-streptomycin<br>Sodium Pyruvate<br>Minimal Essential Medium (MEM)<br>Hanks balanced salt solution (HBSS)<br>HEPES<br>Trypsin EDTA<br>Dulbecco’s Modified Eagle Medium (DMEM)</td>
      <td></td>
      <td>Dulbecco’s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA).</td>
    </tr>
    <tr>
      <th>599</th>
      <td>drug-induced cardiopulmonary toxicity</td>
      <td></td>
      <td>This was an important case of drug-induced cardiopulmonary toxicity.</td>
    </tr>
    <tr>
      <th>73</th>
      <td>metabolites<br>K A</td>
      <td></td>
      <td>Linear regression analysis of the time course was used to determine the K A non-targeted approach was used in order to provide information about all possible metabolites present in the analysed samples.</td>
    </tr>
    <tr>
      <th>650</th>
      <td>anti-diabetic<br>anti-inflammatory<br>anti-oxidative</td>
      <td></td>
      <td>The therapeutic benefits of ginseng include anti-diabetic and anti-inflammatory effect and anti-oxidative response on chronic liver disease [3,4,5,6,7,8].</td>
    </tr>
    <tr>
      <th>1487</th>
      <td>tissue distribution profiles<br>tissue to plasma distribution coefficients</td>
      <td></td>
      <td>CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively.</td>
    </tr>
    <tr>
      <th>1014</th>
      <td>dosage differences</td>
      <td></td>
      <td>If the control group also received medicinal mushrooms, there should be significant dosage differences of the mushrooms in the treatment group.</td>
    </tr>
    <tr>
      <th>400</th>
      <td>CV<br>mean</td>
      <td></td>
      <td>Data represented as mean and CV from five or six independent experiments.</td>
    </tr>
    <tr>
      <th>1439</th>
      <td>Phellodendron bark<br>Anemarrhena</td>
      <td></td>
      <td>), dried orange peel (Citrus aurantium L.), Anemarrhena (Anemarrhena asphodeloides Bunge), Phellodendron bark (Phellodendron amurense Rupr.</td>
    </tr>
    <tr>
      <th>631</th>
      <td>characteristics<br>demographic information</td>
      <td></td>
      <td>The examination of demographic information and characteristics before consumption showed no statistically significant difference between the intake groups.</td>
    </tr>
    <tr>
      <th>1584</th>
      <td>P-gp<br>CYP3A4</td>
      <td></td>
      <td>CYP3A4 and P-gp are richly expressed in the human small intestinal enterocytes.</td>
    </tr>
    <tr>
      <th>531</th>
      <td>age groups</td>
      <td></td>
      <td>'s study,[25] which reported that the trend was more prevalent among middle-aged (50–64) patients compared to other age groups.</td>
    </tr>
    <tr>
      <th>462</th>
      <td>CYP2E1 responsivity<br>allyl sulfide content</td>
      <td></td>
      <td>[42] The difference in extent of inhibition between the two age groups hints at either an age-related diminution in CYP2E1 responsivity or a dissimilarity in allyl sulfide content between the garlic supplements.</td>
    </tr>
    <tr>
      <th>339</th>
      <td>IC50 values<br>four-parameter sigmoid (Hill) model<br>concentration-response<br>percentage control value</td>
      <td>the concentration-response (percentage control value)<br>the IC50 values</td>
      <td>To determine the IC50 values, the concentration-response (percentage control value) curves were fitted to a four-parameter sigmoid (Hill) model, according to eq.</td>
    </tr>
    <tr>
      <th>1033</th>
      <td>gut dysbiosis<br>Warburg-related proteins</td>
      <td></td>
      <td>Notably, a recent study found that such synergistic effect may be due to the inhibition of tumor metabolism via down-regulating Warburg-related proteins and restoration of the gut dysbiosis induced by paclitaxel [97].</td>
    </tr>
    <tr>
      <th>1432</th>
      <td>Radix Isatidis</td>
      <td></td>
      <td>Radix Isatidis (Root of Isatis indigotica Fort., Banlangen).</td>
    </tr>
    <tr>
      <th>758</th>
      <td>E. purpurea</td>
      <td></td>
      <td>We found, however, that E. purpurea was well tolerated, with no evident safety issue of concern.</td>
    </tr>
    <tr>
      <th>790</th>
      <td>PD interactions of warfarin with herbal medicines</td>
      <td></td>
      <td>All included studies investigated the PD interactions of warfarin with herbal medicines, but different parameters were used in each study.</td>
    </tr>
    <tr>
      <th>1596</th>
      <td>immunosuppressive drugs</td>
      <td></td>
      <td>Therapeutic drug monitoring is required as with other immunosuppressive drugs.</td>
    </tr>
    <tr>
      <th>138</th>
      <td>black cohosh hepatotoxicity</td>
      <td></td>
      <td>Similarities and differences among current case studies and published cases of black cohosh hepatotoxicity.</td>
    </tr>
    <tr>
      <th>845</th>
      <td>dizziness<br>nausea<br>skin rash<br>CBZ-related side effects<br>blurred vision</td>
      <td></td>
      <td>In a randomized double-blinded control trial, Xiao-yao-san increased the incidence of CBZ-related side effects including dizziness, blurred vision, skin rash, and nausea in patients with major depression or bipolar disorder.</td>
    </tr>
    <tr>
      <th>1396</th>
      <td>antihistamines<br>rash</td>
      <td></td>
      <td>In our patient, the rash was refractory to glucocorticoids and only resolved once her exposure to the extract ceased, although antihistamines were helpful to reduce pruritis.</td>
    </tr>
    <tr>
      <th>1092</th>
      <td>herb-drug interaction</td>
      <td></td>
      <td>The results suggest that the herb-drug interaction between GLT and AC might occur when they were co-administered.</td>
    </tr>
    <tr>
      <th>69</th>
      <td>cytochrome P450</td>
      <td></td>
      <td>The cytochrome P450 (CYP450) family of enzymes especially plays an important role in the biotransformation of about 70% of xenobiotics and other endogenous substances [14].</td>
    </tr>
    <tr>
      <th>884</th>
      <td>drug metabolizing enzymes<br>drug transporters</td>
      <td></td>
      <td>This study, therefore, scrutinized in vitro whether Samento and Banderol can inhibit the activity or induce the expression of important drug metabolizing enzymes and drug transporters.</td>
    </tr>
    <tr>
      <th>208</th>
      <td>pharmacokinetics of docetaxel</td>
      <td></td>
      <td>The commercially available E. purpurea extract did not significantly alter the pharmacokinetics of docetaxel.</td>
    </tr>
    <tr>
      <th>1017</th>
      <td>antibody production<br>platelets<br>cytotoxicity<br>delayed hypersensitivity<br>survival time<br>T cell apoptosis<br>metastasis<br>tumor inhibition effect<br>caspase 3 and 8 expression and activity<br>Bax expression<br>cell cycle arrest<br>appetite<br>caspase 3 activity<br>WBC (CD3+, CD4+ T cells, NK cells)<br>symptomatic relief<br>T cells count (CD4, CD4/CD8)<br>intestinal damage caused by 5-FU<br>phagocytic activity</td>
      <td>CD3+<br>WBC<br>platelets<br>antibody production<br>T cell apoptosis<br>CD4<br>cells count<br>CD8<br>Bax expression<br>CD4+ T cells<br>NK cells<br>caspase 3<br>caspase 3 activity<br>bone marrow cells<br>phagocytic activity</td>
      <td>Reduce T cell apoptosis and caspase 3 activity through downregulating Bax expression in T cells [170] Increase in efficacy and survival [20], better symptomatic relief [20] increase in T cells count (CD4, CD4/CD8) [20] Better symptomatic relief [141] and increase appetite [144] Less reduction in WBC (CD3+, CD4+ T cells, NK cells) [141, 144], platelets [144] Pharmacodynamic interactions between medicinal mushrooms and cytotoxic drugs in preclinical studies Increase in tumor inhibition effect [83, 84, 98] and survival time [63] Less decrease in WBC [83, 84, 145], platelets [83] and other bone marrow cells [84] Greater recovery rate from intestinal damage caused by 5-FU [173] Increase in survival [67], cytotoxicity and inhibit metastasis [111] Reduce immunosuppression (reduce the decrease in phagocytic activity, antibody production [111], delayed hypersensitivity [111, 112]) Increase in tumor inhibition and apoptotic rate (dose-related or time-dependent) [98–103], similar effect at lower dose of 5-FU [105] Induce cell cycle arrest at different phases [99, 101], increase caspase 3 and 8 expression and activity [100].</td>
    </tr>
    <tr>
      <th>350</th>
      <td>CYP3A4<br>CYP2C19<br>CYP2D6<br>human liver microsomes<br>CYP2C9<br>centelloids<br>human P450 forms</td>
      <td>CYP2C19, CYP3A4, CYP2D6, and CYP2C9<br>P450</td>
      <td>Purified centelloids are weak inhibitors in human liver microsomes and human P450 forms expressed by E. coli of CYP2C19, CYP3A4, CYP2D6, and CYP2C9.</td>
    </tr>
    <tr>
      <th>1684</th>
      <td>USP reference standard</td>
      <td></td>
      <td>The internal standards codeine and betaxolol were of USP reference standard.</td>
    </tr>
    <tr>
      <th>428</th>
      <td>solid residue<br>supernatant<br>purified water</td>
      <td></td>
      <td>The material was allowed to extract for 72 h at room temperature during which supernatant was decanted every 24 h and the solid residue reconstituted in the same volume of purified water for the extraction process to be repeated.</td>
    </tr>
    <tr>
      <th>861</th>
      <td>substrates<br>modulators<br>pharmacokinetic parameters<br>drug interactions</td>
      <td></td>
      <td>An analysis of the drugs commonly prescribed to patients with diabetes show that most of these are substrates or modulators of known pharmacokinetic parameters commonly implicated in drug interactions.</td>
    </tr>
    <tr>
      <th>117</th>
      <td>CL/Fs<br>tolbutamide<br>CYP2C9*3 allele<br>glipizide</td>
      <td>CL/Fs</td>
      <td>By contrast, for carriers of the CYP2C9*3 allele, the CL/Fs of glipizide (Kidd et al., 1999) and tolbutamide (Kirchheiner et al., 2002a) were significantly different from wild-type subjects, with ratios of 0.18 and 0.58, respectively.</td>
    </tr>
    <tr>
      <th>1094</th>
      <td>bioactive constituents<br>dipeptidyl peptidase-4 (DDP-4)</td>
      <td></td>
      <td>(EJ) are considered to be functional foods owing to their anti-diabetic Several research groups studying the protective and therapeutic effect of EJE and have identified presence of various classes of bioactive constituents like anthocyanins, flavonoids Gliptins are a class of oral anti-diabetic agents which act by competitively antagonizing the enzyme dipeptidyl peptidase-4 (DDP-4).</td>
    </tr>
    <tr>
      <th>871</th>
      <td>HDI</td>
      <td></td>
      <td>The present work provides an insight into the mechanism exploration governing HDI between aspirin and PNS.</td>
    </tr>
    <tr>
      <th>1284</th>
      <td>concentration of aqueous extract of herb<br>50% inhibitory concentration</td>
      <td>Fifty percent inhibitory concentration</td>
      <td>Fifty percent inhibitory concentration (IC   where A = log of concentration of aqueous extract of herb in the incubations.</td>
    </tr>
    <tr>
      <th>1635</th>
      <td>thrombin inhibition</td>
      <td></td>
      <td>There are in vitro experiments confirming thrombin inhibition [172].</td>
    </tr>
    <tr>
      <th>1570</th>
      <td>kavalactones</td>
      <td></td>
      <td>The pharmacological activities of kava have been attributed to kavalactones, which are concentrated in the rhizomes [96].</td>
    </tr>
    <tr>
      <th>978</th>
      <td>cytochrome P-450 activity</td>
      <td></td>
      <td>Phytochemical-mediated modulation of cytochrome P-450 (CYP) activity may underlie many herb-drug interactions.</td>
    </tr>
    <tr>
      <th>855</th>
      <td>age group</td>
      <td></td>
      <td>This is possibly because the highest number of patients with type-2 diabetes fell within that age group.</td>
    </tr>
    <tr>
      <th>523</th>
      <td>age group<br>male/female ratio</td>
      <td></td>
      <td>Regarding CAM nonusers, the majority were in the age group of 20–60 years with the male/female ratio of 73/27 percent.</td>
    </tr>
    <tr>
      <th>209</th>
      <td>alkylamides<br>caffeic acid derivatives</td>
      <td></td>
      <td>Of these components, caffeic acid derivatives and the more bioavailable alkylamides are found in ethanolic liquid extracts for medicinal use [8].</td>
    </tr>
    <tr>
      <th>1199</th>
      <td>CYP3A inhibition</td>
      <td></td>
      <td>by carbamazepine and phenytoin, 72 the predominant outcome from a chronic exposure to Schisandra lignans is a CYP3A inhibition and not induction.</td>
    </tr>
    <tr>
      <th>1450</th>
      <td>Mistletoe (Viscum album L.) derived medicinal preparations</td>
      <td></td>
      <td>Mistletoe (Viscum album L.) derived medicinal preparations are widely used and registered as medicines in many European countries.</td>
    </tr>
    <tr>
      <th>12</th>
      <td>ancillary medications<br>combinations in oncology practice<br>narrow therapeutic index<br>chemotherapeutic drugs<br>prolonged life expectancy</td>
      <td></td>
      <td>As known, cancer patients are likely to experience drug interactions due to the increased number and types of chemotherapeutic drugs, their combinations in oncology practice and their narrow therapeutic index, the achievement of a prolonged life expectancy, and the common use of a broad range of ancillary medications to prevent and/or treat cancer-related syndromes and treatment-induced toxicity [8].</td>
    </tr>
    <tr>
      <th>1428</th>
      <td>hydrolase activities<br>hydrolysis enzymes</td>
      <td></td>
      <td>The hydrolase activities in rat plasma may be originated from more than one kind of enzymes (not only hCE1) and the inhibition activities of these herbal components to each kind of hydrolysis enzymes are different.</td>
    </tr>
    <tr>
      <th>697</th>
      <td>SOD<br>GPx<br>CAT<br>MDA</td>
      <td>glutathione peroxidase (GPx)<br>catalase (CAT)<br>superoxide dismutase (SOD)<br>malondialdehyde (MDA)</td>
      <td>Oxidative stress is dramatically increased in PCOS patients, when oxidant/antioxidant status is measured by circulating serum markers, including catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) [3].</td>
    </tr>
    <tr>
      <th>1447</th>
      <td>anti-proliferative effect<br>cell apoptosis</td>
      <td></td>
      <td>A recent study has shown that the combined use of HES, PIP, and BV with TAM showed an enhanced anti-proliferative effect on MCF7 and T47D and can significantly increase cell apoptosis (Khamis et al., 2018).</td>
    </tr>
    <tr>
      <th>305</th>
      <td>Li Xin</td>
      <td></td>
      <td>Li Xin et al.</td>
    </tr>
    <tr>
      <th>292</th>
      <td>concentration range</td>
      <td></td>
      <td>Linearity for AC was obtained over the concentration range of 1–500 ng/mL.</td>
    </tr>
    <tr>
      <th>63</th>
      <td>conventional therapeutic drugs<br>herbal remedies</td>
      <td></td>
      <td>With the boom in conventional therapeutic drugs, the utilization of herbal remedies sometimes in combination with other medications has increased tremendously over the last decade [1,2].</td>
    </tr>
    <tr>
      <th>254</th>
      <td>pharmacokinetics parameters<br>EC<br>ECG<br>EGC<br>AUC<br>EGCG<br>concentration–time profiles</td>
      <td>AUC</td>
      <td>Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration–time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3.</td>
    </tr>
    <tr>
      <th>615</th>
      <td>hígida<br>paciente<br>35 anos de idade</td>
      <td></td>
      <td>O caso ocorreu em uma paciente previamente hígida de 35 anos de idade que foi submetida a investigação exaustiva após a exclusão de outras possíveis causas.</td>
    </tr>
    <tr>
      <th>1668</th>
      <td>conventional antidiabetics<br>Lycium</td>
      <td></td>
      <td>Findings such as these suggest that Lycium may have an additive effect when used in combination with conventional antidiabetics [86].</td>
    </tr>
    <tr>
      <th>1347</th>
      <td>echinacea<br>policosanol</td>
      <td></td>
      <td>Therefore, two commonly used herbal medicines, echinacea and policosanol were investigated for their potential to interact with warfarin.</td>
    </tr>
    <tr>
      <th>167</th>
      <td>reversible inhibition<br>FBS<br>non-essential amino acids<br>MDCK-II cells<br>DMEM</td>
      <td></td>
      <td>Radio labeled digoxin [ Parental and transfected MDCK-II cells were grown in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 1%  The assay for reversible inhibition was conducted in a total volume of 200 μL in 96-well microplates.</td>
    </tr>
    <tr>
      <th>140</th>
      <td>LVFX<br>Relinqing® granule<br>Polygonum capitatum</td>
      <td></td>
      <td>For patients with urinary system infection, Relinqing® granule from Polygonum capitatum is usually combined with LVFX.</td>
    </tr>
    <tr>
      <th>297</th>
      <td>digoxin plasma concentration</td>
      <td></td>
      <td>Endogenous digoxin substances are present in neonates and patients with renal dysfunction, and these substances may lead to elevated or false-positive digoxin plasma concentration monitoring results.</td>
    </tr>
    <tr>
      <th>646</th>
      <td>clofibric acid<br>valproic acid</td>
      <td></td>
      <td>Additionally, it can metabolize many drugs including clofibric acid and valproic acid [25].</td>
    </tr>
    <tr>
      <th>1553</th>
      <td>bioactive components<br>CYP450 family<br>DMEs</td>
      <td></td>
      <td>Phytoestrogens and other bioactive components of celery can interact with the DMEs, including those in the CYP450 family.</td>
    </tr>
    <tr>
      <th>1688</th>
      <td>DEX metabolites<br>Scheffe’s multiple comparison test<br>Asafetida<br>one-way analysis of variance (ANOVA)<br>P value</td>
      <td></td>
      <td>The in vitro formation of DEX metabolites in the presence of Asafetida was compared with the control by using a one-way analysis of variance (ANOVA), and a Post hoc Scheffe’s multiple comparison test with a significant P value ⩽0.05.</td>
    </tr>
    <tr>
      <th>781</th>
      <td>participants</td>
      <td></td>
      <td>Type of participant.</td>
    </tr>
    <tr>
      <th>1009</th>
      <td>clinically relevant interactions</td>
      <td></td>
      <td>This statement was provided even before another comprehensive pharmacokinetic interaction study was published, where no clinically relevant interactions were found for seven test drugs in concomitant application with a low‐hyperforin SJW extract (Zahner et al., 2019).</td>
    </tr>
    <tr>
      <th>896</th>
      <td>HEK-OATP1B1 and HEK-OATP1B3 cell lines<br>P388 and P388/dx cells<br>AZ-AhR cells<br>MDCKII-BCRP cells</td>
      <td></td>
      <td>Thanks to J. Kocher, S. Rosenzweig, C. Mueller, A. Fautsch, and T. Rützert for excellent technical assistance, to D. Ballinari (Pharmacia & Upjohn, Milano, Italy) for providing P388 and P388/dx cells, to A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for providing MDCKII-BCRP cells, to D. Keppler (German Cancer Research Centre, Heidelberg, Germany) for providing HEK-OATP1B1 and HEK-OATP1B3 cell lines, to Z. Dvorak (Palycký University, Olomouc, Czech Republic) for providing the AZ-AhR cells, and to D. Theile for careful proofreading of the manuscript.</td>
    </tr>
    <tr>
      <th>465</th>
      <td>platelet activating factor</td>
      <td></td>
      <td>This interaction appears attributable to the inhibition of platelet activating factor by various ginkgolides.</td>
    </tr>
    <tr>
      <th>706</th>
      <td>antioxidants<br>SOD<br>CAT<br>MDA</td>
      <td>SOD<br>CAT<br>MDA</td>
      <td>Moreover, hesperidin in C. sinensis increases the levels of antioxidants including SOD and CAT, and decreases the MDA level [19].</td>
    </tr>
    <tr>
      <th>777</th>
      <td>pharmacodynamic (PD) parameters<br>pharmacokinetic (PK) parameters</td>
      <td>pharmacokinetic (PK)-pharmacodynamic (PD) parameters</td>
      <td>The aim of this study was to systematically review data regarding pharmacokinetic (PK)-pharmacodynamic (PD) parameters from randomized controlled trials relating to interactions between herbal medicines and warfarin.</td>
    </tr>
    <tr>
      <th>1070</th>
      <td>pharmacokinetic interactions</td>
      <td></td>
      <td>To our knowledge, there is no available information regarding pharmacokinetic interactions between captopril and H. sabdariffa.</td>
    </tr>
    <tr>
      <th>1048</th>
      <td>complementary and alternative (CAM) treatment options</td>
      <td></td>
      <td>Women diagnosed with breast cancer frequently seek complementary and alternative (CAM) treatment options that can help to cope with their disease and the side effects of conventional cancer therapy.</td>
    </tr>
    <tr>
      <th>1110</th>
      <td>SEM<br>mean</td>
      <td></td>
      <td>Values expressed as mean ± SEM of six rats.</td>
    </tr>
    <tr>
      <th>1171</th>
      <td>RCT<br>study design</td>
      <td></td>
      <td>More specifically, most studies did not make clear the type of RCT being conducted and in many cases there were study design problems.</td>
    </tr>
    <tr>
      <th>358</th>
      <td>IC50 values<br>CAW-R61J compounds</td>
      <td>in vivo concentration<br>IC50</td>
      <td>Ultimately, the clinical relevance of the weak P450 inhibition seen in this study will depend on the IC50 values of the as yet unknown inhibitory CAW-R61J compounds and their in vivo concentration achieved in humans.</td>
    </tr>
    <tr>
      <th>471</th>
      <td>ginseng-mediated induction<br>CYP2C9</td>
      <td></td>
      <td>[62] CYP2C9 is the principal isoform involved in the biotransformation of warfarin (more particularly the active enantiomer, S-warfarin) and the aforementioned reports hint strongly at a ginseng-mediated induction of this enzyme.</td>
    </tr>
    <tr>
      <th>1148</th>
      <td>warfarin<br>INR<br>1.7–2.5<br>1.875 mg</td>
      <td>INR<br>monitoring</td>
      <td>The patient was compliant regarding the attendance of appointments and in taking the medication, and maintained a therapeutic INR (1.7–2.5) on a maintenance daily dose of 1.875 mg warfarin with monthly INR monitoring.</td>
    </tr>
    <tr>
      <th>989</th>
      <td>plasma samples</td>
      <td></td>
      <td>Plasma samples were obtained by centrifugation and stored at −80 °C.</td>
    </tr>
    <tr>
      <th>830</th>
      <td>herbal products<br>coadministered substances<br>food<br>pharmacokinetic properties<br>drugs</td>
      <td></td>
      <td>Despite its clinical popularity, CBZ possesses several pharmacokinetic properties which make it prone to interaction with coadministered substances, including drugs, herbal products, and food [7].</td>
    </tr>
    <tr>
      <th>1441</th>
      <td>Lilyturf<br>Ginger<br>Licorice</td>
      <td></td>
      <td>), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)</td>
    </tr>
    <tr>
      <th>1609</th>
      <td>Bilia and Céu Costas review</td>
      <td></td>
      <td>A more detailed description of the regulatory environment in Europe, as well as its practical effects, can be found in the Bilia and Céu Costas review [13].</td>
    </tr>
    <tr>
      <th>1654</th>
      <td>jurisdictional claims<br>institutional affiliations</td>
      <td></td>
      <td>Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</td>
    </tr>
    <tr>
      <th>1337</th>
      <td>herbal medicines<br>bioavailability<br>herbal formulations</td>
      <td>bioavailability</td>
      <td>Herb-drug interactions incidence was predicted to increase due to herbal medicines' worldwide popularity with the development of several herbal formulations with improved bioavailability.</td>
    </tr>
    <tr>
      <th>1613</th>
      <td>species</td>
      <td></td>
      <td>From the combined literature, a list of the most frequently occurring species was established.</td>
    </tr>
    <tr>
      <th>820</th>
      <td>conjugative metabolism</td>
      <td></td>
      <td>Design of drug molecules to avoid oxidative metabolism continues to emphasize the importance of conjugative metabolism in drug development.</td>
    </tr>
    <tr>
      <th>299</th>
      <td>Chuanxiong<br>Carica papaya<br>Tapinanthus sessilifolius<br>Ginkgo biloba L.<br>Biantaobanjiuju<br>P-gP</td>
      <td></td>
      <td>In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides “Chuanxiong” (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing).</td>
    </tr>
    <tr>
      <th>756</th>
      <td>darunavir pharmacokinetics<br>CYP3A4 inductive/inhibitory potential</td>
      <td></td>
      <td>The variability in the effect of echinacea on darunavir pharmacokinetics we observed in this cohort may imply some degree of uncertainty in the CYP3A4 inductive/inhibitory potential of this herbal remedy.</td>
    </tr>
    <tr>
      <th>1085</th>
      <td>expression of the PEPT1 transporter<br>GSH level</td>
      <td></td>
      <td>Two weeks of coadministration of H. sabdariffa extract is sufficient enough to affect the GSH level or the expression of the PEPT1 transporter.</td>
    </tr>
    <tr>
      <th>348</th>
      <td>dmd.120.090860f3</td>
      <td></td>
      <td>Object name is dmd.120.090860f3.jpg Fig.</td>
    </tr>
    <tr>
      <th>230</th>
      <td>tumour progression</td>
      <td></td>
      <td>Considering the risk of tumour progression, randomization was not in the interest of patients with advanced cancer.</td>
    </tr>
    <tr>
      <th>211</th>
      <td>NCI CTCAE, version 3.0<br>grade 3 and 4 toxicities<br>docetaxel</td>
      <td></td>
      <td>The secondary objective was to assess the effect of E. purpurea supplementation on safety parameters, such as grade 3 and 4 toxicities induced by docetaxel [according to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE, version 3.0)].</td>
    </tr>
    <tr>
      <th>466</th>
      <td>G. biloba<br>herb-drug interactions<br>CYP isoforms</td>
      <td></td>
      <td>[18] Taken together these findings indicate that herb-drug interactions attributable to G. biloba are not the result of phytochemical-mediated effects on CYP isoforms.</td>
    </tr>
    <tr>
      <th>1614</th>
      <td>prevalence</td>
      <td></td>
      <td>They found a prevalence of 56.6%.</td>
    </tr>
    <tr>
      <th>1581</th>
      <td>CYP3A4</td>
      <td></td>
      <td>investigated the ability of SJW to interact with CYP3A4 in a 2-way, open-label crossover study of 21 healthy subjects using midazolam as the probe substrate.</td>
    </tr>
    <tr>
      <th>1145</th>
      <td>pharmacokinetics</td>
      <td></td>
      <td>Therefore, the protective effect of A. officinarum on indomethacin-induced gastric injury might also be through the changes of pharmacokinetics for indomethacin and its metabolites to exert.</td>
    </tr>
    <tr>
      <th>1595</th>
      <td>immunosuppressive drug</td>
      <td></td>
      <td>Sirolimus is an immunosuppressive drug used to prevent graft rejection.</td>
    </tr>
    <tr>
      <th>1627</th>
      <td>possible beneficial effects</td>
      <td></td>
      <td>This is debated, and there are hints to possible beneficial effects [135].</td>
    </tr>
    <tr>
      <th>197</th>
      <td>10 mg/mL<br>Stock solutions</td>
      <td></td>
      <td>Stock solutions (10 mg/mL) were prepared by diluting the extracts and compounds in distilled water.</td>
    </tr>
    <tr>
      <th>1425</th>
      <td>hydrolysis of OS<br>herbal extracts<br>herbal components</td>
      <td></td>
      <td>The metabolic inhibition studies performed in rat plasma suggested that all the herbal extracts (500 μg/mL) and all the herbal components (100 μg/mL) could inhibit the hydrolysis of OS in rat plasma, but the % inhibition rate varied between herbs/herbal components.</td>
    </tr>
    <tr>
      <th>826</th>
      <td>Traditional Chinese medicine<br>other herbs/botanicals<br>food<br>dietary supplements</td>
      <td></td>
      <td>Traditional Chinese medicine accounted for most of the interactions (n = 17), followed by food (n = 10), dietary supplements (n = 3), and other herbs/botanicals (n = 3).</td>
    </tr>
    <tr>
      <th>742</th>
      <td>clinical interview<br>HIV-1 RNA load<br>chemistry<br>CD4+ T-cell count<br>physical examination<br>blood counts</td>
      <td>blood counts<br>CD4+ T-cell count</td>
      <td>Safety was evaluated by clinical interview and physical examination and by laboratory assessment (blood counts, chemistry, CD4+ T-cell count, and HIV-1 RNA load) on days 0, 14, and 28.</td>
    </tr>
    <tr>
      <th>1173</th>
      <td>kidney function<br>hepatotoxicity<br>liver function</td>
      <td></td>
      <td>Studies demonstrate that HS consumption does not adversely effect liver and kidney function at lower doses, but may be hepatotoxic at extremely high doses.</td>
    </tr>
    <tr>
      <th>139</th>
      <td>third-generation fluoroquinolone antibiotic family</td>
      <td></td>
      <td>Levofloxacin (LVFX) is used to treat numerous bacterial infections belonging to the third-generation fluoroquinolone antibiotic family [8].</td>
    </tr>
    <tr>
      <th>980</th>
      <td>botanical supplements</td>
      <td></td>
      <td>Concomitant ingestion of botanical supplements with prescription medications, therefore, should be strongly discouraged in the elderly.</td>
    </tr>
    <tr>
      <th>1529</th>
      <td>water<br>food</td>
      <td></td>
      <td>Food and water were supplied ad libitum.</td>
    </tr>
    <tr>
      <th>1685</th>
      <td>HPLC grade solvents<br>General-purpose reagents</td>
      <td></td>
      <td>General-purpose reagents (GPR) were used for extraction processes, while HPLC grade solvents were used for HPLC determinations.</td>
    </tr>
    <tr>
      <th>324</th>
      <td>systemic levels of the victim drug</td>
      <td></td>
      <td>Metabolic drug interactions normally occur between two or more drugs such that the addition of the perpetrator drug alters the systemic levels of the victim drug (Lin and Lu, 1998; Bohnert et al., 2016).</td>
    </tr>
    <tr>
      <th>663</th>
      <td>herb–drug interactions involving valsartan</td>
      <td></td>
      <td>The results revealed that the repeated administration of RGE and high dose of Rc did not significantly induce herb–drug interactions involving valsartan (Figure 5 and Figure 8).</td>
    </tr>
    <tr>
      <th>872</th>
      <td>conceived and designed the whole experiments</td>
      <td></td>
      <td>conceived and designed the whole experiments.</td>
    </tr>
    <tr>
      <th>738</th>
      <td>Spain<br>Arkopharma<br>V05895B<br>Madrid</td>
      <td></td>
      <td>V05895B; Arkopharma, Madrid, Spain).</td>
    </tr>
    <tr>
      <th>1636</th>
      <td>tea consumption<br>HILI</td>
      <td></td>
      <td>A scientific opinion of EFSA [196] from 2018 states that the common food consumption is safe, as there are only few cases of HILI associated with tea consumption despite the widespread use.</td>
    </tr>
    <tr>
      <th>1031</th>
      <td>tumor cell angiogenesis<br>reactive oxygen species production</td>
      <td></td>
      <td>In addition, the enhancement of the antitumor effect was shown to be achieved via the inhibition of tumor cell angiogenesis [104] or increase in the reactive oxygen species production [124].</td>
    </tr>
    <tr>
      <th>1398</th>
      <td>selected single herbs<br>OS<br>Wen Bing formulas</td>
      <td></td>
      <td>To explore more, we would like to investigate the interactions between OS and selected single herbs from these Wen Bing formulas.</td>
    </tr>
    <tr>
      <th>252</th>
      <td>adverse events</td>
      <td></td>
      <td>Sixteen subjects reported 27 adverse events.</td>
    </tr>
    <tr>
      <th>819</th>
      <td>interaction potential</td>
      <td></td>
      <td>Alternate study designs, including silibinin predosing and multiple dosing of raloxifene, could provide further insight into interaction potential.</td>
    </tr>
    <tr>
      <th>277</th>
      <td>red ginseng extract</td>
      <td></td>
      <td>Sample Availability: Red ginseng extract are available from the authors.</td>
    </tr>
    <tr>
      <th>1229</th>
      <td>microcirculation<br>VKOR<br>platelet aggregation<br>TM</td>
      <td></td>
      <td>Danshen and Gegen elicit their effects by improving microcirculation and inhibiting platelet aggregation [24, 32], whereas warfarin exerts its anticoagulant effect by inhibiting the activity of VKOR and inducing TM.</td>
    </tr>
    <tr>
      <th>132</th>
      <td>vasomotor symptoms of menopause</td>
      <td></td>
      <td>The American College of Obstetrics and Gynecology included black cohosh as a possible remedy for the vasomotor symptoms of menopause [15].</td>
    </tr>
    <tr>
      <th>391</th>
      <td>QC sample<br>inter-day accuracy<br>standard curve sample<br>intra-day accuracy<br>Guideline of Bioanalytical method validation</td>
      <td></td>
      <td>Owing to slight variations in the analytical process (e.g., changes in recovery during preparation of a biological sample and variability in the performance of the analytical instrument), there may be cases where the response of a QC sample is higher than that of a standard curve sample, but the inter- and intra-day accuracy in Table 2 were within the acceptance criteria for accuracy (i.e., 85~115%) according to the Guideline of Bioanalytical method validation from FDA, EMA, and ICH [37].</td>
    </tr>
    <tr>
      <th>581</th>
      <td>MAO-inhibitory properties<br>opioids<br>delirium</td>
      <td></td>
      <td>Given that none of these herbal medicines has been proven to have MAO-inhibitory properties, while induction of delirium, and a positive drug screening on opioids was reported, the assumption of an involvement of the valerian preparation does not seem to be plausible.</td>
    </tr>
    <tr>
      <th>278</th>
      <td>ginsenosides</td>
      <td></td>
      <td>Contents of ginsenosides in RGE.</td>
    </tr>
    <tr>
      <th>638</th>
      <td>safety of RHC intake</td>
      <td></td>
      <td>However, further research is needed on the safety of RHC intake for a long period in large-scale menopausal subjects.</td>
    </tr>
    <tr>
      <th>1278</th>
      <td>HPLC‐grade acetonitrile<br>Acetic acid</td>
      <td></td>
      <td>Acetic acid and HPLC‐grade acetonitrile were purchased from Merck (LiChrosolv GG, Darmstadt, Germany).</td>
    </tr>
    <tr>
      <th>769</th>
      <td>bioequivalence approach<br>phenotyping metrics<br>adjusted margins</td>
      <td></td>
      <td>Evaluation of phenotyping metrics followed the standard bioequivalence approach, with adjusted margins.</td>
    </tr>
    <tr>
      <th>903</th>
      <td>t = 0<br>β2mg<br>RT-PCR<br>CYP2J2 mRNA</td>
      <td></td>
      <td>Expression of CYP2J2 mRNA was quantified by RT-PCR and results normalized to β2mg and to t = 0.</td>
    </tr>
    <tr>
      <th>565</th>
      <td>valeriana<br>valerian</td>
      <td></td>
      <td>A search with the search terms (valerian or valeriana) was conducted in the databases MEDLINE and TOXLIT, via DIMDI (Cologne, Germany).</td>
    </tr>
    <tr>
      <th>1170</th>
      <td>antioxidant activity</td>
      <td></td>
      <td>The HS varieties with deeper red calyxes exhibited greater antioxidant activity as compared to lighter red or white varieties [44, 45].</td>
    </tr>
    <tr>
      <th>879</th>
      <td>CYP3A4 inhibition<br>CYP2C19 inhibition</td>
      <td></td>
      <td>The highest inhibition was demonstrated for CYP3A4 by Samento (around 40% at a concentration of 1%) and Banderol (around 20% at a concentration of 1%) and for CYP2C19 by Banderol (about 20% at a concentration of 1%).</td>
    </tr>
    <tr>
      <th>1066</th>
      <td>quinidine<br>CYP2D6</td>
      <td></td>
      <td>Dextromethorphan in vitro inhibition profiles of CYP2D6 by reference inhibitor: Quinidine (0.1-1-2-5-10-100 μM).</td>
    </tr>
    <tr>
      <th>365</th>
      <td>fimasartan-amide<br>amlodipine<br>hydrochlorothiazide<br>fimasartan</td>
      <td></td>
      <td>Fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide levels in each sample were determined using an Agilent 6470 Triple Quadrupole LC-MS/MS system (Agilent, Wilmington, DE, USA).</td>
    </tr>
    <tr>
      <th>1693</th>
      <td>formation of DOR<br>DEX</td>
      <td></td>
      <td>In the in vitro study, Asafetida resin alcoholic extract inhibited the formation of DOR from DEX in a concentration dependent manner (Fig.</td>
    </tr>
    <tr>
      <th>994</th>
      <td>resting lactate level</td>
      <td>lactate level</td>
      <td>Resting lactate level was measured at baseline and after 12 weeks, and results are presented in Figure 2.</td>
    </tr>
    <tr>
      <th>1644</th>
      <td>inter-individual variability<br>ASA<br>AUC +28%</td>
      <td>AUC</td>
      <td>With MTX doses between 7.5 and 15 mg weekly, this effect is moderate (AUC +28% with ASA, less for the others), and there is inter-individual variability.</td>
    </tr>
    <tr>
      <th>1062</th>
      <td>long-term outcomes in breast cancer<br>CYP2D6 metabolic activity</td>
      <td></td>
      <td>The metabolic activity of CYP2D6 was suggested to be associated with the long-term outcomes in breast cancer, although the studies are inconsistent [35].</td>
    </tr>
    <tr>
      <th>1476</th>
      <td>CIP<br>GA<br>PCA</td>
      <td></td>
      <td>The supernate was utilized for the quantification of GA, PCA, and CIP.</td>
    </tr>
    <tr>
      <th>149</th>
      <td>integrities</td>
      <td></td>
      <td>The diluted samples were analyzed using a calibration curve to derive their integrities, which were within the acceptable limit of ±15%.</td>
    </tr>
    <tr>
      <th>1098</th>
      <td>aqueous extract<br>dried seed<br>double maceration technique<br>Eugenia jambolana</td>
      <td></td>
      <td>Dried seed of Eugenia jambolana were powdered and used for preparation of aqueous extract by using the double maceration technique.</td>
    </tr>
    <tr>
      <th>337</th>
      <td>IC50 values<br>P450 enzyme activity<br>NADPH</td>
      <td>Potential TDI of P450 enzyme activity<br>NADPH<br>IC50</td>
      <td>Potential TDI of P450 enzyme activity by CAW-R61J was determined using the shift in IC50 values between 30-minute preincubations in the presence and absence of NADPH.</td>
    </tr>
    <tr>
      <th>1078</th>
      <td>precision<br>within-run accuracy</td>
      <td></td>
      <td>The within-run accuracy and precision of captopril analysis ranged from 1.56% to 14.38% (Table 3).</td>
    </tr>
    <tr>
      <th>221</th>
      <td>total amount of extract</td>
      <td></td>
      <td>Our commercial product was only labelled to contain 95% aerial parts and 5% roots of E. purpurea, and no information was provided about the total amount of extract used.</td>
    </tr>
    <tr>
      <th>1311</th>
      <td>immunologic disease<br>endocrine disease<br>hematologic disease<br>renal disease<br>cardiovascular disease<br>pulmonary disease<br>gastrointestinal disease<br>neurologic disease/disorder<br>hepatic disease<br>dermatologic disease</td>
      <td></td>
      <td>Volunteers were excluded if they had any clinically significant history or presence of a cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, or neurologic disease/disorder.</td>
    </tr>
    <tr>
      <th>890</th>
      <td>Banderol<br>Samento</td>
      <td></td>
      <td>Therefore, Samento and Banderol were tested up to a dilution of 1% in the induction assay.</td>
    </tr>
    <tr>
      <th>1184</th>
      <td>cooling block<br>NADPH</td>
      <td>NADPH</td>
      <td>The reaction was initiated by the addition of NADPH and terminated by placing the tubes on a cooling block (Selleckchem, Houston, TX, USA).</td>
    </tr>
    <tr>
      <th>951</th>
      <td>Pgp/MDR1 protein</td>
      <td></td>
      <td>The APG-pretreated rats showed significant inhibition of the Pgp/MDR1 protein, that is 65.38% and 69.90% inhibition, respectively, as compared to DAS alone (p < 0.05).</td>
    </tr>
    <tr>
      <th>692</th>
      <td>potential for interactions with other drugs<br>efficacy<br>safety</td>
      <td>efficacy and safety</td>
      <td>Therefore, herbal products must be assessed for their efficacy and safety, including their potential for interactions with other drugs [14].</td>
    </tr>
    <tr>
      <th>1010</th>
      <td>data mining<br>pharmacoepidemiology methods<br>bioinformatics</td>
      <td></td>
      <td>Based on the high quality clinical data, pharmacoepidemiology methods and bioinformatics or data mining could be adopt for further identification of clinical meaningful herb-drug interactions in cancer therapies.</td>
    </tr>
    <tr>
      <th>50</th>
      <td>CAM</td>
      <td></td>
      <td>In China, 93.4% of cancer patients reported having used CAM in 2009-2010 [4].</td>
    </tr>
    <tr>
      <th>1044</th>
      <td>accountability<br>work<br>accuracy<br>integrity</td>
      <td></td>
      <td>Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: All.</td>
    </tr>
    <tr>
      <th>603</th>
      <td>myocardial biopsy<br>LBA<br>detection of autoimmune diseases<br>studies of imaging<br>cardiac catheterization</td>
      <td></td>
      <td>Uma investigação ampla foi realizada, incluindo LBA, estudos de imagem, detecção de doenças autoimunes, cateterismo cardíaco direito e biópsia miocárdica.</td>
    </tr>
    <tr>
      <th>1468</th>
      <td>prostatitis<br>pyelonephritis<br>urinary tract infections</td>
      <td></td>
      <td>ex D. Don (P. capitatum), a Chinese herbal plant, is often used alone or in combination with antibacterial agents to treat urinary tract infections, pyelonephritis, and prostatitis in China (Chinese Pharmacopoeia Commission, 2010; Liao et al., 2011).</td>
    </tr>
    <tr>
      <th>634</th>
      <td>hot flash<br>headache<br>pruritus</td>
      <td></td>
      <td>In addition, one subject with pruritus and hot flash and another subject with headache fully recovered after discontinuation of administration in the placebo group.</td>
    </tr>
    <tr>
      <th>502</th>
      <td>quinine<br>3-hydroxyquinine</td>
      <td></td>
      <td>The limit of quantitation was 0.37µg/ml and 0.5µg/ml for quinine and for 3-hydroxyquinine respectively.</td>
    </tr>
    <tr>
      <th>1411</th>
      <td>OS<br>rat plasma</td>
      <td></td>
      <td>The incubation system for rat plasma contains 1 μg/mL of OS and 10% rat plasma since the super-fast reaction rate of 100% rat plasma resulted in no discrimination for nearly all the studied herb/herbal components.</td>
    </tr>
    <tr>
      <th>58</th>
      <td>TPMT gene<br>hypoglycemic effect</td>
      <td>The rs1142345 (A>G) SNP in the thiopurine S-methyltransferase (TPMT) gene</td>
      <td>The rs1142345 (A>G) SNP in the thiopurine S-methyltransferase (TPMT) gene was significantly associated with the hypoglycemic effect of the drug (P = 0.001, FDR P = 0.043).</td>
    </tr>
    <tr>
      <th>1177</th>
      <td>bosutinib systemic exposure</td>
      <td></td>
      <td>Conversely, S. sphenanthera at a clinically‐relevant dose results in a predicted three‐fold increase in bosutinib systemic exposure.</td>
    </tr>
    <tr>
      <th>1310</th>
      <td>ammonium acetate</td>
      <td></td>
      <td>34860-2.5L-R) and ammonium acetate (catalog No.</td>
    </tr>
    <tr>
      <th>1523</th>
      <td>OCT1<br>OAT3<br>OATP1B1<br>OAT1<br>OATP1B3<br>OCT2</td>
      <td>OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters</td>
      <td>[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA).</td>
    </tr>
    <tr>
      <th>231</th>
      <td>CYP3A4-mediated interactions</td>
      <td></td>
      <td>Thus, the risk of CYP3A4-mediated interactions may be product dependent.</td>
    </tr>
    <tr>
      <th>868</th>
      <td>22 compounds</td>
      <td></td>
      <td>A total of 22 compounds were identified or tentatively identified (Figure 1).</td>
    </tr>
    <tr>
      <th>1610</th>
      <td>knowledge of risks<br>knowledge of benefits</td>
      <td></td>
      <td>It most often means that we have less knowledge of benefits, as well as risks.</td>
    </tr>
    <tr>
      <th>1503</th>
      <td>hypocholesterolemic properties<br>quinic acid<br>triterpenic saponins<br>mono-caffeolquinic acids<br>minerals<br>adrengenic effects<br>di-caffeolquinic acids<br>vitamins<br>anti-lipolytic<br>caffeic acid</td>
      <td></td>
      <td>The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5].</td>
    </tr>
    <tr>
      <th>202</th>
      <td>pharmacodynamics<br>safety</td>
      <td></td>
      <td>Statistical analyses were performed using GraphPad Prism This in vitro study indicated that combining nutraceuticals containing rooibos extracts with drugs metabolized by CYP2C8 and CYP3A4 could potentially alter the pharmacodynamics and safety of these drugs.</td>
    </tr>
    <tr>
      <th>814</th>
      <td>herb–drug interactions<br>ADME processes<br>constituents</td>
      <td>ADME processes</td>
      <td>This limitation applies particularly to the prediction of herb–drug interactions, as herbal products are typically mixtures of multiple constituents that can alter ADME processes via multiple mechanisms.</td>
    </tr>
    <tr>
      <th>1499</th>
      <td>24% increase</td>
      <td></td>
      <td>This increase is comparable with 24% increase found during low to moderate exercise intensities determined using an incremental protocol in our previous study [22].</td>
    </tr>
    <tr>
      <th>821</th>
      <td>Curcumin<br>pure powder capsule<br>95%</td>
      <td></td>
      <td>Curcumin commercially available as pure powder capsule (95%) was obtained from Quality Supplements and Vitamins (Fort Lauderdale, FL, USA).</td>
    </tr>
    <tr>
      <th>1015</th>
      <td>database searching<br>literature selection</td>
      <td></td>
      <td>Figure 1 summarizes the process of database searching and literature selection.</td>
    </tr>
    <tr>
      <th>1119</th>
      <td>indomethacin<br>feces<br>metabolites<br>bile</td>
      <td></td>
      <td>A. Officinarum could accelerate the excretions of indomethacin and its three metabolites in the bile and feces of rats in the excretion study.</td>
    </tr>
    <tr>
      <th>556</th>
      <td>complementary medicines<br>herb–drug interaction</td>
      <td></td>
      <td>Current address: Drug Metabolism and Pharmacokinetics, Covance Laboratories Inc., Madison, WI, USA Patients commonly take complementary medicines in conjunction with warfarin yet evidence supporting the safety or the risk of a herb–drug interaction is lacking.</td>
    </tr>
    <tr>
      <th>1236</th>
      <td>CYP enzymes</td>
      <td></td>
      <td>CYP enzymes represent some of the most highly conserved entities among different species, with relatively small differences in the primary amino acid sequences of the CYP enzymes across different species [50, 51].</td>
    </tr>
    <tr>
      <th>865</th>
      <td>herbal medicines</td>
      <td></td>
      <td>Healthcare practitioners who are aware of their patients' use of herbal medicines and its identity can more easily monitor them for any possible interactions using available information, such as that presented in Tables 3, 4.</td>
    </tr>
    <tr>
      <th>900</th>
      <td>pregnane x receptor (PXR) activity</td>
      <td></td>
      <td>(a) Concentration-dependent effect of Samento and the positive control rifampicin (insert) on pregnane x receptor (PXR) activity.</td>
    </tr>
    <tr>
      <th>529</th>
      <td>herbal usage prevalence<br>age range of 50–70 years</td>
      <td></td>
      <td>The majority of the patients identified as herbal users were in the age range of 50–70 years, and herbal usage prevalence was high among this age range.</td>
    </tr>
    <tr>
      <th>8</th>
      <td>lesion size<br>location</td>
      <td></td>
      <td>In spite of chemotherapy, the lesion progressed rapidly reaching 16 × 10 cm and extending into the pre-aortic seat of the retro-peritoneum space.</td>
    </tr>
    <tr>
      <th>844</th>
      <td>beverage containing alcohol</td>
      <td></td>
      <td>Caution should also be paid for beverage containing alcohol.</td>
    </tr>
    <tr>
      <th>1457</th>
      <td>glutathione<br>sGPT<br>TBARS<br>sGOT<br>liver transaminases<br>antioxidant enzymes</td>
      <td>glutathione concomitant<br>TBARS<br>liver transaminases<br>antioxidant enzymes<br>the activity of sGPT and sGOT</td>
      <td>DDB is found to alleviate the oxidative stress status of TAM-intoxicated liver injury in rats, with the study reporting a significant increase in antioxidant enzymes, a significant decrease in the activity of sGPT and sGOT, reduction of glutathione concomitant, and a significant reduction of TBARS and liver transaminases (El-Beshbishy, 2005b).</td>
    </tr>
    <tr>
      <th>1074</th>
      <td>captopril dose<br>p.o.</td>
      <td></td>
      <td>daily for two weeks at morning and a single captopril dose (4.5 mg/200 g BW; p.o.)</td>
    </tr>
    <tr>
      <th>669</th>
      <td>1.5<br>0.67<br>0.33<br>8<br>4<br>24<br>48<br>0.17<br>2</td>
      <td></td>
      <td>Blood samples were collected via the retro-orbital vein at 0.17, 0.33, 0.67, 1.5, 2, 4, 8, 24, and 48 h after valsartan dosing.</td>
    </tr>
    <tr>
      <th>973</th>
      <td>supervision</td>
      <td></td>
      <td>; supervision, K.M.A.</td>
    </tr>
    <tr>
      <th>46</th>
      <td>morphine</td>
      <td></td>
      <td>Given this patient’s genetic results, guidelines, and current pain status, the clinical pharmacist suggested morphine as an alternative, as it does not utilize CYP2D6 for metabolism [34].</td>
    </tr>
    <tr>
      <th>986</th>
      <td>knee joint center<br>femoral epicondyles<br>isokinetic dynamometer</td>
      <td></td>
      <td>The subject’s knee joint center, measured using the femoral epicondyles as a joint center reference, was aligned with the axis of the isokinetic dynamometer.</td>
    </tr>
    <tr>
      <th>10</th>
      <td>co-morbidity<br>other drugs</td>
      <td></td>
      <td>Due to the absence of co-morbidity, the patient had not received any other drugs during treatment with trabectedin.</td>
    </tr>
    <tr>
      <th>1090</th>
      <td>Agilent 1290 series liquid chromatography system</td>
      <td></td>
      <td>The analysis was performed on an Agilent 1290 series liquid chromatography system (Agilent Technologies, Palo Alto, CA, USA).</td>
    </tr>
    <tr>
      <th>1601</th>
      <td>S. D.<br>n<br>mean</td>
      <td></td>
      <td>Data are expressed as mean ± S. D. (n = 6).</td>
    </tr>
    <tr>
      <th>508</th>
      <td>77 additional participants</td>
      <td></td>
      <td>In Stage 2 77 additional participants were randomized to either 1,200 mg S. frutescens or placebo.</td>
    </tr>
    <tr>
      <th>1191</th>
      <td>pharmacokinetic parameters<br>clinically-reported parameter values<br>PBPK model prediction</td>
      <td></td>
      <td>Prediction differences of pharmacokinetic parameters for the three lignans, expressed as the ratio of PBPK model prediction to clinically‐reported parameter values were also evaluated.</td>
    </tr>
    <tr>
      <th>1194</th>
      <td>Schisandra lignans<br>midazolam<br>tacrolimus<br>PBPK models</td>
      <td></td>
      <td>PBPK simulations were also carried out to evaluate the capability of PBPK models of Schisandra lignans in predicting the extent of interactions with midazolam and tacrolimus with trial designs as detailed in Table 3.</td>
    </tr>
    <tr>
      <th>229</th>
      <td>plasma levels of docetaxel</td>
      <td></td>
      <td>For example, the potent P-gp inhibitors R101933 [27, 28] and zosuquidar [29] did not significantly alter plasma levels of docetaxel in cancer patients.</td>
    </tr>
    <tr>
      <th>216</th>
      <td>docetaxel AUC0–∞</td>
      <td>AUC0–∞</td>
      <td>The individual differences in docetaxel AUC0–∞ are depicted in Figure 3.</td>
    </tr>
    <tr>
      <th>1262</th>
      <td>mean of 37 months<br>range 4–113 months</td>
      <td></td>
      <td>The 48 (80%) women who had received adjuvant chemotherapy were a mean of 37 months (range 4–113) from completion of chemotherapy.</td>
    </tr>
    <tr>
      <th>1638</th>
      <td>HILI</td>
      <td></td>
      <td>HILI could occur more frequently in these groups because of the combination of risk factors.</td>
    </tr>
    <tr>
      <th>505</th>
      <td>quinine<br>trace metals<br>flavonoids</td>
      <td>Cmax<br>tmax</td>
      <td>[38]  Although, the exact mechanism responsible for the delayed and decreased absorption of quinine in the presence of G. kola in this current study is not known, it is possible that quinine may have interacted through complex formation with the trace metals or flavonoids usually found in G. kola [6, 11] as evidenced from a significant reduction in the Cmax and tmax of quinine but no significant change in parameters which are indicative of interference with elimination.</td>
    </tr>
    <tr>
      <th>1053</th>
      <td>total mistletoe lectin concentration</td>
      <td></td>
      <td>5 mg (VAEM, host tree Malus domestica, Lot 7054/0, total mistletoe lectin concentration 306 ng/mL), and Iscador Qu spec.</td>
    </tr>
    <tr>
      <th>1625</th>
      <td>product quality</td>
      <td></td>
      <td>There are only food supplements available, with insufficiently defined product quality.</td>
    </tr>
    <tr>
      <th>1237</th>
      <td>catalytic activity<br>catalytic specificity</td>
      <td></td>
      <td>Although these isoforms are expressed in several different species, a high degree of similarity in their gene sequences between rats and human may not automatically result in similar levels of catalytic specificity and activity.</td>
    </tr>
    <tr>
      <th>1091</th>
      <td>Student’s paired t-test</td>
      <td></td>
      <td>Statistical analysis of results obtained from clinical study was performed using Student’s paired t-test.</td>
    </tr>
    <tr>
      <th>1455</th>
      <td>Jiawei Xiaoyao San</td>
      <td></td>
      <td>Jiawei Xiaoyao San (JWXYS) is a very common Chinese herbal formula used by the Chinese for thousands of years (Chen et al., 2014).</td>
    </tr>
    <tr>
      <th>1695</th>
      <td>25 μg/ml concentration</td>
      <td></td>
      <td>The activation was highest at 25 μg/ml concentration.</td>
    </tr>
    <tr>
      <th>1125</th>
      <td>model group<br>M-AOE group</td>
      <td></td>
      <td>And other experiments were divided into 2 groups: model group and M-AOE group, with six rats in each group.</td>
    </tr>
    <tr>
      <th>424</th>
      <td>CYP2B6</td>
      <td></td>
      <td>The study showed that Launaea taraxacifolia Hyptis suaveolens, Boerhavia diffusa and Myrothamnus flabellifolius extracts caused a concentration-dependent inhibition in CYP2B6.</td>
    </tr>
    <tr>
      <th>476</th>
      <td>phenols<br>benxophenones<br>saponins<br>xanthones<br>copper<br>alkaloids<br>aluminum<br>biflavonoid complex<br>metallic ions<br>magnesium<br>calcium<br>kolaviron<br>tannins</td>
      <td></td>
      <td>[4] Studies on phytochemical analysis of G. kola seeds [6–11] reveal benxophenones, xanthones, alkaloids, phenols, tannins and saponins, kolaviron a biflavonoid complex, and metallic ions such as aluminum, magnesium, calcium and copper as major chemical components of G. kola.</td>
    </tr>
    <tr>
      <th>836</th>
      <td>Cochrane Database of Systematic Reviews</td>
      <td></td>
      <td>2012), Cochrane Database of Systematic Reviews (2005–Dec.</td>
    </tr>
    <tr>
      <th>1106</th>
      <td>SITA<br>PRM</td>
      <td></td>
      <td>Mass chromatograms of SITA and PRM (Peak for SITA at 0.642min, PRM at 0.482 min).</td>
    </tr>
    <tr>
      <th>622</th>
      <td>alanine aminotransferase (ALT)<br>Pap smears<br>mammographies<br>creatinine levels<br>aspartate aminotransferase (AST)</td>
      <td>alanine aminotransferase (ALT)<br>cholesterol<br>creatinine<br>aspartate aminotransferase (AST)<br>fasting blood sugar<br>triglyceride</td>
      <td>Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone–related cancers; 4) women with uncontrolled hypertension (160/100 mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180 mg/dL or higher, or cases of starting or changing medication due to diabetes within 3 mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1 yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4 wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4 wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4 wk; 12) women who were administered female hormone formulations within 6 mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10 h) within 3 mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1 mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study.</td>
    </tr>
    <tr>
      <th>1394</th>
      <td>treatment<br>rashes caused by Lomatium</td>
      <td></td>
      <td>The naturopathic literature from which most information about rashes caused by Lomatium is drawn do not indicate a well-studied treatment of the rash aside from supportive care and cessation of Lomatium ingestion.</td>
    </tr>
    <tr>
      <th>414</th>
      <td>soluble extract<br>GI tract<br>bioavailable concentration</td>
      <td>bioavailability<br>bioavailable concentration</td>
      <td>Since the intestinal absorption and plasma concentrations of each test compound are not known, and with the knowledge that herbal extracts have different bioavailability [28], the estimated bioavailable concentration was calculated using the % yield to give the soluble extract available in the GI tract.</td>
    </tr>
    <tr>
      <th>156</th>
      <td>antioxidant<br>anti-inflammatory<br>anticancer<br>anti-osteoporosis</td>
      <td></td>
      <td>Furthermore, the extract and constituents of KF have been shown to possess anticancer, antioxidant, anti-osteoporosis, and anti-inflammatory properties (Nadia et al., 2012; Fathilah et al., 2013).</td>
    </tr>
    <tr>
      <th>284</th>
      <td>supernatant</td>
      <td></td>
      <td>After centrifuging at 3500 rpm for 10 min, the supernatant was obtained and frozen at −40 °C until analysis.</td>
    </tr>
    <tr>
      <th>123</th>
      <td>plasma cell rich interface hepatitis<br>portal tracts<br>periportal hepatocyte apoptosis<br>cholangiolar proliferation<br>chronic hepatitis</td>
      <td>periportal hepatocyte</td>
      <td>At this time, the liver histology demonstrated chronic hepatitis with fibroinflammatory expansion of portal tracts by moderate plasma cell rich interface hepatitis, rare periportal hepatocyte apoptosis, and mild cholangiolar proliferation (Figures 1(a) and 1(b)).</td>
    </tr>
    <tr>
      <th>1381</th>
      <td>Waters Alliance 2690 HPLC<br>Waters LCT Time of Flight Mass Spectrometer<br>High resolution LC-MS</td>
      <td></td>
      <td>High resolution LC-MS was conducted using a Waters LCT Time of Flight Mass Spectrometer (Waters Micromass Ltd., Wilmslow, UK), with a Waters Alliance 2690 HPLC and Mass Lynx V4.1 software using similar HPLC conditions to those described above.</td>
    </tr>
    <tr>
      <th>942</th>
      <td>90% confidence intervals<br>geometric mean ratios</td>
      <td></td>
      <td>Geometric mean ratios (GMRs) with 90% confidence intervals (CIs) were calculated after log transformation of within-subject data.</td>
    </tr>
    <tr>
      <th>1480</th>
      <td>GA<br>PCA<br>PK changes</td>
      <td></td>
      <td>After co-administration of CIP and PCE, the PK changes of GA and PCA are displayed in Figures 3, 4, respectively.</td>
    </tr>
    <tr>
      <th>1556</th>
      <td>Anecdotal evidence<br>clinical decisions<br>consequences of HDIs</td>
      <td></td>
      <td>Anecdotal pieces of evidence like this not only highlight the reality and severity of the consequences of HDIs, they underscore the importance of further studies to guide clinical decisions.</td>
    </tr>
    <tr>
      <th>551</th>
      <td>AUC of S-warfarin</td>
      <td>AUC</td>
      <td>(2007) also investigated the effect of pretreatment with cranberry juice for 5 days on warfarin pharmacokinetics and found no clinically significant change in the AUC of S-warfarin.</td>
    </tr>
    <tr>
      <th>1282</th>
      <td>positive ion mode<br>MRM mode</td>
      <td></td>
      <td>Multiple reaction monitoring (MRM) mode using positive ion mode.</td>
    </tr>
    <tr>
      <th>377</th>
      <td>amlodipine<br>hydrochlorothiazide<br>fimasartan</td>
      <td></td>
      <td>Each rat in the combination group received a mixture of fimasartan (3 mg/kg), amlodipine (5 mg/kg), and hydrochlorothiazide (5 mg/kg) dissolved in saline containing 10% DMSO.</td>
    </tr>
    <tr>
      <th>678</th>
      <td>Rb2<br>PPT<br>PPD<br>Rb1<br>Rd<br>Rc</td>
      <td></td>
      <td>Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE).</td>
    </tr>
    <tr>
      <th>1115</th>
      <td>Table 2</td>
      <td></td>
      <td>9, Table 2).</td>
    </tr>
    <tr>
      <th>1123</th>
      <td>plasma sample preparation<br>tissue homogenates</td>
      <td></td>
      <td>Tissue homogenates were treated by the same method as plasma sample preparation except dilution process.</td>
    </tr>
    <tr>
      <th>886</th>
      <td>drug metabolizing enzymes<br>drug transporters</td>
      <td>bioavailability</td>
      <td>PXR activating drugs (e.g., rifampicin) or herbal preparations (e.g., St. John’s Wort) consequently induce drug metabolizing enzymes, and drug transporters can deteriorate drug efficacy by reducing the bioavailability or increasing the clearance of concomitantly used drugs, being substrates of such enzymes and/or transporters [16,17].</td>
    </tr>
    <tr>
      <th>1371</th>
      <td>5′-methoxydehydropodophyllotoxin<br>deoxydehydropodophyllotoxin<br>cadina-4,10(15)-dien-3-one<br>dehydro-b-peltatin methyl ether<br>4′-demethyldesoxypodophyllotoxin<br>dehydropodophyllotoxin<br>β-Sitosterol</td>
      <td></td>
      <td>β-Sitosterol, cadina-4,10(15)-dien-3-one and a mix of five lignans comprised of dehydropodophyllotoxin, deoxydehydropodophyllotoxin, 4′-demethyldesoxypodophyllotoxin, 5′-methoxydehydropodophyllotoxin, and dehydro-b-peltatin methyl ether were supplied by the Department of Chemistry, University of the West Indies, Mona Campus, Jamaica.</td>
    </tr>
    <tr>
      <th>642</th>
      <td>competitive inhibition</td>
      <td></td>
      <td>When the intersection is in the second quadrant and vertical axis for Dixon and Lineweaver-Burk plots respectively, the inhibition type is competitive.</td>
    </tr>
    <tr>
      <th>684</th>
      <td>plasma concentration-time curve<br>dose<br>pharmacokinetic parameters<br>valsartan<br>AUC<br>Rc<br>intravenous injection<br>rats</td>
      <td>AUC: area under the plasma</td>
      <td>AUC: area under the plasma concentration-time curve from 0 to 48 h C Pharmacokinetic parameters of valsartan and Rc following intravenous injection of valsartan at a dose of 1 mg/kg in rats.</td>
    </tr>
    <tr>
      <th>971</th>
      <td>electrospray ionization</td>
      <td></td>
      <td>Electrospray ionization was used to ionize samples in a positive direction.</td>
    </tr>
    <tr>
      <th>1670</th>
      <td>pharmacological data<br>system-to-system methodology</td>
      <td></td>
      <td>System-to-system or systems biology methodology is a more appropriate model for the evaluation of more complex interactions but its use is often limited by the availability of the relevant chemical and pharmacological data, especially in complex herbal interventions.</td>
    </tr>
    <tr>
      <th>116</th>
      <td>(2003)</td>
      <td></td>
      <td>(2003).</td>
    </tr>
    <tr>
      <th>525</th>
      <td>congenital kidney disease<br>polycystic kidney disease<br>drug-induced renal failure<br>acute kidney injury</td>
      <td></td>
      <td>The others (13.23%) consisted of congenital kidney disease, polycystic kidney disease, drug-induced renal failure, and acute kidney injury.</td>
    </tr>
    <tr>
      <th>759</th>
      <td>major CYP enzymes<br>metabolic drug–drug interactions</td>
      <td>CYP enzymes</td>
      <td>EGb 761® has no relevant effect on the in vivo activity of the major CYP enzymes in humans and therefore has no relevant potential to cause respective metabolic drug–drug interactions.</td>
    </tr>
    <tr>
      <th>39</th>
      <td>pain models<br>routes of administration<br>healthy subjects vs. patients<br>sources of the product</td>
      <td></td>
      <td>Numerous factors can explain discrepancies between study results such as pain models, healthy subjects vs. patients, routes of administration (inhalation vs. oral), and sources of the product [19,20,21].</td>
    </tr>
    <tr>
      <th>1227</th>
      <td>mRNA expression ratio of CYP2C6</td>
      <td></td>
      <td>Compared with the vehicle control group, there was a significant increase of 420 % (P < 0.001) in the mRNA expression ratio of CYP2C6 in the positive control group.</td>
    </tr>
    <tr>
      <th>515</th>
      <td>prevalence</td>
      <td></td>
      <td>Data were reported as prevalence (percent) of the occurrence.</td>
    </tr>
    <tr>
      <th>999</th>
      <td>hypericin<br>hyperforin<br>flavonoids</td>
      <td></td>
      <td>SJW extracts as well as isolated constituents (hyperforin, hypericin, or flavonoids) have been investigated in vitro and in vivo for their interactions with a variety of potentially relevant targets for depression.</td>
    </tr>
    <tr>
      <th>1157</th>
      <td>warfarin<br>bleeding<br>atrial fibrillation<br>China</td>
      <td></td>
      <td>Due to public concern regarding the risk of bleeding during treatment with warfarin, as well as the uneasy relationship between allopathic doctors and their patients, no more than 10% of patients with atrial fibrillation take warfarin in China [5].</td>
    </tr>
    <tr>
      <th>1103</th>
      <td>filtrate</td>
      <td></td>
      <td>It was filtered and the filtrate obtained in this step was mixed with the previous filtrate.</td>
    </tr>
    <tr>
      <th>403</th>
      <td>quality of life</td>
      <td></td>
      <td>However, attention has now shifted from reduction in mortality to improvement of the quality of life for people taking ART [1,2].</td>
    </tr>
    <tr>
      <th>1521</th>
      <td>R.A.</td>
      <td></td>
      <td>R.A. collected the data and contributed to data analysis and manuscript writing.</td>
    </tr>
    <tr>
      <th>1275</th>
      <td>isoenzymes</td>
      <td></td>
      <td>These isoenzymes are responsible for the metabolism of over 70% of prescription and over‐the‐counter medications (Rendic & Guengerich, 2014).</td>
    </tr>
    <tr>
      <th>644</th>
      <td>serotonin glucuronidation<br>UGT1A6 expression</td>
      <td></td>
      <td>For example, 120-fold variability of UGT1A6 expression in human liver might result in 13-fold variablity in serotonin glucuronidation [24].</td>
    </tr>
    <tr>
      <th>76</th>
      <td>HDI<br>DDI studies</td>
      <td></td>
      <td>With the tremendous surge in the acceptance of and public interest in herbal medicinal remedies, researchers are adopting the guidelines and opinions proposed for DDI studies to study HDI.</td>
    </tr>
    <tr>
      <th>133</th>
      <td>liver failure</td>
      <td></td>
      <td>This case culminated in liver failure despite discontinuation of the herbal supplement [4].</td>
    </tr>
    <tr>
      <th>404</th>
      <td>nausea<br>liver damage<br>dyslipidemia<br>fever<br>vomiting<br>headache<br>diarrhoea</td>
      <td></td>
      <td>EFV and NVP have been associated with a number of side effects including liver damage, nausea, vomiting, fever, diarrhoea, dyslipidemia and headache [10].</td>
    </tr>
    <tr>
      <th>761</th>
      <td>Ginkgo biloba extract</td>
      <td></td>
      <td>Ginkgo biloba extract is a popular herbal remedy used for a variety of disorders.</td>
    </tr>
    <tr>
      <th>1183</th>
      <td>traditional hypoglycemic herbs</td>
      <td></td>
      <td>Go to: 2.</td>
    </tr>
    <tr>
      <th>459</th>
      <td>phenotypic ratio<br>midazolam clearance</td>
      <td>clearance<br>area-under-the-curve</td>
      <td>[17] The single-time point phenotypic ratio approach confirmed what other investigators observed with St. John’s wort when more conventional “area-under-the-curve” methods were utilized to determine midazolam clearance.</td>
    </tr>
    <tr>
      <th>412</th>
      <td>mechanisms of action</td>
      <td></td>
      <td>Although effective in the treatment of some diseases, the mechanisms of action for most herbal medicines remain largely unknown.</td>
    </tr>
    <tr>
      <th>261</th>
      <td>Subject baseline characteristics<br>AUC</td>
      <td>AUC</td>
      <td>Relationship between the catechin AUC Abbreviations: AUC Subject baseline characteristics at the start of the study Note: Data are presented as mean ± SD for continuous variables and as ratios for categorical variables.</td>
    </tr>
    <tr>
      <th>1531</th>
      <td>polyethylene tubing<br>jugular vein</td>
      <td>anesthesia</td>
      <td>Rats were cannulated with polyethylene tubing (PE-50, Natsume Co, Tokyo, Japan) in the jugular vein for sampling under anesthesia with isoflurane.</td>
    </tr>
    <tr>
      <th>1353</th>
      <td>Adenosine diphosphate<br>Open in a separate window<br>Arachidonic acid<br>Collagen<br>Mean (95% CI)<br>Platelet aggregation (Ohms)<br>Geometric mean ratio to control (90% CI)</td>
      <td>Platelet aggregation</td>
      <td>Table 3  Platelet aggregation (Ohms) after 2 weeks of echinacea and policosanol pre-treatment (n= 12) \tControl\tPolicosanol treatment\tEchinacea treatment Agonist\tMean (95% CI)\tMean (95% CI)\tGeometric mean ratio to control (90% CI)\tMean (95% CI)\tGeometric mean ratio to control (90% CI) ADP*\t7.8 (5.5, 10.0)\t6.8 (4.9, 8.8)\t0.92 (0.64, 1.30)\t7.5 (4.1, 10.8)\t0.84 (0.59, 1.19) Arachidonic acid\t11.0 (9.6, 12.5)\t11.2 (9.4, 12.9)\t1.00 (0.82, 1.23)\t12.1 (9.3, 15.0)\t1.06 (0.86, 1.30) Collagen\t13.0 (11.5, 14.6)\t14.9 (12.6, 17.2)\t1.13 (0.93, 1.37)\t15.8 (12.2, 19.5)\t1.17 (0.97, 1.42) Open in a separate window *Adenosine diphosphate.</td>
    </tr>
    <tr>
      <th>155</th>
      <td>efficacy</td>
      <td></td>
      <td>People with diabetes receiving this combination should be closely monitored to evaluate possible signs of reduced efficacy.</td>
    </tr>
    <tr>
      <th>593</th>
      <td>warnings regarding a specific risk of interactions</td>
      <td></td>
      <td>In summary, it can be concluded that warnings regarding a specific risk of interactions of valerian are without any recent evidence.</td>
    </tr>
    <tr>
      <th>237</th>
      <td>M/Z values</td>
      <td></td>
      <td>The monitored M/Z values of the parent and product ions under the positive electrospray mode of ECG, EGC, EC, and internal standard (IS) injected into MS through the Atlantis T3 (4.6×50 mm ×3 µm) C18 (Waters) column were 443.10 → 123.00, 307.20 → 151.00, 291.20 → 139.00, and 199.00 → 127.03, respectively.</td>
    </tr>
    <tr>
      <th>1500</th>
      <td>RER<br>metabolic rate<br>blood lipid metabolites</td>
      <td></td>
      <td>Previous studies in human participants have shown promising effects of YM ingestion on metabolic rate and RER acutely [21], and after 12 weeks of ingestion, on blood lipid metabolites in healthy obese participants [11,21].</td>
    </tr>
    <tr>
      <th>1617</th>
      <td>plants</td>
      <td></td>
      <td>Thus, two studies from Canada and the USA were screened to find plants that patients might use.</td>
    </tr>
    <tr>
      <th>602</th>
      <td>cardiopulmonary toxicity</td>
      <td></td>
      <td>The present case details the occurrence of cardiopulmonary toxicity, which was probably associated with venlafaxine.</td>
    </tr>
    <tr>
      <th>1360</th>
      <td>Cmax<br>trough plasma concentrations</td>
      <td>Cmax</td>
      <td>Trough plasma concentrations of the major echinacea alkamide tetraene ranged from 1 to 23 ng ml−1, and the Cmax was found to range from 13 to 65 ng ml−1.</td>
    </tr>
    <tr>
      <th>545</th>
      <td>prothrombin complex activity<br>INR data<br>S-warfarin concentration</td>
      <td>INR<br>prothrombin complex activity (PCA</td>
      <td>In brief, a two-compartment pharmacokinetic model was used to describe S-warfarin concentration–time data and an indirect pharmacodynamic model described the relationship between percentage of prothrombin complex activity (PCA; which was derived from the INR data in this study) and S-warfarin concentration.</td>
    </tr>
    <tr>
      <th>217</th>
      <td>CYP3A4 induction<br>dosing regimen<br>midazolam<br>dose</td>
      <td></td>
      <td>Compared with the clinical studies in which significant induction of CYP3A4 by E. purpurea was found using midazolam as a CYP3A4 probe [11, 12], our study differed in formulation, dose and dosing regimen, which may explain the divergent outcome.</td>
    </tr>
    <tr>
      <th>1327</th>
      <td>sequentially numbered drug containers</td>
      <td></td>
      <td>Double-blinded treatments were allocated using sequentially numbered drug containers.</td>
    </tr>
    <tr>
      <th>877</th>
      <td>P-glycoprotein<br>intracellular calcein fluorescence</td>
      <td></td>
      <td>Neither Samento nor Banderol increased intracellular calcein fluorescence in L-MDR1 cells over-expressing human P-glycoprotein (P-gp), indicating lack of P-gp inhibition (data not shown).</td>
    </tr>
    <tr>
      <th>96</th>
      <td>unique substrates</td>
      <td>Oat3<br>Oat1</td>
      <td>Further, unique substrates that interact with Oat1, but not with Oat3 (and vice-versa) have been identified [7].</td>
    </tr>
    <tr>
      <th>48</th>
      <td>conventional medicines<br>CAM</td>
      <td></td>
      <td>During the past two decades, the world has witnessed an increased rate of conventional medicines integrated with CAM for treatment.</td>
    </tr>
    <tr>
      <th>1083</th>
      <td>Ammonia</td>
      <td></td>
      <td>Ammonia was used during derivatization since the reaction is optimal at basic pH.</td>
    </tr>
    <tr>
      <th>1201</th>
      <td>anti‐cancer activity</td>
      <td></td>
      <td>Constituents of S. sphenanthera extract also exhibited anti‐cancer activity, although with evidence strictly limited to in vitro data in different cancer cell lines.</td>
    </tr>
    <tr>
      <th>227</th>
      <td>docetaxel pretreatment<br>dexamethasone</td>
      <td></td>
      <td>Besides the dosing regimen and content of the applied E. purpurea product, docetaxel pretreatment with dexamethasone may also have contributed to the lack of a significant effect of E. purpurea on the pharmacokinetics of docetaxel.</td>
    </tr>
    <tr>
      <th>1461</th>
      <td>BCRP<br>OAT1/3<br>MDR1</td>
      <td></td>
      <td>In the transporter-mediated in vitro HDI, GA and PCA presented inhibitory effects on OAT1/3 and inductive effects on MDR1 and BCRP.</td>
    </tr>
    <tr>
      <th>1076</th>
      <td>anaesthetized</td>
      <td></td>
      <td>The animals were anaesthetized before blood collection process.</td>
    </tr>
    <tr>
      <th>1013</th>
      <td>clinical outcomes</td>
      <td></td>
      <td>Although systematic reviews and meta-analysis of Lingzhi and Yunzhi as an adjunct for cancer treatment have been performed [8–10], these reviews mostly focused on clinical outcomes with no mechanistic explanations for the potential beneficial or harmful interactions.</td>
    </tr>
    <tr>
      <th>22</th>
      <td>HTR2A<br>COMT</td>
      <td></td>
      <td>It was discovered that the patient took cannabis for chronic back pain, and a pharmacogenomics (PGx) test indicated the presence of variants for the COMT and HTR2A genes.</td>
    </tr>
    <tr>
      <th>798</th>
      <td>pathologic inhibitors of coagulation<br>disseminated intravascular coagulation (DIC)<br>warfarin or super-warfarin exposure<br>vitamin K malabsorption</td>
      <td></td>
      <td>Other diagnostic considerations in a patient presenting with coagulopathy of unknown origin include warfarin or super-warfarin exposure, disseminated intravascular coagulation (DIC), vitamin K malabsorption, and pathologic inhibitors of coagulation (6).</td>
    </tr>
    <tr>
      <th>411</th>
      <td>medicinal plants</td>
      <td></td>
      <td>There is substantial evidence supporting the potential of medicinal plants in combating diseases, especially in developing countries [12,13,14,15].</td>
    </tr>
    <tr>
      <th>473</th>
      <td>herb-drug interactions</td>
      <td></td>
      <td>Therefore, botanical supplements, when taken concomitantly with conventional medications, can give rise to serious herb-drug interactions.</td>
    </tr>
    <tr>
      <th>1089</th>
      <td>laboratory rodent chow</td>
      <td></td>
      <td>Water and food (laboratory rodent chow, Shanghai, China) were allowed ad libitum.</td>
    </tr>
    <tr>
      <th>425</th>
      <td>HREC REF: 826/2014<br>Ethical approval<br>University of Cape Town Human Research Ethics committee</td>
      <td></td>
      <td>Ethical approval was obtained from the University of Cape Town Human Research Ethics committee with number HREC REF: 826/2014.</td>
    </tr>
    <tr>
      <th>707</th>
      <td>Clevenger type apparatus<br>Na Total flavonoids<br>Folin-Ciocalteau reagent<br>hydrodistillation</td>
      <td></td>
      <td>One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 µL of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 °C for further analyses.</td>
    </tr>
    <tr>
      <th>232</th>
      <td>p-glycoprotein (p-gp)</td>
      <td></td>
      <td>Previous in vitro studies have reported the inhibitory effect of green tea on p-glycoprotein (p-gp) encoded by ABCB1.</td>
    </tr>
    <tr>
      <th>1606</th>
      <td>et Zucc.</td>
      <td></td>
      <td>et Zucc.)</td>
    </tr>
    <tr>
      <th>474</th>
      <td>plasma quinine<br>3-hydroxyquinine</td>
      <td></td>
      <td>Blood samples were collected and analyzed for plasma quinine and its metabolite, (3-hydroxyquinine) using a validated HPLC method.</td>
    </tr>
    <tr>
      <th>280</th>
      <td>Dybro et al.</td>
      <td></td>
      <td>2014; Dybro et al.</td>
    </tr>
    <tr>
      <th>816</th>
      <td>glucuronidation<br>silibinin<br>silibinin–raloxifene interaction</td>
      <td>intestinal glucuronidation</td>
      <td>Silibinin was selected as a model herbal product perpetrator based on well‐characterized composition, availability of human pharmacokinetic data, and in vitro inhibitory potency (K Because standard approaches to evaluate herb–drug interactions mediated via inhibition of intestinal glucuronidation in humans have not been described, two different modeling platforms were used to predict the likelihood and magnitude of the silibinin–raloxifene interaction.</td>
    </tr>
    <tr>
      <th>1370</th>
      <td>CYP assays</td>
      <td></td>
      <td>The IC It was not possible to determine the IC In vitro CYP assays offer an accurate, and relatively inexpensive, first stage assessment tool for gauging the potential for herb-drug interactions.</td>
    </tr>
    <tr>
      <th>789</th>
      <td>reporting percentage</td>
      <td></td>
      <td>Based on the two CONSORT statements, the reporting percentage for each of the articles ranged from 36.5% to 61.5% and the mean percentage for all articles was 45.6%.</td>
    </tr>
    <tr>
      <th>856</th>
      <td>pharmacological management<br>hypoglycaemic agents<br>pharmacological agents</td>
      <td></td>
      <td>Tabular summary of the pharmacological management of the patients' based on their prescribed hypoglycaemic agents.</td>
    </tr>
    <tr>
      <th>1598</th>
      <td>metabolizing enzymes<br>transporter proteins</td>
      <td></td>
      <td>Previous studies have shown the interactions between sirolimus and drugs that affect the activities of metabolizing enzymes and transporter proteins.</td>
    </tr>
    <tr>
      <th>147</th>
      <td>LVFX<br>complex matrices</td>
      <td></td>
      <td>Based on our findings, the developed method is acceptable and accurate for analyzing LVFX in complex matrices.</td>
    </tr>
    <tr>
      <th>80</th>
      <td>water</td>
      <td></td>
      <td>Extraction was performed using water to mimic the indigenous mode of extraction.</td>
    </tr>
    <tr>
      <th>1652</th>
      <td>mentions to the wrong species<br>translation errors</td>
      <td></td>
      <td>This may result in translation errors or assigning mentions to the wrong species, in some cases.</td>
    </tr>
    <tr>
      <th>850</th>
      <td>individual herbs</td>
      <td></td>
      <td>Composition of individual herbs in the included herbal formulae.</td>
    </tr>
    <tr>
      <th>1328</th>
      <td>lovastatin<br>internal standard<br>simvastatin hydroxy acid<br>simvastatin<br>plasma concentrations</td>
      <td></td>
      <td>The mean (SD) plasma concentrations of simvastatin, its metabolite simvastatin hydroxy acid, and internal standard lovastatin are shown in Figure 4.</td>
    </tr>
    <tr>
      <th>773</th>
      <td>steady state<br>CYPs induction<br>EGb 761® daily dose<br>exposure duration</td>
      <td></td>
      <td>A maximum exposure was realized with a 240-mg EGb 761® daily dose, and exposure duration was sufficient to eventually induce CYPs, as steady state for EGb 761® components was reached, and 1 week is typically sufficient to achieve full induction [35].</td>
    </tr>
    <tr>
      <th>701</th>
      <td>antioxidant and polyphenolic properties</td>
      <td></td>
      <td>Therefore, use of an herbal agent with antioxidant and polyphenolic properties without significant side effects helps to treat PCOS as a disease of antioxidant deficiency [13].</td>
    </tr>
    <tr>
      <th>298</th>
      <td>digoxin</td>
      <td></td>
      <td>Based on our analysis of the literature, the mechanism of interaction between TCM formulations and digoxin is as follows: A.</td>
    </tr>
    <tr>
      <th>1434</th>
      <td>drug interactions</td>
      <td></td>
      <td>30%–70% of clinical breast cancer patients use natural products, which may increase the likelihood of drug interactions.</td>
    </tr>
    <tr>
      <th>1444</th>
      <td>autophagy<br>cell cycle arrest<br>apoptosis</td>
      <td></td>
      <td>The key mechanisms of action of anti-cancer drugs involve apoptosis, autophagy, and cell cycle arrest (Chen and Karantza-Wadsworth, 2009; Wang et el., 2011; Kon et al., 2013).</td>
    </tr>
    <tr>
      <th>511</th>
      <td>PR interval<br>corrected QT interval (QTc)<br>QRS duration</td>
      <td>the PR interval<br>corrected QT interval (QTc)<br>QRS duration</td>
      <td>On serial electrocardiograms the PR interval, QRS duration and corrected QT interval (QTc) were similar in both arms (S2 Table).</td>
    </tr>
    <tr>
      <th>1064</th>
      <td>CYP2D6 activity<br>genetic polymorphisms</td>
      <td></td>
      <td>The significant inter-individual variability of CYP2D6 activity due to genetic polymorphisms was mitigated by the use of pooled microsomes from 50 donors [41].</td>
    </tr>
    <tr>
      <th>853</th>
      <td>significant relationship</td>
      <td></td>
      <td>A significant relationship between variables was identified if p < 0.05.</td>
    </tr>
    <tr>
      <th>1540</th>
      <td>echinacea<br>kratom<br>St. John’s wort<br>hydroxycut<br>piperine<br>celery<br>rhodiola<br>moringa<br>valerian<br>terminalia/commiphora ayurvedic mixture<br>ginkgo<br>ginseng<br>kava</td>
      <td></td>
      <td>These are celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John’s wort, terminalia/commiphora ayurvedic mixture and valerian.</td>
    </tr>
    <tr>
      <th>967</th>
      <td>Group IV<br>APG 40 mg/kg administration<br>2 h after<br>7th day</td>
      <td></td>
      <td>on the 7th day, 2 h after APG 40 mg/kg administration, and Group IV was administered with APG 40 mg/kg for 7 days.</td>
    </tr>
    <tr>
      <th>902</th>
      <td>CYP2J2 mRNA decay</td>
      <td></td>
      <td>Effect of Samento on CYP2J2 mRNA decay in LS180 cells.</td>
    </tr>
    <tr>
      <th>1522</th>
      <td>Prof. Yeong Bae Seo</td>
      <td></td>
      <td>Co., Seoul, Korea) and their identity was kindly confirmed by Prof. Yeong Bae Seo (a specialist in plant classification, Natural Products Research Institute, Seoul National University, Seoul, Korea).</td>
    </tr>
    <tr>
      <th>1276</th>
      <td>metabolic capacity of CYP isoenzymes</td>
      <td></td>
      <td>Little is known of the effect of most tropical medicinal herbs on the metabolic capacity of CYP isoenzymes.</td>
    </tr>
    <tr>
      <th>285</th>
      <td>metabolic rate<br>maximum plasma concentration<br>liver microsomes</td>
      <td></td>
      <td>The maximum plasma concentration (C Rat liver microsomes were used to determine the metabolic rate of AC.</td>
    </tr>
    <tr>
      <th>901</th>
      <td>protein expression of P-glycoprotein (P-gp)</td>
      <td></td>
      <td>Effects of Samento (0.033–1%) and the positive control rifampicin (20 µM) on the protein expression of P-glycoprotein (P-gp) after four days of exposure.</td>
    </tr>
    <tr>
      <th>731</th>
      <td>proliferative phase<br>lipid profile<br>secretory phase<br>sexual hormones</td>
      <td></td>
      <td>We recommend that further research should be undertaken regarding the effects of herbal mixtures on hormonal factors of PCOS women such as sexual hormones in both proliferative and secretory phases, and lipid profile in a longer follow-up.</td>
    </tr>
    <tr>
      <th>867</th>
      <td>elimination half-life</td>
      <td>an elimination half-life</td>
      <td>After administration, aspirin is rapidly hydrolyzed in the body with an elimination half-life of approximatly 15 min [11,12].</td>
    </tr>
    <tr>
      <th>1369</th>
      <td>CYP1A2 activity</td>
      <td></td>
      <td>Key phytochemicals were individually assessed for their impact on CYP1A2 activity.</td>
    </tr>
    <tr>
      <th>888</th>
      <td>BCRP<br>pheophorbide A</td>
      <td></td>
      <td>BCRP inhibition was tested by flow cytometry using pheophorbide A as a specific BCRP substrate in MDCKII-BCRP cells compared to the parental cell line MDCKII as described previously [24].</td>
    </tr>
    <tr>
      <th>24</th>
      <td>dopamine concentrations</td>
      <td></td>
      <td>Neuronal death in this region results in low dopamine concentrations; therefore, treatment strategies for PD often involve initiating medications (e.g., carbidopa-levodopa, ropinirole, entacapone) that result in increased concentrations of dopamine to improve movement control [8].</td>
    </tr>
    <tr>
      <th>953</th>
      <td>BCPR/ABCG2 protein<br>DAS<br>inhibition</td>
      <td></td>
      <td>The APG-pretreated rats showed significant inhibition of the BCPR/ABCG2 protein that is (66.77% and 41.06% inhibition, respectively) as compared to DAS only (p < 0.05).</td>
    </tr>
    <tr>
      <th>723</th>
      <td>antioxidant activity</td>
      <td></td>
      <td>In fact, polyphenols determine the antioxidant activity, and this positive relationship renders a trend in many medicinal plants [36].</td>
    </tr>
    <tr>
      <th>296</th>
      <td>Western drugs</td>
      <td></td>
      <td>Most of these reports and studies are on combinations with Western drugs.</td>
    </tr>
    <tr>
      <th>772</th>
      <td>EGb 761</td>
      <td></td>
      <td>Administration of EGb 761® 120 mg b.i.d.</td>
    </tr>
    <tr>
      <th>1043</th>
      <td>medicinal mushrooms</td>
      <td></td>
      <td>In summary, the aforementioned outcomes suggest that medicinal mushrooms have great potential to ameliorate the adverse effects of chemotherapeutic drugs in clinical settings.</td>
    </tr>
    <tr>
      <th>1687</th>
      <td>Zorbax SB-CN column</td>
      <td></td>
      <td>Urine samples were eluted on a Zorbax SB-CN column (5 μm, 250 × 4.6 mm).</td>
    </tr>
    <tr>
      <th>1003</th>
      <td>PXR<br>xenobiotic receptor<br>xenosensor<br>PXRRE</td>
      <td></td>
      <td>In the network of genes involved in drug metabolism, the PXR functions as a xenobiotic receptor or “xenosensor,” which, after ligand binding, translocates to the nucleus, where it binds to specific PXR response elements (PXRRE) in the promotor of various genes, modulating their transcription.</td>
    </tr>
    <tr>
      <th>416</th>
      <td>Epicatechin<br>Catechin<br>Caffeic acid<br>Chlorogenic acid<br>p-Coumaric acid</td>
      <td></td>
      <td>Note: values are expressed as mg·kg Structures of the phenolic compounds identified and quantified from crude herbal extracts (1) Caffeic acid; (2) Catechin; (3) Chlorogenic acid; (4) Epicatechin; (5) p-Coumaric acid.</td>
    </tr>
    <tr>
      <th>464</th>
      <td>anticoagulant therapy</td>
      <td></td>
      <td>[11,12] Such an interaction is particularly relevant to elderly patients on anticoagulant therapy.</td>
    </tr>
    <tr>
      <th>325</th>
      <td>drug-metabolizing enzymes<br>type of extract (CAW)</td>
      <td></td>
      <td>None of the aforementioned studies investigated the effects on drug-metabolizing enzymes of the type of extract (CAW) used in our preclinical studies and in our current phase I (NCT03929250, NCT03937908) and proposed phase II clinical trials investigating CAW as a botanical drug for cognitive decline.</td>
    </tr>
    <tr>
      <th>653</th>
      <td>CYP2C19<br>CYP2D6<br>CYP2C9<br>probe substrates for five cytochrome P450 (CYP) enzymes<br>CYP1A2<br>CYP3A</td>
      <td></td>
      <td>In case of ginseng interactions, it was reported that no herb–drug interaction between single oral dose of Korean red ginseng extract (RGE) (0.5–2.0 g/kg) and the probe substrates for five cytochrome P450 (CYP) enzymes (i.e., CYP1A2, 2C9, 2C19, 2D6, 3A) in mouse [12].</td>
    </tr>
    <tr>
      <th>714</th>
      <td>standard deviation (SD)<br>frequency<br>measures of central tendency<br>measures of dispersion<br>mean<br>percentage</td>
      <td></td>
      <td>Descriptive statistics, including the frequency and percentage, and measures of central tendency and dispersion, including the mean and standard deviation (SD), were also used to describe the study variable.</td>
    </tr>
    <tr>
      <th>1612</th>
      <td>analgetic drugs</td>
      <td></td>
      <td>Though non-pharmacological treatments are the main therapy for these patients, application of analgetic drugs is common, often over years.</td>
    </tr>
    <tr>
      <th>795</th>
      <td>activated partial thromboplastin time<br>prothrombin time<br>international normalized ratio</td>
      <td>international normalized ratio (INR)<br>prothrombin time (PT)<br>activated partial thromboplastin time (aPTT)</td>
      <td>At the time of admission to ED, she had a prothrombin time (PT) of more than 37 seconds, activated partial thromboplastin time (aPTT) more than 70 seconds, and international normalized ratio (INR) greater than seven.</td>
    </tr>
    <tr>
      <th>1471</th>
      <td>PCE tracer components</td>
      <td></td>
      <td>Consequently, GA and PCA were chosen as PCE tracer components in the pharmacokinetic- and tissue distribution-based HDIs studies.</td>
    </tr>
    <tr>
      <th>1380</th>
      <td>chromatographic methods</td>
      <td></td>
      <td>The following chromatographic methods were employed.</td>
    </tr>
    <tr>
      <th>1608</th>
      <td>Maxim extract</td>
      <td></td>
      <td>Maxim extract are available from the authors.</td>
    </tr>
    <tr>
      <th>92</th>
      <td>HDI<br>DDI models<br>IVIVE</td>
      <td></td>
      <td>Currently, there is no specific pharmacological tool to predict HDI since almost all in vitro-in vivo-extrapolation (IVIVE) Drug-Drug Interaction (DDI) models deal with one inhibitor-drug and one victim-drug.</td>
    </tr>
    <tr>
      <th>825</th>
      <td>curcumin</td>
      <td></td>
      <td>This effect of curcumin can be attributed due to one or more possible mechanisms as reported earlier.</td>
    </tr>
    <tr>
      <th>1620</th>
      <td>surgical intervention<br>pain relief<br>opioids<br>short-term use</td>
      <td></td>
      <td>Short-term use of opioids for patients who cannot reach pain relief otherwise may occur, e.g., to bridge the time until surgical intervention.</td>
    </tr>
    <tr>
      <th>841</th>
      <td>antiepileptic therapy</td>
      <td></td>
      <td>Patients on antiepileptic therapy are usually on a long-term basis.</td>
    </tr>
    <tr>
      <th>1572</th>
      <td>clinically relevant interaction</td>
      <td></td>
      <td>A study in 18 health volunteers did not show any clinically relevant interaction between kava and bromazepam [104].</td>
    </tr>
    <tr>
      <th>1081</th>
      <td>sulfhydryl group<br>2-4-dibromoacetophenone</td>
      <td></td>
      <td>In this experiment, we used 2-4-dibromoacetophenone as a derivatization agent to prevent the sulfhydryl group in captopril from binding to plasma sulfhydryl groups.</td>
    </tr>
    <tr>
      <th>614</th>
      <td>medicamentos cardíacos</td>
      <td></td>
      <td>A maioria dos medicamentos cardíacos foi, portanto, descontinuada.</td>
    </tr>
    <tr>
      <th>1182</th>
      <td>herb–drug interactions</td>
      <td></td>
      <td>21 Clearly, a reliable and systematic approach to predict these herb–drug interactions is needed.</td>
    </tr>
    <tr>
      <th>995</th>
      <td>high lactate production<br>reduced oxidative metabolism</td>
      <td>lactate</td>
      <td>have shown the association between high lactate production and reduced oxidative metabolism [47].</td>
    </tr>
    <tr>
      <th>360</th>
      <td>DDI potential<br>tolerability<br>safety</td>
      <td></td>
      <td>Therefore, the tolerability and safety of combination drugs were evaluated in the context of their DDI potential.</td>
    </tr>
    <tr>
      <th>1698</th>
      <td>CYP3A4 metabolic activity<br>Asafetida</td>
      <td></td>
      <td>In conclusion, the significant Asafetida inhibitory effect on CYP3A4 metabolic activity was an important finding of this study.</td>
    </tr>
    <tr>
      <th>1153</th>
      <td>Dong quai<br>Ginkgo biloba<br>Danshen</td>
      <td></td>
      <td>or other herbs (Danshen, Ginkgo biloba, Dong quai, etc.).</td>
    </tr>
    <tr>
      <th>134</th>
      <td>immunogen<br>autoimmune response<br>hapten</td>
      <td></td>
      <td>The immune mechanism is precipitated by a drug or a metabolite acting as a hapten covalently binding to host cellular protein, converting into an immunogen [24] and thereby eliciting an autoimmune response.</td>
    </tr>
    <tr>
      <th>1203</th>
      <td>warfarin<br>Gegen<br>Danshen</td>
      <td></td>
      <td>Sixty Sprague–Dawley rats were used to investigate the effects of warfarin (0.2 mg/kg), Danshen (240 or 480 mg/kg) and Gegen (240 or 480 mg/kg) both in isolation and combination.</td>
    </tr>
    <tr>
      <th>696</th>
      <td>study participants</td>
      <td></td>
      <td>In order to compensate for study participants who did not complete both treatment phases, a total of 24 subjects were to be randomised.</td>
    </tr>
    <tr>
      <th>182</th>
      <td>CYP2C9<br>CYP3A4<br>CYP2C8</td>
      <td></td>
      <td>Flavonoids, common in the diet, are responsible for the modulation of the clinically relevant CYP2C8, CYP2C9, and CYP3A4 enzymes [31].</td>
    </tr>
    <tr>
      <th>215</th>
      <td>AUC0–∞<br>maximum plasma concentration (Cmax)<br>elimination half-life (t1/2)</td>
      <td>maximum plasma concentration (Cmax)<br>area under the plasma concentration–time curve from time zero to infinity (AUC0–∞)<br>elimination half-life (t1/2)</td>
      <td>The following pharmacokinetic parameters of docetaxel were calculated: area under the plasma concentration–time curve from time zero to infinity (AUC0–∞), elimination half-life (t1/2) and maximum plasma concentration (Cmax).</td>
    </tr>
    <tr>
      <th>869</th>
      <td>BNPP<br>PNS</td>
      <td>BNPP</td>
      <td>There was no significant difference between BNPP (68 µg/mL) and PNS (150 µg/mL).</td>
    </tr>
    <tr>
      <th>875</th>
      <td>cytochrome P450 enzymes<br>drug transporters</td>
      <td></td>
      <td>Inhibition of cytochrome P450 enzymes (CYPs) was quantified by commercial kits and inhibition of drug transporters by use of fluorescent probe substrates.</td>
    </tr>
    <tr>
      <th>835</th>
      <td>CBZ</td>
      <td></td>
      <td>In view of all the constraints of the existing literature, a comprehensive systematic review focusing on CBZ and overcoming the mentioned hurdles is warranted for healthcare professionals to make proper decisions.</td>
    </tr>
    <tr>
      <th>1235</th>
      <td>Danshen</td>
      <td></td>
      <td>Although there were no clinical reports in the literature pertaining to the interactions between Gegen and warfarin, the results of several case reports indicated that Danshen can interact with warfarin in humans [20–22].</td>
    </tr>
    <tr>
      <th>399</th>
      <td>mass fragmentation patterns</td>
      <td></td>
      <td>We also used the same MRM condition as previously published reports [39,40] and the product ion mass spectra from fimasartan, amlodipine, and hydrochlorothiazide showed different mass fragmentation patterns (Figure 1).</td>
    </tr>
    <tr>
      <th>0</th>
      <td>progressive mobilization<br>complete normalization of the laboratory findings</td>
      <td></td>
      <td>Progressive mobilization of the patient was obtained as well as a complete normalization of the laboratory findings.</td>
    </tr>
    <tr>
      <th>65</th>
      <td>Faangum<br>Sasanemasa/Sesemasa<br>Lifui<br>Akoko</td>
      <td></td>
      <td>Local names for this shrub include Faangum in Cameroon, Sasanemasa/Sesemasa or Esisimansa in Ghana, Lifui in Togo, and Akoko in Nigeria.</td>
    </tr>
    <tr>
      <th>793</th>
      <td>CYP enzyme activity<br>liver</td>
      <td>CYP enzyme activity</td>
      <td>Another in vivo study reported that gingko induced CYP enzyme activity in a dose-dependent manner, but did not cause hepatic damage [48].</td>
    </tr>
    <tr>
      <th>762</th>
      <td>EGb 761® 120 mg<br>EGb 761® 240 mg</td>
      <td></td>
      <td>The following treatments were administered for 8 days each: placebo twice daily (treatment A), EGb 761® 120 mg twice daily (treatment B), and EGb 761® 240 mg in the morning and placebo in the evening (treatment C).</td>
    </tr>
    <tr>
      <th>1607</th>
      <td>pretreatment period</td>
      <td></td>
      <td>Second, the pretreatment period of Epimedium sagittatum extract might have been too short to identify the possible herbal drug effect.</td>
    </tr>
    <tr>
      <th>870</th>
      <td>PON influence test</td>
      <td>PON</td>
      <td>The influence test for PON was conducted by the method of Furlong et al.</td>
    </tr>
    <tr>
      <th>1415</th>
      <td>HDI<br>metabolism<br>absorption</td>
      <td></td>
      <td>S4, the P The above in-vitro experiments suggested that there should be some potential HDI between OS and these anti-influenza herbs/herbal components during absorption and metabolism.</td>
    </tr>
    <tr>
      <th>1297</th>
      <td>(2000)</td>
      <td></td>
      <td>(2000).</td>
    </tr>
    <tr>
      <th>806</th>
      <td>volume used to aid swallowing<br>time of administration<br>Siliphos<br>adverse events<br>beverage<br>pill diary</td>
      <td>approximate volume used to aid swallowing</td>
      <td>Each subject received his/her Siliphos in a blister pack and was asked to complete a pill diary documenting the time of administration, beverage, and approximate volume used to aid swallowing, and adverse events, if applicable.</td>
    </tr>
    <tr>
      <th>720</th>
      <td>CC with herbal mixture<br>herbal mixture<br>CC</td>
      <td></td>
      <td>Then, 75 participants were randomly allocated into 3 groups including group 1: CC (n = 25); group 2: herbal mixture (n = 25); and group 3: CC with herbal mixture (n = 25).</td>
    </tr>
    <tr>
      <th>238</th>
      <td>EC<br>calibration curve range<br>ECG<br>EGC<br>EGCG</td>
      <td></td>
      <td>Using this LC-MS/MS method, a calibration curve range was generated by 0.1–50 ng/mL for EC and 1–500 ng/mL for EGCG, ECG, and EGC.</td>
    </tr>
    <tr>
      <th>1430</th>
      <td>HDI relevancy with OS<br>absolute z-score</td>
      <td></td>
      <td>After such a normalization, the absolute z-score of an herb/herbal component effect on OS would be proportional to its level of HDI relevancy with OS.</td>
    </tr>
    <tr>
      <th>1597</th>
      <td>Parsley</td>
      <td></td>
      <td>Parsley, Petroselinum crispum, is a food, spice, and also a medicinal herb.</td>
    </tr>
    <tr>
      <th>51</th>
      <td>range</td>
      <td></td>
      <td>In South Korean population reported a range from 29% to 83% [5].</td>
    </tr>
    <tr>
      <th>454</th>
      <td>probe drug administration</td>
      <td></td>
      <td>Adherence to these restrictions was further emphasized five days before each probe drug administration.</td>
    </tr>
    <tr>
      <th>1641</th>
      <td>CYP susceptibility</td>
      <td>CYP</td>
      <td>They favor CYP, as the patient could be unusually susceptible due to the individual genotype [207].</td>
    </tr>
    <tr>
      <th>1517</th>
      <td>fat-loss outcomes<br>YM<br>physically active<br>BF%</td>
      <td></td>
      <td>The BF% data indicated all females who took part were at the lower BF% percentile, indicating that they were physically active, with higher  Although the positive effects of YM on fat-loss outcomes during exercise are found only in single trials, future research could test the longitudinal YM effectiveness, especially when combining regular exercise training with YM treatment.</td>
    </tr>
    <tr>
      <th>504</th>
      <td>dizziness</td>
      <td></td>
      <td>Precisely, only 3 participants complained of very light dizziness.</td>
    </tr>
    <tr>
      <th>265</th>
      <td>Rh1<br>Re<br>Rg3</td>
      <td></td>
      <td>However, other ginsenosides, such as Rg3, Re, and Rh1, were not detected in rat plasma despite their high content in RGE (Table 1 and Table 2).</td>
    </tr>
    <tr>
      <th>1384</th>
      <td>cytochrome P450 enzymes<br>CYPs 1A1, 1A2, 1B1, 3A4, 2D6</td>
      <td></td>
      <td>[15] to screen natural products for cytochrome P450 inhibition potential with a particular emphasis on the P450 enzymes, CYPs 1A1, 1A2, 1B1, 3A4 and 2D6.</td>
    </tr>
    <tr>
      <th>518</th>
      <td>age<br>marital status<br>occupational status<br>educational status<br>sex</td>
      <td></td>
      <td>After obtaining institutional ethics committee approval (project number and ethics code: 294155) from the university research affairs, patients' demographic information (sex, age, educational status, occupational status, and marital status) were collected from patients' hospital records or by direct interviewing of patients and filled in a specially designed form for this study.</td>
    </tr>
    <tr>
      <th>839</th>
      <td>nicotinamide<br>CBZ plasma level</td>
      <td>clearance</td>
      <td>As regards the dietary supplement-CBZ interactions, folinic acid did not alter the plasma level of CBZ in rats [61] while nicotinamide increased CBZ plasma level and decreased its clearance in two children with epilepsy [70].</td>
    </tr>
    <tr>
      <th>1489</th>
      <td>intestinal epithelia<br>renal epithelia</td>
      <td></td>
      <td>Since the liver metabolism (approximately 10%) and biliary excretion (approximately 1%) of the drug is relatively low (Vance-Bryan et al., 1990), the reduced circulating CIP in humans was mainly attributed to the change of CIP across the renal and intestinal epithelia.</td>
    </tr>
    <tr>
      <th>510</th>
      <td>failure differences</td>
      <td></td>
      <td>With respect to the MOS-HIV, failure differences were found between placebo and 1200 mg, favouring the 1200mg group.</td>
    </tr>
    <tr>
      <th>1421</th>
      <td>enzymes<br>cells<br>influenza viruses<br>microsomes</td>
      <td></td>
      <td>In our current study, a screening platform based on microsomes, enzymes, cells and influenza viruses have for the first time been developed and utilized to screen potential interaction between OS and anti-influenza herb/herbal components.</td>
    </tr>
    <tr>
      <th>493</th>
      <td>certified healthy<br>written informed consent</td>
      <td></td>
      <td>Participants were certified healthy by a physician based on medical history, clinical examination, and laboratory tests and they gave their written informed consent to comply with the study protocol.</td>
    </tr>
    <tr>
      <th>1513</th>
      <td>active ingredients<br>bioavailability</td>
      <td>bioavailability</td>
      <td>However, further research is required to assess active ingredients of YM capsules and analyze their bioavailability following ingestion.</td>
    </tr>
    <tr>
      <th>110</th>
      <td>CYP2C9*3<br>CYP2C9*2</td>
      <td></td>
      <td>Detection of the CYP2C9*2 and CYP2C9*3 alleles were carried out using a polymerase chain reaction based restriction fragment length polymorphism (polymerase chain reaction-RFLP) analysis.</td>
    </tr>
    <tr>
      <th>336</th>
      <td>ambient temperature</td>
      <td></td>
      <td>Plates were thawed at ambient temperature.</td>
    </tr>
    <tr>
      <th>695</th>
      <td>deviation of ±1 day</td>
      <td></td>
      <td>For each visit, a deviation of ±1 day was permitted.</td>
    </tr>
    <tr>
      <th>1058</th>
      <td>extensive<br>ultra-rapid metabolizers<br>intermediate<br>poor</td>
      <td></td>
      <td>Based on genotype combinations encoding for varying enzyme phenotypes, patients have been classified as poor, intermediate, extensive, or ultra-rapid metabolizers [32, 33].</td>
    </tr>
    <tr>
      <th>1664</th>
      <td>diabetic treatment</td>
      <td></td>
      <td>This herb has been in use for diabetic treatment for almost two millennia [72].</td>
    </tr>
    <tr>
      <th>369</th>
      <td>standard calibration curves<br>concentrations</td>
      <td></td>
      <td>Three concentrations of quality control (QC) samples were prepared at low, medium, and high concentrations in the range of the standard calibration curves.</td>
    </tr>
    <tr>
      <th>1215</th>
      <td>10 min<br>30 min<br>10%<br>15 min<br>35%<br>5%<br>17%<br>90%<br>solvent A<br>13 min<br>12 min<br>5 min</td>
      <td></td>
      <td>The linear gradient elution was carried out as follows with a total running time of 90 min: solvent A was kept at 5 % for the first 5 min, and then increased to 10, 17, 35 and 90 % in the next 13, 12, 10 and 30 min, respectively, then returned to 5 % in 5 min and equilibrated for 15 min before the next injection.</td>
    </tr>
    <tr>
      <th>60</th>
      <td>clinical effect of traditional hypoglycemic herbs</td>
      <td>rs1142345</td>
      <td>Therefore, rs1142345 was associated with the clinical effect of traditional hypoglycemic herbs.</td>
    </tr>
    <tr>
      <th>1243</th>
      <td>CYP2C-<br>CYP1A-<br>CYP3A-inducing agents</td>
      <td></td>
      <td>Furthermore, CYP1A-, CYP2C- and CYP3A-inducing agents were found in the ethyl acetate extract, but not in the aqueous extract of Danshen [57].</td>
    </tr>
    <tr>
      <th>866</th>
      <td>herb–drug interactions</td>
      <td></td>
      <td>Herb–drug interactions strongly challenge the clinical combined application of herbs and drugs.</td>
    </tr>
    <tr>
      <th>509</th>
      <td>TCAM</td>
      <td></td>
      <td>More than 50% of adults in KwaZulu-Natal attending public sector facilities for ART initiation disclose using TCAM [10], and similar levels of TCAM use by HIV positive individuals may occur worldwide [11].</td>
    </tr>
    <tr>
      <th>1345</th>
      <td>drug interactions<br>drug – lifestyle</td>
      <td></td>
      <td>Object name is PGPM-14-963-g0003.jpg Figure 3  Drug interactions and drug – lifestyle reported by the personalized prescription software.</td>
    </tr>
    <tr>
      <th>1618</th>
      <td>Aloe vera</td>
      <td></td>
      <td>A Spanish study reports Aloe vera [37].</td>
    </tr>
    <tr>
      <th>1472</th>
      <td>CIP<br>urine</td>
      <td></td>
      <td>Approximately 60% of CIP is excreted in unchanged form into the urine (Vance-Bryan et al., 1990).</td>
    </tr>
    <tr>
      <th>1167</th>
      <td>anthocyanins<br>delphinidin-3-sambubioside<br>cyanidin-3-sambubioside</td>
      <td></td>
      <td>Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, are generally believed to be the active constituents responsible for the antihypertensive, antioxidant, and hypocholesterolemic effects of HS, possibly because they are found in high relative quantities in aqueous extracts [8, 11, 13, 16].</td>
    </tr>
    <tr>
      <th>944</th>
      <td>CYP2B6 inhibitory effects<br>bupropion<br>pharmacokinetics</td>
      <td></td>
      <td>Go to: Discussion  In this study, we examined the CYP2B6 inhibitory effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion.</td>
    </tr>
    <tr>
      <th>1301</th>
      <td>polyherbal formulation<br>menopause symptoms</td>
      <td></td>
      <td>Ltd., Varanasi, India) is a patented polyherbal formulation developed to manage menopause symptoms that can be taken along with other allopathic medicines.</td>
    </tr>
    <tr>
      <th>120</th>
      <td>serological titers for acute CMV<br>serological titers for Epstein Barr virus</td>
      <td></td>
      <td>Serological titers for acute cytomegalovirus (CMV) and Epstein Barr virus (EBV) were negative.</td>
    </tr>
    <tr>
      <th>600</th>
      <td>DIP<br>reversibility</td>
      <td></td>
      <td>Although DIP can occur from hours to months after the beginning of treatment, Another typical feature of DIP is its reversibility after drug discontinuation.</td>
    </tr>
    <tr>
      <th>958</th>
      <td>DAS<br>APG</td>
      <td></td>
      <td>The purpose of the current study was to determine whether or not APG has a pharmacokinetic interaction with DAS, and if so, how they would interact.</td>
    </tr>
    <tr>
      <th>1661</th>
      <td>allyl thiosulfinates<br>allyl<br>sulfur compounds</td>
      <td></td>
      <td>It is composed of a large number of sulfur compounds, with suspected bioactive compounds called allyl thiosulfinates (mainly allicin) [65].</td>
    </tr>
    <tr>
      <th>553</th>
      <td>pharmacodynamic interactions<br>warfarin<br>cranberry juice</td>
      <td></td>
      <td>(2007) concluded that there were no pharmacodynamic interactions between warfarin and cranberry juice, but they employed a low dose of warfarin (10 mg), which made this end point difficult to assess.</td>
    </tr>
    <tr>
      <th>1247</th>
      <td>SAB<br>bioavailability</td>
      <td>bioavailability</td>
      <td>In our study, although SAB was used as a major component of the Danshen granules, the in vivo effects were very different to those observed in cells because of the poor absorption and bioavailability of SAB.</td>
    </tr>
    <tr>
      <th>1587</th>
      <td>bioactive compounds</td>
      <td></td>
      <td>Medicinal herbs are rich sources of natural bioactive compounds that could interact with drugs.</td>
    </tr>
    <tr>
      <th>1435</th>
      <td>natural products<br>TAM<br>clinical evidence</td>
      <td></td>
      <td>Conclusion: There is evidence for potential interactions of various natural products with TAM in pre-clinical studies, although the relevant clinical evidence is still lacking.</td>
    </tr>
    <tr>
      <th>1264</th>
      <td>conflicts of interests</td>
      <td></td>
      <td>Competing interests          The authors have declared no conflicts of interests.</td>
    </tr>
    <tr>
      <th>1233</th>
      <td>PT time<br>warfarin plasma concentration</td>
      <td>PT time</td>
      <td>The results of our previous study showed that the administration of a DFG-warfarin combination led to a reduction in the warfarin plasma concentration and PT time of rats [23, 32].</td>
    </tr>
    <tr>
      <th>1665</th>
      <td>blood sugar levels</td>
      <td>blood sugar</td>
      <td>These findings suggest further research in individuals with diabetes is required to determine the effect of the combination of gymnema tea and metformin on blood sugar levels.</td>
    </tr>
    <tr>
      <th>938</th>
      <td>Foster City, CA<br>Analyst software<br>version 1.4<br>Applied Biosystems</td>
      <td></td>
      <td>The analytical data were processed using Analyst software (version 1.4, Applied Biosystems, Foster City, CA).</td>
    </tr>
    <tr>
      <th>935</th>
      <td>positive ion mode<br>5500 V<br>500°C</td>
      <td></td>
      <td>The TurboIonSpray interface was operated in positive ion mode at 5500 V and 500°C.</td>
    </tr>
    <tr>
      <th>1213</th>
      <td>diclofenac sodium<br>naringin</td>
      <td></td>
      <td>The plant names in current study were used according to the latest revision in “The Plant List” ( Racemic warfarin, diclofenac sodium and naringin (internal standards) were purchased from Sigma-Aldrich (St. Louis, MO, USA).</td>
    </tr>
    <tr>
      <th>934</th>
      <td>safety monitoring</td>
      <td></td>
      <td>Safety monitoring was performed throughout the study.</td>
    </tr>
    <tr>
      <th>982</th>
      <td>lactate level<br>QMS</td>
      <td>lactate level</td>
      <td>In ANOVA results, QMS (p = 0.001) and lactate level (p = 0.038) showed significant interactions.</td>
    </tr>
    <tr>
      <th>753</th>
      <td>pharmacokinetic parameters<br>ritonavir concentration-versus-time profile</td>
      <td></td>
      <td>Figure ​Figure11 displays the ritonavir concentration-versus-time profile, and Table ​Table22 lists the pharmacokinetic parameters of ritonavir after multiple-dose administration of darunavir-ritonavir alone or in combination with E. purpurea.</td>
    </tr>
    <tr>
      <th>1137</th>
      <td>recovery<br>precision<br>matrix effect<br>selectivity<br>accuracy<br>dilution integrity<br>linearity<br>stability</td>
      <td></td>
      <td>The method was fully validated in compliance with the U.S. Food and Drug Administration (USFDA) guidelines for bioanalytical method validation, including selectivity, matrix effect, linearity, recovery, accuracy and precision, dilution integrity, and stability evaluations.</td>
    </tr>
    <tr>
      <th>560</th>
      <td>the elderly</td>
      <td></td>
      <td>It therefore was recommended that they should be avoided in the elderly [10, 12].</td>
    </tr>
    <tr>
      <th>1405</th>
      <td>glycyl-sarcosine (Gly-Sar)<br>Hygromycin B<br>thiazolyl blue tetrazolium bromide (MTT)</td>
      <td></td>
      <td>Hygromycin B, glycyl-sarcosine (Gly-Sar) and thiazolyl blue tetrazolium bromide (MTT) were purchased from Sigma-Aldrich Chem.</td>
    </tr>
    <tr>
      <th>1335</th>
      <td>P < 0.05</td>
      <td></td>
      <td>A difference was considered significant at P < 0.05.</td>
    </tr>
    <tr>
      <th>576</th>
      <td>12 weeks<br>Haloperidol<br>15 days</td>
      <td></td>
      <td>Haloperidol (38 mg/kg bw) was applied intramuscularly once every 4 weeks over 12 weeks beginning after 15 days of treatment with valerian [51].</td>
    </tr>
    <tr>
      <th>387</th>
      <td>amlodipine<br>hydrochlorothiazide<br>fimasartan<br>chromatograms</td>
      <td></td>
      <td>Figure 2 shows the chromatograms of the blank matrix and those of fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide spiked at the LLOQ or rat plasma samples 1 h after oral administration of fimasartan, amlodipine, and hydrochlorothiazide.</td>
    </tr>
    <tr>
      <th>357</th>
      <td>plasma concentrations</td>
      <td>plasma concentrations for these compounds</td>
      <td>Based on the centelloid content of CAW-R61J, we expect similar plasma concentrations for these compounds in our clinical studies using this extract.</td>
    </tr>
    <tr>
      <th>1156</th>
      <td>Gouqizi</td>
      <td></td>
      <td>In China, Gouqizi is a popular component of the daily diet, making the prohibition of its consumption in patients taking warfarin difficult to implement.</td>
    </tr>
    <tr>
      <th>233</th>
      <td>ethyl acetate<br>ethyl gallate<br>plasma<br>ascorbic acid-EDTA solution</td>
      <td></td>
      <td>Briefly, 1 mL of ethyl acetate was added to 100 µL plasma and ascorbic acid-EDTA solution 10:1 (v/v) mixture with 10 µL ethyl gallate (1 µg/mL) as internal standard and vortexed for 15 minutes and centrifuged at 4,500 rpm for 20 minutes.</td>
    </tr>
    <tr>
      <th>448</th>
      <td>patients taking prescription medications<br>herbal supplement usage<br>individuals greater than 65 years of age</td>
      <td></td>
      <td>[1–3,8,9] Still other surveys indicate that herbal supplement usage is prevalent among patients taking prescription medications,[10–12] with many individuals greater than 65 years of age.</td>
    </tr>
    <tr>
      <th>327</th>
      <td>drug disposition<br>transporter function<br>nuclear receptor agonists</td>
      <td>nuclear receptor</td>
      <td>Hepatocytes cultured in this format are responsive to nuclear receptor agonists and maintain important transporter function necessary for proper drug disposition (Yang et al., 2016).</td>
    </tr>
    <tr>
      <th>1228</th>
      <td>mRNA expression level of CYP2C6</td>
      <td></td>
      <td>Furthermore, no inductive effects were observed in the mRNA expression level of CYP2C6 for both doses of Danshen compared with the vehicle control group.</td>
    </tr>
    <tr>
      <th>194</th>
      <td>CYP2C9<br>FRE<br>CYP3A4 activity</td>
      <td></td>
      <td>GRT containing higher levels of polyphenols, in particular ASP (12.78% compared to 0.36%), demonstrated a more potent inhibition of CYP3A4 activity than FRE with IC CYP2C9 plays a role in the oxidation of xenobiotic and endogenous compounds and is responsible for the metabolism of 15%–20% of drugs undergoing phase I metabolism [52,53].</td>
    </tr>
    <tr>
      <th>1378</th>
      <td>type 1 Whatman filter paper<br>suction-filtered</td>
      <td></td>
      <td>The resulting liquor was suction-filtered through type 1 Whatman filter paper and stored in a sealed darkened glass container.</td>
    </tr>
    <tr>
      <th>279</th>
      <td>Bautista et al.</td>
      <td></td>
      <td>2016; Bautista et al.</td>
    </tr>
    <tr>
      <th>1165</th>
      <td>warfarin<br>Lycium barbarum L.</td>
      <td></td>
      <td>The interaction study of warfarin and Lycium barbarum L.  Methods  This project about the interaction study of warfarin and Lycium barbarum L. is approved by Fujian Medical University Union Hospital ethics committee (NO: 2015KY002).</td>
    </tr>
    <tr>
      <th>1559</th>
      <td>anxiety and mood disorders<br>fatigue and general well-being<br>cardiovascular disorders<br>symptoms of cognition decline and memory loss</td>
      <td></td>
      <td>Several controlled clinical studies, as shown by review and meta-analysis of published data, suggest that the use of ginkgo is associated with clinically significant improvement in symptoms of cognition decline and memory loss, anxiety and mood disorders, fatigue and general well-being, as well as cardiovascular disorders [59-61].</td>
    </tr>
    <tr>
      <th>461</th>
      <td>St. John’s wort</td>
      <td></td>
      <td>[54] Thus, a potential interaction may exist between these agents and St. John’s wort.</td>
    </tr>
    <tr>
      <th>1151</th>
      <td>anticoagulant therapy<br>thrombin times (TTs)<br>moderate intake of alcohol</td>
      <td>thrombin times (TTs)</td>
      <td>[7] previously showed that administration of 375 ml wine did not result in thrombin times (TTs) outside the therapeutic range, which suggested that a moderate intake of alcohol occasionally may be acceptable during anticoagulant therapy.</td>
    </tr>
    <tr>
      <th>648</th>
      <td>UGT2B7<br>4-MU glucuronidation</td>
      <td></td>
      <td>Inhibition kinetic analysis of celastrol (Cela) towards UGT2B7-catalyzed 4-MU glucuronidation.</td>
    </tr>
    <tr>
      <th>961</th>
      <td>12 h fasting<br>12-h light/dark cycle<br>25 °C</td>
      <td></td>
      <td>All animals were retained in polypropylene cages: 6 animals were caged (n = 6) per cage with a 12-h light/dark cycle, at 25 °C in humane conditions with free access to food and water and adapted to the living conditions one week prior to experiment The animals were categorized into four groups (n = 6) and fasted for 12 h before the experiment.</td>
    </tr>
    <tr>
      <th>271</th>
      <td>MTX<br>red ginseng</td>
      <td></td>
      <td>Therefore, the use of MTX and red ginseng alone or in combination is highly plausible for treatment of rheumatoid arthritis.</td>
    </tr>
    <tr>
      <th>402</th>
      <td>HAART administration</td>
      <td></td>
      <td>However, there are several challenges associated with the chronic nature of HAART administration.</td>
    </tr>
    <tr>
      <th>1071</th>
      <td>plasma captopril<br>ammonia solution<br>2-4-dibromoacetophenone</td>
      <td></td>
      <td>For derivatization of plasma captopril, a plasma sample (180 µL) was first mixed with 20 µL of 520 ppm 2-4-dibromoacetophenone stock solution and 20 µL of 5% ammonia solution, vortexed for 30 seconds, and incubated at room temperature for 30 min.</td>
    </tr>
    <tr>
      <th>179</th>
      <td>anti-diabetic<br>cardio-protective effects<br>anti-obesity</td>
      <td></td>
      <td>The anti-diabetic [9,10], anti-obesity [11], and cardio-protective effects [12,13,14] of rooibos extracts are of specific relevance given the global increase in the prevalence of diabetes and obesity [15,16,17].</td>
    </tr>
    <tr>
      <th>1433</th>
      <td>Fructus Arctii</td>
      <td></td>
      <td>Fructus Arctii (Fruit of Arctium lappa L., Niubangzi).</td>
    </tr>
    <tr>
      <th>1068</th>
      <td>jurisdictional claims<br>institutional affiliations</td>
      <td></td>
      <td>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</td>
    </tr>
    <tr>
      <th>105</th>
      <td>alternative medicines</td>
      <td></td>
      <td>Furthermore, 31% of diabetic patients have been reported to take alternative medicines, most in conjunction with conventional medicines (Ryan et al., 2001).</td>
    </tr>
    <tr>
      <th>1365</th>
      <td>Ginkgo biloba<br>Panax ginseng<br>Allium sativum<br>Hypericum perforatum</td>
      <td></td>
      <td>Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John’s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9].</td>
    </tr>
    <tr>
      <th>852</th>
      <td>use of herbal medicines</td>
      <td></td>
      <td>In identifying these possible interactions, we have highlighted the need for healthcare professionals to promote a proactive monitoring of patients' use of herbal medicines.</td>
    </tr>
    <tr>
      <th>1418</th>
      <td>OSA<br>systemic exposure of OS</td>
      <td></td>
      <td>The results suggested that co-administration with RS could significantly increase the systemic exposure of OS and decrease that of OSA (Fig.</td>
    </tr>
    <tr>
      <th>37</th>
      <td>tremors</td>
      <td></td>
      <td>The clinical pharmacist recommended dose increases of carbidopa-levodopa to help control his tremors still present early in the morning (Figure 1).</td>
    </tr>
    <tr>
      <th>1483</th>
      <td>tissue distribution profiles<br>tissue distribution curves<br>tissue to plasma distribution coefficients<br>K tissue distribution coefficients</td>
      <td></td>
      <td>PCE significantly increased the tissue to plasma distribution coefficients (K  Tissue distribution profiles of ciprofloxacin (CIP) after intravenous administration of CIP in the absence (A) and presence (B) of PCE to rats, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of GA in normal rats after intragastric administration of PCE in the absence and presence of CIP are displayed in Figures 7A,B, respectively.</td>
    </tr>
    <tr>
      <th>61</th>
      <td>AUC: concentration-time curve<br>PM<br>EMs</td>
      <td>AUC: concentration-time curve</td>
      <td>AUC: concentration-time curve; EMs: extensive metabolizer; PM: poor metabolizer.</td>
    </tr>
    <tr>
      <th>534</th>
      <td>Karnofsky performance status scale<br>TEM</td>
      <td></td>
      <td>The patient had a Karnofsky performance status scale of 90% after resection without neurological deficiencies and was referred to our department for further treatment with radiotherapy and temozolomide (TEM).</td>
    </tr>
    <tr>
      <th>643</th>
      <td>inhibition kinetic parameter (Ki)</td>
      <td></td>
      <td>The second plot (Figure 3C) using slope (obtained from Lineweaver-Burk plot) vs. celastrol concentration showed that the inhibition kinetic parameter (Ki) was 0.49 μM.</td>
    </tr>
    <tr>
      <th>751</th>
      <td>Darunavir pharmacokinetics</td>
      <td></td>
      <td>Darunavir pharmacokinetics.</td>
    </tr>
    <tr>
      <th>1188</th>
      <td>competitive inhibition<br>K m values<br>noncompetitive inhibition</td>
      <td>K m values<br>concentrations of substrates</td>
      <td>Theoretically, the discrimination between competitive and noncompetitive inhibitions is not critical when concentrations of substrates are much lower than their K m values, which is often the case in the clinical setting.</td>
    </tr>
    <tr>
      <th>874</th>
      <td>pharmacological safety</td>
      <td></td>
      <td>However, there is hardly any data on the pharmacological safety of these two herbal medicines.</td>
    </tr>
    <tr>
      <th>785</th>
      <td>composition<br>extraction and formulation method<br>bioanalytical data</td>
      <td></td>
      <td>Extraction and formulation method, composition, and bioanalytical data regarding the herbal preparations from the included RCTs are summarized Table 2.</td>
    </tr>
    <tr>
      <th>908</th>
      <td>tablet form</td>
      <td></td>
      <td>Its original formulation was in a tablet form.</td>
    </tr>
    <tr>
      <th>1566</th>
      <td>pharmacokinetic parameters<br>AUC<br>CYP3A4<br>midazolam</td>
      <td>AUC</td>
      <td>The inhibitory and inductive effect of the different phytochemicals in ginseng on CYP3A4 is demonstrated through the observed changes in the AUC and other pharmacokinetic parameters of midazolam in these human studies [27, 88].</td>
    </tr>
    <tr>
      <th>842</th>
      <td>gastric absorption<br>plasma level of CBZ</td>
      <td></td>
      <td>Ispaghula husk, septilin, soybean and Xiao-cha-hu-tang reduced the plasma level of CBZ by affecting its gastric absorption.</td>
    </tr>
    <tr>
      <th>1260</th>
      <td>analyte</td>
      <td></td>
      <td>The extraction recovery from human plasma was considered acceptable with a mean recovery of greater than 88% for each analyte.</td>
    </tr>
    <tr>
      <th>997</th>
      <td>bioavailability<br>efficacy</td>
      <td>bioavailability</td>
      <td>The first clinically relevant reports of preparations of St. John's wort (SJW), a herbal medicine with anti‐depressant effects, interacting with other drugs, altering their bioavailability and efficacy, were published about 20 years ago.</td>
    </tr>
    <tr>
      <th>137</th>
      <td>Naranjo Causality Scale</td>
      <td></td>
      <td>Naranjo [8] Causality Scale for Adverse Drug Reactions.</td>
    </tr>
    <tr>
      <th>666</th>
      <td>plasma samples<br>valsartan<br>ginsenosides</td>
      <td></td>
      <td>After centrifugation of the blood samples at 16,000× g for 10 min, aliquots (50 μL each) of plasma samples were stored at −80 °C until the analysis of ginsenosides and valsartan.</td>
    </tr>
    <tr>
      <th>1593</th>
      <td>herb–drug interactions</td>
      <td></td>
      <td>Contrary to this safety perception, herb–drug interactions could lead to serious adverse effects.</td>
    </tr>
    <tr>
      <th>1588</th>
      <td>calcineurin inhibitors</td>
      <td></td>
      <td>Sirolimus displays a synergistic action with calcineurin inhibitors and a distinctive mechanism of action from calcineurin inhibitors, which are indispensable immunosuppressive agents in kidney transplantation.</td>
    </tr>
    <tr>
      <th>992</th>
      <td>BMI<br>height<br>weight</td>
      <td>BMI</td>
      <td>There were no significant differences between the groups for height, weight, or BMI at baseline (Table 1).</td>
    </tr>
    <tr>
      <th>1134</th>
      <td>0–6 h<br>6–18 h<br>18–28 h</td>
      <td></td>
      <td>Urine and feces were collected 0–6 h, 6–18 h and 18–28 h after administration.</td>
    </tr>
    <tr>
      <th>1293</th>
      <td>aqueous extract<br>Allium sativum bulbs</td>
      <td></td>
      <td>In this study, aqueous extract of oven‐dried Allium sativum bulbs was used.</td>
    </tr>
    <tr>
      <th>28</th>
      <td>nicotine dependence<br>spinal stenosis<br>chronic neck pain<br>alcohol dependence<br>mild kidney disease<br>frequent falls<br>chronic back pain<br>chronic shoulder pain<br>vitamin D deficiency</td>
      <td></td>
      <td>In addition to PD, the patient’s past medical history includes spinal stenosis, vitamin D deficiency, frequent falls, a history of nicotine and alcohol dependence, mild kidney disease, and chronic neck, back, and shoulder pain.</td>
    </tr>
    <tr>
      <th>489</th>
      <td>adverse side effects from taking G. kola seeds<br>histories of hypersensitivity to quinine or similar agents<br>breastfeeding<br>pregnancy</td>
      <td></td>
      <td>Pregnancy, breastfeeding, histories of hypersensitivity to quinine or similar agents, or adverse side effects from taking G. kola seeds were also used as exclusion criteria for the study.</td>
    </tr>
    <tr>
      <th>188</th>
      <td>DMSO<br>acetonitrile<br>methanol</td>
      <td></td>
      <td>The organic solvents such as methanol, acetonitrile and DMSO showed no inhibitory effects on the respective enzymes (Supplementary Materials, Figure S1a–c).</td>
    </tr>
    <tr>
      <th>1202</th>
      <td>haemorrhage</td>
      <td></td>
      <td>Ginkgo biloba is available as an over-the-counter drug and reported to cause haemorrhage when coadministered with other antiplatelet agents.</td>
    </tr>
    <tr>
      <th>224</th>
      <td>alkylamide content<br>DTAI</td>
      <td></td>
      <td>For example, alkylamide content is known to vary considerably across different parts of E. purpurea plants [20], and DTAI are more abundant in roots than in leaves.</td>
    </tr>
    <tr>
      <th>1002</th>
      <td>time of immobility</td>
      <td></td>
      <td>The tail suspension test, which also measures changes in immobility in rodents after antidepressant treatment, was applied by several investigators (Butterweck, Christoffel, et al., 2003; Machado et al., 2008; Tian et al., 2014) and SJW extracts significantly reduced the time of immobility in this test.</td>
    </tr>
    <tr>
      <th>1118</th>
      <td>pharmacokinetic parameters</td>
      <td></td>
      <td>Our results first clarified that oral administration of A. officinarum produced significant alterations in the pharmacokinetic parameters of indomethacin.</td>
    </tr>
    <tr>
      <th>1295</th>
      <td>CYP2C9<br>CYP1A2</td>
      <td></td>
      <td>Aqueous extract of Moringa oleifera leaves showed weak inhibition of CYP1A2 and CYP2C9.</td>
    </tr>
    <tr>
      <th>1287</th>
      <td>type of the extract<br>assay method<br>extraction procedure<br>enzyme sources<br>CYP isoenzymes<br>concentration</td>
      <td></td>
      <td>Though we did not report any inhibition of CYP isoenzymes by Allium sativum, the discrepancies in these reports and ours may be due to the extraction procedure, assay method, concentration and type of the extract used and enzyme sources.</td>
    </tr>
    <tr>
      <th>150</th>
      <td>distribution rate<br>LVFX</td>
      <td></td>
      <td>Polygonum capitatum may inhibit the entrance of LVFX into blood, thereby directly affecting its distribution rate in the tissue.</td>
    </tr>
    <tr>
      <th>469</th>
      <td>Panax ginseng<br>CYP isoforms</td>
      <td></td>
      <td>Like G. biloba, Panax ginseng appears to have little effect on the activities of the specific CYP isoforms investigated in this study.</td>
    </tr>
    <tr>
      <th>536</th>
      <td>positron emission tomography<br>residual tumor</td>
      <td></td>
      <td>Unfortunately, a [18 F]-fluorethylenthyrosin positron emission tomography positive residual tumor was detected 2 months after the end of radiotherapy.</td>
    </tr>
    <tr>
      <th>559</th>
      <td>CYP 3A4</td>
      <td></td>
      <td>However, they state that warnings that valerian (Valeriana officinalis) may stimulate CYP 3A4.</td>
    </tr>
    <tr>
      <th>1656</th>
      <td>additive/synergistic interactions<br>clinical safety<br>clinical efficacy<br>antagonistic interactions</td>
      <td></td>
      <td>Herb–drug interactions (HDI) may affect clinical safety and efficacy via additive/synergistic or antagonistic interactions among the herbal components and drug molecules.</td>
    </tr>
    <tr>
      <th>1336</th>
      <td>40 mg simvastatin</td>
      <td></td>
      <td>(B) Plasma obtained from the volunteer received single oral dose of 40 mg simvastatin.</td>
    </tr>
    <tr>
      <th>1108</th>
      <td>inflammatory response<br>oxidative stress</td>
      <td></td>
      <td>The underlying mechanism of diabetes that contributes to liver damage is the combination of increased oxidative stress and an aberrant inflammatory response.</td>
    </tr>
    <tr>
      <th>497</th>
      <td>1, 2, 3,4, 6, 8, 12, 24, 36 and 48 h<br>time zero<br>concurrently with the scheduled dose of G. kola<br>quinine sulphate tablets<br>quinine alone</td>
      <td></td>
      <td>Sample collection  Venous blood samples (5ml) was collected into heparinised tubes at time zero (just before the administration of quinine sulphate tablets)) and at 1, 2, 3,4, 6, 8, 12, 24, 36 and 48 h after each participant received quinine alone or concurrently with the scheduled dose of G. kola.</td>
    </tr>
    <tr>
      <th>1404</th>
      <td>Albuterol</td>
      <td></td>
      <td>Albuterol (as internal standard) was purchased from Sigma-Aldrich Chem.</td>
    </tr>
    <tr>
      <th>1080</th>
      <td>rats plasma</td>
      <td></td>
      <td>In selectivity testing, six rats plasma was used.</td>
    </tr>
    <tr>
      <th>268</th>
      <td>P-gp<br>bile acid receptor</td>
      <td></td>
      <td>Nuclear receptors, such as farnesoid X receptor (FXR, also known as bile acid receptor) and pregnane X receptor (PXR), are known as major regulators of the expression of Bsep and P-gp, respectively [35].</td>
    </tr>
    <tr>
      <th>664</th>
      <td>plasma concentration<br>unbound fraction of tri-glycosylated PPD-type ginsenosides</td>
      <td></td>
      <td>The plasma concentration was ranged from 7.8 μM to 34.1 μM but unbound fraction of tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc) was very low (0.1–0.2% in rat plasma, 0.4–0.5% in rat liver; Figure 9B).</td>
    </tr>
    <tr>
      <th>349</th>
      <td>triplicate determinations</td>
      <td></td>
      <td>of triplicate determinations.</td>
    </tr>
    <tr>
      <th>812</th>
      <td>terminal elimination rate constant<br>SAS Institute</td>
      <td></td>
      <td>The terminal elimination rate constant (λ All statistical analyses were conducted using SAS (v. 9.2; SAS Institute).</td>
    </tr>
    <tr>
      <th>824</th>
      <td>percent blood glucose reduction</td>
      <td></td>
      <td>However, multiple-dose combination of curcumin with gliclazide produced significantly greater reduction in percent blood glucose reduction at 3-, 4-, 6-, 8-, 10-, and 12-hour intervals after treatment in normal rats and rabbits when compared with gliclazide control.</td>
    </tr>
    <tr>
      <th>791</th>
      <td>herb-warfarin interaction</td>
      <td></td>
      <td>These relevant case reports indicated a potential herb-warfarin interaction, but it was difficult to identify a causal relationship.</td>
    </tr>
    <tr>
      <th>998</th>
      <td>pregnane‐X‐receptor (PXR) activation</td>
      <td></td>
      <td>These interactions were caused by pregnane‐X‐receptor (PXR) activation.</td>
    </tr>
    <tr>
      <th>371</th>
      <td>berberine (IS)<br>1 ng/mL</td>
      <td></td>
      <td>Then, 150 μL acetonitrile containing 1 ng/mL berberine (IS) was added to the reconstituted standard curves.</td>
    </tr>
    <tr>
      <th>1491</th>
      <td>potential conflict of interest</td>
      <td></td>
      <td>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</td>
    </tr>
    <tr>
      <th>1649</th>
      <td>HMP<br>Valerian<br>Garcia-Alvarez</td>
      <td></td>
      <td>Valerian, for example, is marketed in Germany, mainly as HMP, and, thus, possibly a great proportion of consumption was not included in the survey by Garcia-Alvarez [7].</td>
    </tr>
    <tr>
      <th>281</th>
      <td>AC<br>DST</td>
      <td></td>
      <td>However, it is unknown whether there is an interaction between AC and DST.</td>
    </tr>
    <tr>
      <th>1586</th>
      <td>neuropsychiatric drugs</td>
      <td></td>
      <td>This review identified 13 herbal products - celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John’s wort, terminalia/commiphora ayurvedic mixture and valerian – all of which have shown interactions with specific neuropsychiatric drugs.</td>
    </tr>
    <tr>
      <th>1681</th>
      <td>dextrorphan (DOR)<br>DEX</td>
      <td></td>
      <td>The O-demethylation of DEX to dextrorphan (DOR) is predominantly mediated by CYP2D6 (Barnhart, 1980; Schadel et al., 1995).</td>
    </tr>
    <tr>
      <th>17</th>
      <td>transport mechanisms<br>unknown mechanisms<br>death receptor</td>
      <td></td>
      <td>Moreover, as the patient took a commercial preparation of chokeberry juice which did not provide information on the amounts of its compounds, it cannot be excluded that other interactions might have occurred such as the inhibition of transport mechanisms, the activation of the death receptor and other unknown mechanisms.</td>
    </tr>
    <tr>
      <th>584</th>
      <td>drug-drug interactions</td>
      <td></td>
      <td>A good understanding of the mechanisms of drug-drug interactions is essential for assessing and minimizing clinical risks.</td>
    </tr>
    <tr>
      <th>538</th>
      <td>education about the risk of interactions with herbal formulas</td>
      <td></td>
      <td>Therefore, we think that a comprehensive management of our patients should also include education about the risk of interactions with herbal formulas.</td>
    </tr>
    <tr>
      <th>907</th>
      <td>drug interactions</td>
      <td></td>
      <td>Drug interactions may occur between woohwangcheongsimwon suspension and bupropion.</td>
    </tr>
    <tr>
      <th>724</th>
      <td>insulin<br>FBS level<br>pancreatic β cells<br>serotonin receptors</td>
      <td>FBS level</td>
      <td>demonstrated that ginger could decrease the FBS level by the mechanism of serotonin receptors which activate pancreatic β cells to release insulin [56].</td>
    </tr>
    <tr>
      <th>1537</th>
      <td>felodipine<br>P-glycoprotein<br>cytochrome P450</td>
      <td></td>
      <td>Since the accidental discovery of the ability of grapefruit juice to alter the pharmacokinetic profiles of felodipine through the inhibition of cytochrome P450 (CYP) and P-glycoprotein (P-gp), more studies have elucidated various mechanisms of HDI [11].</td>
    </tr>
    <tr>
      <th>1363</th>
      <td>herb-drug use<br>awareness of herb-drug use</td>
      <td></td>
      <td>A survey of cancer patients attending the oncology and urology clinics at the University Hospital of the West Indies in Kingston, and two earlier surveys of Jamaican prescription drug users identified high levels of herb-drug use (80% [4] 80% [5] and 81% [6], respectively), while awareness of such herb-drug use amongst health care professionals was low across all four surveys (13% [5], 15% [4], 18% [6] and 19% [3], respectively).</td>
    </tr>
    <tr>
      <th>226</th>
      <td>CYP3A4 induction</td>
      <td></td>
      <td>In LS180 cells, our group has shown significant induction of CYP3A4 by isolated alkylamides and E. purpurea extracts using a gene reporter assay, which is a reliable method to assess the CYP3A4 induction potential of compounds [23].</td>
    </tr>
    <tr>
      <th>983</th>
      <td>angular velocity<br>isokinetic knee extensions<br>2 min</td>
      <td></td>
      <td>In the main test session, subjects performed 5 isokinetic knee extensions of the leg at an angular velocity of 60 degrees/second, and subjects recovered passively for 2 min between sets of measurements [26,27].</td>
    </tr>
    <tr>
      <th>585</th>
      <td>metabolism of extract components<br>in vivo bioavailability</td>
      <td>bioavailability</td>
      <td>Especially the open questions of in vivo bioavailability and of the metabolism of extract components relevant for in vitro effects often prevent reliable extrapolations from in vitro to in vivo data.</td>
    </tr>
    <tr>
      <th>70</th>
      <td>CYP2C19<br>CYP2C9<br>CYP1A2</td>
      <td></td>
      <td>This study concentrated on investigating the effects of potential interaction between extracts from Newbouldia laevis and Cassia abbreviata on CYP1A2, CYP2C9, and CYP2C19 activities.</td>
    </tr>
    <tr>
      <th>1590</th>
      <td>sirolimus<br>tacrolimus<br>tremors</td>
      <td></td>
      <td>The patient received tacrolimus-based immunosuppression until April 2016, and then the treatment was switched from tacrolimus to sirolimus due to evident tremors.</td>
    </tr>
    <tr>
      <th>981</th>
      <td>quadriceps muscle strength (QMS)<br>lactate at rest</td>
      <td>quadriceps muscle strength (QMS)<br>lactate</td>
      <td>The purpose of this study was to evaluate the effect of SC extract supplementation on quadriceps muscle strength (QMS) and lactate at rest in adult women.</td>
    </tr>
    <tr>
      <th>641</th>
      <td>inhibition of compounds towards UGT isoforms</td>
      <td></td>
      <td>Therefore, evaluation of inhibition of compounds towards UGT isoforms was always carried out using recombinant UGTs and nonspecific substrates [19,20,21].</td>
    </tr>
    <tr>
      <th>421</th>
      <td>phytochemical profiling<br>drug interacting constituents<br>mechanistic studies</td>
      <td></td>
      <td>The advantage of phytochemical profiling is that similar drug interacting constituents could be identified in other related herbs that are used for therapeutic purposes and that necessary mechanistic studies are performed on them.</td>
    </tr>
    <tr>
      <th>558</th>
      <td>anticancer drugs</td>
      <td></td>
      <td>Academic Editor: Igho J. Onakpoya In recent popular publications as well as in widely used information websites directed to cancer patients, valerian is claimed to have a potential of adverse interactions with anticancer drugs.</td>
    </tr>
    <tr>
      <th>38</th>
      <td>additional medication for pain control</td>
      <td></td>
      <td>However, his PCP determined that additional medication for pain control was warranted.</td>
    </tr>
    <tr>
      <th>295</th>
      <td>effective plasma drug concentration</td>
      <td></td>
      <td>Its effective plasma drug concentration is close to the toxic concentration, and large individual differences in the effects of the drug have been observed.</td>
    </tr>
    <tr>
      <th>1647</th>
      <td>adverse effects<br>natural</td>
      <td></td>
      <td>It is important to make patients aware of the fact that plants can cause adverse effects and are not safe in every situation by being “natural”.</td>
    </tr>
    <tr>
      <th>1112</th>
      <td>diabetic control group<br>normal group</td>
      <td></td>
      <td>*significantly different from normal group, # significantly different from diabetic control group at p < 0.001.</td>
    </tr>
    <tr>
      <th>1176</th>
      <td>interaction</td>
      <td></td>
      <td>Interaction between imatinib and Schisandra lignans was unlikely to be of clinical importance.</td>
    </tr>
    <tr>
      <th>1036</th>
      <td>traditional hypoglycemic herbs</td>
      <td></td>
      <td>a.</td>
    </tr>
    <tr>
      <th>1619</th>
      <td>hepatotoxic herbs</td>
      <td></td>
      <td>Many potentially hepatotoxic herbs are not studied extensively enough to determine a safe daily dose.</td>
    </tr>
    <tr>
      <th>1114</th>
      <td>BUN levels</td>
      <td>BUN</td>
      <td>Treatment with EJE and EJE + SITA significantly (p < 0.001) reduced the elevated levels of BUN (Fig.</td>
    </tr>
    <tr>
      <th>283</th>
      <td>3.5 μm</td>
      <td></td>
      <td>; 3.5 μm) at room temperature.</td>
    </tr>
    <tr>
      <th>1683</th>
      <td>DEX<br>CYP2D6<br>CYP3A</td>
      <td>CYP2D6<br>CYP3A</td>
      <td>So, DEX has been used as a common probe for both CYP3A and CYP2D6 activities (Spanakis et al., 2009; Yu and Haining, 2001), as well as in vivo in several studies (Ducharme et al., 1996; Funck-Brentano et al., 2005; Jones et al., 1996).</td>
    </tr>
    <tr>
      <th>333</th>
      <td>dried CA<br>CAW-R61F<br>CAW-R61H</td>
      <td></td>
      <td>Aliquots of the two filtrates were shipped to Oregon Health & Science University (OHSU, Portland, OR), where they were frozen and lyophilized, yielding 21.4% from dried CA for CAW-R61F (extraction lot 1) and 23.9% from dried CA for CAW-R61H (extraction lot 2).</td>
    </tr>
    <tr>
      <th>608</th>
      <td>inhibidores da isoenzima CYP2D6<br>fenótipo de metabolização lenta de CYP2D6</td>
      <td></td>
      <td>A administração circunstancial de inibidores da isoenzima CYP2D6 e a presença de um fenótipo de metabolização lenta de CYP2D6 podem ter resultado na acumulação tóxica da venlafaxina e na manifestação clínica subsequente.</td>
    </tr>
    <tr>
      <th>837</th>
      <td>traditional hypoglycemic herbs</td>
      <td></td>
      <td>2012).</td>
    </tr>
    <tr>
      <th>382</th>
      <td>amlodipine<br>berberine<br>acetonitrile</td>
      <td></td>
      <td>For amlodipine analysis, 50 μL aliquots were mixed with 150 μL acetonitrile containing 1 ng/mL berberine (IS).</td>
    </tr>
    <tr>
      <th>960</th>
      <td>pharmacokinetic parameters</td>
      <td></td>
      <td>The radical alteration in the pharmacokinetic parameters of DAS 25 mg/kg P.O.</td>
    </tr>
    <tr>
      <th>570</th>
      <td>clinical relevance</td>
      <td></td>
      <td>These limitations do not allow valid extrapolations with respect to a clinical relevance of the results.</td>
    </tr>
    <tr>
      <th>432</th>
      <td>7 ± 1-day washout period</td>
      <td></td>
      <td>Each participant received three treatments with a 7 ± 1-day washout period in-between.</td>
    </tr>
    <tr>
      <th>1408</th>
      <td>PBS<br>dichlorvos</td>
      <td></td>
      <td>The reaction was terminated by adding 5 μL of 8 mg/mL dichlorvos and then mixed with 600 μL PBS.</td>
    </tr>
    <tr>
      <th>517</th>
      <td>drug interactions</td>
      <td></td>
      <td>However, a large number of these therapies have been shown that they are not safe and can be harmful due to their interactions with other drugs which are used contemporaneously.</td>
    </tr>
    <tr>
      <th>567</th>
      <td>completeness and validity of data<br>clinical relevance of the results<br>potential bias in the presentation of results and conclusions</td>
      <td></td>
      <td>Studies were assessed for completeness and validity of data on material and methods, on the potential clinical relevance of the results and on potential bias in the presentation of results and conclusions.</td>
    </tr>
    <tr>
      <th>1401</th>
      <td>Radix Scutellariae extract<br>quality of control standard number<br>batch number</td>
      <td></td>
      <td>A commercially available, standardized and purified Radix Scutellariae extract (RS) was obtained from Shanghai U-sea Biotech Co., Ltd. (Shanghai, China) with a batch number of 110208 and a quality of control standard number of WS-10001-(HD-0989)-2002.</td>
    </tr>
    <tr>
      <th>95</th>
      <td>OATs<br>SLC22 family members</td>
      <td>OATs<br>SLC22</td>
      <td>Currently, there are 29 putative SLC22 family members, 18 of which are believed to be OATs.</td>
    </tr>
    <tr>
      <th>595</th>
      <td>CYP3A inhibition<br>CYP3A induction</td>
      <td></td>
      <td>Subjects also received rifampin (600 mg) and clarithromycin (1000 mg) for 7 days as positive controls for CYP3A induction and inhibition, respectively.</td>
    </tr>
    <tr>
      <th>1147</th>
      <td>traditional hypoglycemic herbs</td>
      <td></td>
      <td>1).</td>
    </tr>
    <tr>
      <th>1571</th>
      <td>CNS benefits</td>
      <td></td>
      <td>Despite the general concern about its safety, kava is still popularly consumed for CNS benefits.</td>
    </tr>
    <tr>
      <th>1449</th>
      <td>synergistic inhibitory effect</td>
      <td>MCF-7 and T-47D cell growth</td>
      <td>When combined with TAM, it exhibits a significant synergistic inhibitory effect on MCF-7 and T-47D cell growth (Cho et al., 2010).</td>
    </tr>
    <tr>
      <th>1206</th>
      <td>protein expression<br>mRNA expression</td>
      <td></td>
      <td>Microsomes incubation, Real Time-Polymerase Chain Reaction and Western blot was applied respectively to study the activity, mRNA expression and protein expression of CYP, VKOR and TM.</td>
    </tr>
    <tr>
      <th>1185</th>
      <td>noncompetitive<br>competitive<br>mixed-inhibition</td>
      <td></td>
      <td>The competitive, noncompetitive and mixed‐inhibition models (Equations 1–3, respectively) were considered.</td>
    </tr>
    <tr>
      <th>1249</th>
      <td>liver cytochrome P450<br>beta-naphthoflavone<br>enzyme-linked immunosorbent assay<br>vitamin K epoxide reductase<br>cyclosporine<br>thrombomodulin<br>phenobarbital<br>vitamin K<br>Danshen–Gegen Formula<br>salvianolic acid B</td>
      <td></td>
      <td>liver cytochrome P450 vitamin K epoxide reductase vitamin K vitamin K thrombomodulin Danshen–Gegen Formula salvianolic acid B phenobarbital beta-naphthoflavone cyclophosphamide enzyme-linked immunosorbent assay Beikang Ge and Zhen Zhang contributed equally to this work BKG, ZZh and ZZu conceived and designed the study.</td>
    </tr>
    <tr>
      <th>854</th>
      <td>Table 1</td>
      <td></td>
      <td>A summary of the background characteristics of the interviewed patients is given in Table 1.</td>
    </tr>
    <tr>
      <th>802</th>
      <td>WSU Institutional Review Board</td>
      <td></td>
      <td>The WSU Institutional Review Board reviewed and approved the study protocol and consent form prior to subject enrollment.</td>
    </tr>
    <tr>
      <th>1583</th>
      <td>dietary supplements</td>
      <td></td>
      <td>This is because many marketed herbal products are made of mixtures of different herbal species and/or dietary supplements whose biological disposition in humans is poorly understood.</td>
    </tr>
    <tr>
      <th>561</th>
      <td>daily doses<br>tablets<br>capsules<br>valerian root extracts</td>
      <td></td>
      <td>Recommended daily doses of valerian root extracts are about 600 mg, usually taken as capsules or tablets.</td>
    </tr>
    <tr>
      <th>516</th>
      <td>Chronic kidney disease (CKD)</td>
      <td></td>
      <td>Chronic kidney disease (CKD) is a global public health problem with an increasing incidence and a lot of economic burden for treatment.</td>
    </tr>
    <tr>
      <th>974</th>
      <td>Research Ethics Committee of King Saud University College of Pharmacy Riyadh<br>KSU-SE-21-58</td>
      <td></td>
      <td>The research was approved by the Research Ethics Committee of King Saud University College of Pharmacy Riyadh, Saudi Arabia (KSU-SE-21-58).</td>
    </tr>
    <tr>
      <th>788</th>
      <td>attrition</td>
      <td></td>
      <td>For incomplete outcome data, seven trials [21–24, 26, 28, 29] reported detailed information regarding attrition by describing the number and reasons for withdrawal.</td>
    </tr>
    <tr>
      <th>1037</th>
      <td>GATA-3<br>caspase 3<br>Foxp3<br>Bax<br>T-bet<br>PD-1</td>
      <td></td>
      <td>Multiple mechanisms may be involved, including upregulation of transcription factors such as T-box protein expressed in T cells (T-bet) and GATA-3, which modulate the T helper cell balance [169]; downregulation of Bax expression to reduce caspase 3 activity and T cell apoptosis [170]; and reduction of the expression of negative regulators/transcription factors of immune responses, including Forkhead box protein 3 (Foxp3) and programmed death 1 (PD-1) [171].</td>
    </tr>
    <tr>
      <th>438</th>
      <td>GGT 7680 mg once daily<br>AAP 1000 mg once daily<br>AAP 1000 mg × 4 times daily</td>
      <td></td>
      <td>Therefore, two simulation scenarios were used to evaluate the magnitude of any interaction, (AAP 1000 mg once daily + GGT 7680 mg once daily) and (AAP 1000 mg × 4 times daily + GGT 7680 mg once daily) in a week.</td>
    </tr>
    <tr>
      <th>345</th>
      <td>CYP2B6<br>CYP2C9<br>CYP1A2</td>
      <td>IC50</td>
      <td>The strongest reversible inhibition was against CYP2C9 (IC50 330 µg/ml), and the least inhibition was against CYP1A2 and CYP2B6 (IC50 > 1000 µg/ml).</td>
    </tr>
    <tr>
      <th>204</th>
      <td>participants<br>Echinacea</td>
      <td></td>
      <td>Echinacea was well tolerated, and all participants completed the study.</td>
    </tr>
    <tr>
      <th>543</th>
      <td>apparent volume of distribution (V/F)<br>half-life<br>apparent clearance (CL/F)</td>
      <td>CL/F<br>half-life<br>AUC0−∞<br>CL/kel</td>
      <td>The half-life was calculated as ln 2/kel, the apparent clearance (CL/F) as dose/AUC0−∞ and the apparent volume of distribution (V/F) as CL/kel.</td>
    </tr>
    <tr>
      <th>244</th>
      <td>C1236T<br>G2677A<br>ABCB1<br>rs2032582<br>G2677T<br>rs1128503<br>C3435T<br>rs1045642</td>
      <td></td>
      <td>The identification of genotyping was performed for 4 single-nucleotide polymorphisms (SNPs) in ABCB1, namely C3435T (rs1045642), C1236T (rs1128503), G2677A (rs2032582), and G2677T (rs2032582).</td>
    </tr>
    <tr>
      <th>851</th>
      <td>herbal medicines</td>
      <td></td>
      <td>Fifty percent of the informants used herbal medicines alongside their prescription drugs.</td>
    </tr>
    <tr>
      <th>396</th>
      <td>fimasartan combination therapy<br>hypertension<br>fimasartan monotherapy</td>
      <td></td>
      <td>These results suggest that fimasartan is an attractive candidate for the treatment of hypertension and suggest the increasing use of fimasartan monotherapy and combination therapy.</td>
    </tr>
    <tr>
      <th>990</th>
      <td>SC extract supplementation<br>placebo compliance</td>
      <td></td>
      <td>The mean SC extract supplementation and placebo compliance were 97.3% (90.2−100%) in the SC group and 95.8% (86.7–100%) in the placebo group.</td>
    </tr>
    <tr>
      <th>1246</th>
      <td>warfarin hydroxylation</td>
      <td></td>
      <td>This finding is also supported by Yueng’s study, where the major tanshinone components rather than the aqueous extract of Danshen showed effects on warfarin hydroxylation in vitro and in vivo [58].</td>
    </tr>
    <tr>
      <th>206</th>
      <td>traditional hypoglycemic herbs</td>
      <td></td>
      <td>2).</td>
    </tr>
    <tr>
      <th>1057</th>
      <td>proliferation</td>
      <td></td>
      <td>Significances are given relative to the VAEM untreated values (*p < 0.05, **p < 0.01, ***p < 0.001) VAEM, as well as endoxifen, showed a concentration-dependent inhibition of proliferation (Fig.</td>
    </tr>
    <tr>
      <th>1077</th>
      <td>body fluid</td>
      <td></td>
      <td>The loss of body fluid was compensated by administrating 1.0 mL saline solution (p.o.)</td>
    </tr>
    <tr>
      <th>1339</th>
      <td>bleeding<br>diabetes<br>hypertension<br>fatigue<br>stent</td>
      <td></td>
      <td>Case Report: Fatigue and Bleeding in a Polymedicated Patient Using Several Herbal Supplementations, Detected with g-Nomic® Software Abel Saldarreaga Marin, 1 Marc Cendros, 2 Carlos J Ciudad, 3 and Ana Sabater 2 Author information Article notes Copyright and License information PMC Disclaimer Go to: Abstract  This was a case report of severe fatigue and bleeding in a 65-year-old man with ischemic heart disease who was wearing a stent and taking multiple medications for hypertension and diabetes.</td>
    </tr>
    <tr>
      <th>1265</th>
      <td>herbal medicines<br>dietary supplements</td>
      <td></td>
      <td>Increasing use of medicinal herbs as nutritional supplements and traditional medicines for the treatment of diabetes, hypertension, hyperlipidemia, and malaria fever with conventional drugs poses possibilities of herb–drug interactions ( In vitro inhibition of eight major   Mangifera indica moderately inhibited  Potential for clinically important     Funding information  This research did not receive any specific grant from funding agencies in the public, commercial, or not‐for‐profit sectors Management of chronic diseases is burdensome to patients (Eton et al., 2013; Ørtenblad, Meillier, & Jønsson, 2017) who tend to seek alternative remedies to conventional medications that may supposedly provide cure or offer safe use (Yarney et al., 2013; Joeliantina, Agil, Qomaruddin, Jonosewojo, & Kusnanto, 2016) This self‐medication practice is common among chronically ill patients or patients with terminal diseases (Bodenheimer, Lorig, Holman, & Grumbach, 2002; Hasan, Ahmed, Bukhari, & Loon, 2009), and the major culprit in this group of patients are dietary supplements and herbal medicines (Gardiner, Graham, Legedza, Eisenberg, & Phillips, 2006; Gardiner, Phillips, & Shaughnessy, 2008).</td>
    </tr>
    <tr>
      <th>779</th>
      <td>warfarin<br>PK-PD parameters<br>herbal medicines</td>
      <td>PK-PD parameters</td>
      <td>The aim of this article was to systematically review clinical data, including PK-PD parameters, from randomized controlled trials (RCTs) and to discuss interactions between herbal medicines and warfarin.</td>
    </tr>
    <tr>
      <th>550</th>
      <td>population PKPD parameter estimates</td>
      <td></td>
      <td>Pharmacokinetic–pharmacodynamic modelling  The population PKPD parameter estimates for warfarin are presented in the Table 3.</td>
    </tr>
    <tr>
      <th>1533</th>
      <td>LC-MS/MS system control<br>Mass Hunter software<br>data processing</td>
      <td></td>
      <td>Mass Hunter software (Agilent Technologies) was used for LC-MS/MS system control and data processing.</td>
    </tr>
    <tr>
      <th>443</th>
      <td>pharmacokinetic (PK) parameters</td>
      <td></td>
      <td>Non-compartmental analysis (NCA) result of pharmacokinetic (PK) parameters of AAP.</td>
    </tr>
    <tr>
      <th>290</th>
      <td>plasma samples<br>selectivity</td>
      <td></td>
      <td>In the present study, the selectivity was examined using independent plasma samples from six different rats.</td>
    </tr>
    <tr>
      <th>1088</th>
      <td>traditional hypoglycemic herbs</td>
      <td></td>
      <td>2016).</td>
    </tr>
    <tr>
      <th>320</th>
      <td>TCM formulations<br>digoxin</td>
      <td></td>
      <td>Therefore, the interactions between TCM formulations and digoxin are difficult to elucidate, and they are easily ignored by physicians.</td>
    </tr>
    <tr>
      <th>1675</th>
      <td>hysteria<br>bronchitis<br>convulsions<br>flatulence<br>cough<br>asthma</td>
      <td></td>
      <td>Asafetida has been used as a folk medication for various ailments including flatulence, cough, asthma, bronchitis, hysteria, and convulsions (Eigner and Scholz, 1999).</td>
    </tr>
    <tr>
      <th>243</th>
      <td>DNA</td>
      <td></td>
      <td>DNA was isolated from the 200 µL of whole blood samples using a QIAamp DNA Blood Mini Kit (Qiagen, Germantown, MD, USA).</td>
    </tr>
    <tr>
      <th>45</th>
      <td>hallucinations</td>
      <td></td>
      <td>Additionally, a previous study evaluated patients with PD and their subsequent reactions to cannabis use, reporting that one out of five patients experienced hallucinations [12].</td>
    </tr>
    <tr>
      <th>143</th>
      <td>pharmacokinetic features</td>
      <td></td>
      <td>In vivo distribution studies are crucial in drug research as they can be performed to demonstrate the pharmacokinetic features of a drug [21, 22].</td>
    </tr>
    <tr>
      <th>590</th>
      <td>P-gp<br>UGT<br>CYP-isoenzymes</td>
      <td></td>
      <td>In a data base for interactions of medicinal drugs (MedIQ), the rating “weak interaction” is given for CYP-isoenzymes, P-gp, and UGT, based on in vitro data.</td>
    </tr>
    <tr>
      <th>979</th>
      <td>CYP activity</td>
      <td></td>
      <td>If so, herb-mediated changes in CYP activity may take on greater clinical relevance in this population.</td>
    </tr>
    <tr>
      <th>1267</th>
      <td>cancer<br>peptic ulcer<br>diabetes<br>antimalarials<br>hypertension<br>antimicrobials<br>asthma<br>minor ailments</td>
      <td></td>
      <td>Others such as Alstonia boonei, Bauhinia monandra, and Picralima nitida are frequently used in sub‐Saharan Africa and India in the management of chronic diseases such as hypertension, diabetes, asthma, peptic ulcer, and cancer, as antimalarials and antimicrobials and other minor ailments (Mahomoodally, 2013; Ezuruike & Prieto, 2014; Iwu, 2014).</td>
    </tr>
    <tr>
      <th>1696</th>
      <td>healthy human volunteers</td>
      <td></td>
      <td>The in vivo study was conducted on healthy human volunteers.</td>
    </tr>
    <tr>
      <th>587</th>
      <td>pharmacodynamic interactions</td>
      <td></td>
      <td>At present therefore a relevant risk of pharmacodynamic interactions is not proven by valid clinical observations.</td>
    </tr>
    <tr>
      <th>276</th>
      <td>pharmacokinetic studies</td>
      <td></td>
      <td>Pharmacokinetic studies started 2 h after the last RGE treatment.</td>
    </tr>
    <tr>
      <th>1386</th>
      <td>2,2-diphenyl-1-picrylhydrazyl (DPPH)<br>concentrations of the extracts</td>
      <td></td>
      <td>100 µL of various concentrations of the extracts, and the ascorbic acid control, in methanol, were added to 100 µL of a 0.02% (w/v) stock solution of the free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) in methanol.</td>
    </tr>
    <tr>
      <th>1672</th>
      <td>synergism</td>
      <td></td>
      <td>Conversely, it is important to keep in mind that these interactions may also present therapeutic benefits as a result of synergism which may lead to enhanced drug effects or reduced adverse reactions.</td>
    </tr>
    <tr>
      <th>764</th>
      <td>5-OH-OME<br>DEX<br>DOR<br>OME<br>MID</td>
      <td></td>
      <td>Precipitation was done the same way without an internal standard for OME, 5-OH-OME, DEX, DOR), and MID assays, respectively.</td>
    </tr>
    <tr>
      <th>1697</th>
      <td>clinical study</td>
      <td></td>
      <td>Therefore, the clinical study was conducted to confirm the in vitro results.</td>
    </tr>
    <tr>
      <th>1093</th>
      <td>Eugenia jambolana</td>
      <td></td>
      <td>Eugenia jambolana (EJ) is an Indian traditional herb widely used for the treatment of diabetes mellitus.</td>
    </tr>
    <tr>
      <th>792</th>
      <td>metabolism of drugs metabolized by CYP2C9</td>
      <td>CYP2C9</td>
      <td>However, an in vivo study indicated that echinacea did not significantly affect the metabolism of drugs metabolized by CYP2C9 [47].</td>
    </tr>
    <tr>
      <th>322</th>
      <td>herb-drug interactions</td>
      <td></td>
      <td>Many view these medicines as benign because they are of natural origin; however, because their constituents may be metabolized through the same enzymatic pathways as pharmaceutical agents, there is a potential for herb-drug interactions.</td>
    </tr>
    <tr>
      <th>1388</th>
      <td>H. verticillata<br>aqueous extract<br>aerial<br>dried<br>phytochemicals</td>
      <td></td>
      <td>Structures of phytochemicals identified in the aqueous extract of H. verticillata (aerial, dried).</td>
    </tr>
    <tr>
      <th>532</th>
      <td>common cold<br>respiratory problems</td>
      <td></td>
      <td>[2526] Iranian borage (E. amoenum) as unformulated and anticough syrups as formulated herbal products were the most used ones in our study population, while common cold and respiratory problems were determined to be the main indications for this trend.</td>
    </tr>
    <tr>
      <th>1414</th>
      <td>ten marker components</td>
      <td></td>
      <td>Results from RLM and hCE1 showed a similar trend for the ten marker components (Figs.</td>
    </tr>
    <tr>
      <th>950</th>
      <td>tyrosine kinases</td>
      <td></td>
      <td>The overexpression or somatic mutations of tyrosine kinases are dysregulated in various malignancies [3].</td>
    </tr>
    <tr>
      <th>185</th>
      <td>CYP2C9<br>CYP3A4<br>CYP2C8</td>
      <td></td>
      <td>Qualitative screening of extracts and compounds was used to identify potential inhibitory effects on CYP2C8, CYP2C9 and CYP3A4.</td>
    </tr>
    <tr>
      <th>1579</th>
      <td>serotonergic effects<br>CYP/P-gp induction</td>
      <td></td>
      <td>Apart from CYP/P-gp induction, SJW mediates interactions through its serotonergic effects.</td>
    </tr>
    <tr>
      <th>53</th>
      <td>HDIs</td>
      <td></td>
      <td>To date an increasing number of studies in evaluating HDIs have been reported [11].</td>
    </tr>
    <tr>
      <th>1049</th>
      <td>estrogen receptor (ER) positive</td>
      <td></td>
      <td>Approximately 70–80% of all breast tumors are estrogen receptor (ER) positive [2], and hormonal therapy plays therefore an important role in the therapy of early stage and metastatic ER-positive breast cancer.</td>
    </tr>
    <tr>
      <th>952</th>
      <td>BCRP/ABCG2 protein expression</td>
      <td></td>
      <td>The inhibitory potential of APG on BCRP/ABCG2 protein expression was investigated and shown in Figure 5A,B.</td>
    </tr>
    <tr>
      <th>191</th>
      <td>CYP2C9<br>CYP3A4<br>CYP2C8</td>
      <td></td>
      <td>GRT and FRE inhibited the reaction rate of CYP2C8, CYP2C9, and CYP3A4 as measured over 30 min (Figure 2a–c).</td>
    </tr>
    <tr>
      <th>97</th>
      <td>Danshen components<br>clinical pharmacokinetic profile</td>
      <td>the OATs<br>transporter families</td>
      <td>For the most part these latter two transporter families and the OATs have fairly distinct substrate interactions; however, the possibility that they also may contribute to the overall clinical pharmacokinetic profile of Danshen components in vivo needs to be considered until investigated directly.</td>
    </tr>
    <tr>
      <th>129</th>
      <td>right upper quadrant abdominal pain<br>lower extremity edema<br>fatigue</td>
      <td></td>
      <td>Although she was initially asymptomatic, she developed right upper quadrant abdominal pain, fatigue, and lower extremity edema by the time of her presentation.</td>
    </tr>
    <tr>
      <th>1666</th>
      <td>antidiabetics<br>Lycium</td>
      <td></td>
      <td>Evidence supporting the interaction between Lycium and antidiabetics is experimental only.</td>
    </tr>
    <tr>
      <th>458</th>
      <td>Phenotypic Ratio (CYP)</td>
      <td></td>
      <td>Table I  Pre- and Postsupplementation Phenotypic Ratios (means, 95% confidence intervals) Phenotypic Ratio (CYP)\tSupplement\tPresupplementation (mean and 95% CI)\tPostsupplementation.</td>
    </tr>
    <tr>
      <th>1280</th>
      <td>concentration used in the N‐in‐one assay<br>CYP isoenzymes</td>
      <td></td>
      <td>Positive controls (see Supporting Information data, Table S1), CYP isoenzymes inhibited, and concentration used in the N‐in‐one assay are as reported in the validated methods (Turpeinen et al., 2005; Tolonen et al., 2007; Showande et al., 2013).</td>
    </tr>
    <tr>
      <th>892</th>
      <td>RNA<br>cDNA</td>
      <td></td>
      <td>RNA was isolated using the GeneElute Mammalian Total RNA Miniprep Kit and cDNA was synthesized with the RevertAid™ H Minus First Strand cDNA Synthesis Kit according to the manufacturers’ instructions.</td>
    </tr>
    <tr>
      <th>911</th>
      <td>Bupleuri Radix<br>Paeoniae Radix<br>Atractylodis Rhizoma Alba<br>Dioscoreae Rhizoma<br>Poria Sclerotium<br>Bovis Calculus<br>Saposhnikoviae Radix<br>Cinnamomi cortex<br>Ginseng Radix<br>Liriopis Tuber<br>Armeniacae Semen<br>Angelicae Gigantis Radix<br>Platycodonis Radix<br>Cnidii Rhizoma<br>Massa Medicata Fermentata<br>Borneolum<br>Glycyrrhizae Radix et Rhizoma<br>Scutellariae Radix<br>Antelopis Cornu<br>Glycine Semen Germinatum</td>
      <td></td>
      <td>Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol.</td>
    </tr>
    <tr>
      <th>512</th>
      <td>LDL<br>P-value for interaction effect of groups over time<br>HDL</td>
      <td>LDL (low density lipoprotein)<br>HDL (high density lipoprotein)</td>
      <td>Abbreviations: HDL (high density lipoprotein); LDL (low density lipoprotein) *P-value for interaction effect of groups over time.</td>
    </tr>
    <tr>
      <th>199</th>
      <td>sulfaphenazole<br>quercetin<br>ketoconazole</td>
      <td></td>
      <td>quercetin (positive CYP2C8 inhibitor), sulfaphenazole (positive CYP2C9 inhibitor), and ketoconazole (positive CYP3A4 inhibitor).</td>
    </tr>
    <tr>
      <th>588</th>
      <td>therapeutic safety<br>interactions</td>
      <td></td>
      <td>That therapeutic safety regarding interactions is high in valerian and is mentioned in the respective monograph of the HMPC [18] and also in a fact sheet of the Office of Dietary Supplements at the NIH [32].</td>
    </tr>
    <tr>
      <th>1600</th>
      <td>level of sirolimus</td>
      <td></td>
      <td>In this patient, we reported the possible effect of parsley juice on the level of sirolimus.</td>
    </tr>
    <tr>
      <th>1536</th>
      <td>concomitant herbal use</td>
      <td></td>
      <td>showed that the practice of herbal co-medication with prescription drugs cut across various patient demographics, with 38% of respondents reporting concomitant herbal use [6].</td>
    </tr>
    <tr>
      <th>323</th>
      <td>cytochrome P450</td>
      <td>cytochrome P450 (P450)<br>monooxygenase forms</td>
      <td>The most important class of enzymes involved in human drug metabolism is cytochrome P450 (P450), which occurs as a superfamily of related monooxygenase forms responsible for oxidative metabolism of xenobiotics and endogenous compounds (Nebert et al., 2013).</td>
    </tr>
    <tr>
      <th>1344</th>
      <td>interactions between medication and lifestyle</td>
      <td></td>
      <td>Actions and Outcome  After evaluating the possible interactions between medication and lifestyle, some measures were taken to avoid those interactions.</td>
    </tr>
    <tr>
      <th>75</th>
      <td>% yield<br>bioavailable concentration</td>
      <td>bioavailability<br>bioavailable concentration</td>
      <td>Since the intestinal absorption and plasma concentration of each test compound are not known and with the knowledge that herbal extracts have different bioavailability [24], the bioavailable concentration was estimated using the % yield (weight extracted powdered material/weight of original starting material) to give the soluble extract available in the GIT tract.</td>
    </tr>
    <tr>
      <th>1146</th>
      <td>plasma concentration-time curves</td>
      <td></td>
      <td>In our study, the changing trends in the plasma concentration-time curves of indomethacin in S-AOE and M-AOE groups were similar to those in model group shown in Fig.</td>
    </tr>
    <tr>
      <th>1413</th>
      <td>OSA</td>
      <td></td>
      <td>The formation rate of OSA could be significantly suppressed by all the herb/herbal components.</td>
    </tr>
    <tr>
      <th>222</th>
      <td>alkylamides<br>DTAI</td>
      <td></td>
      <td>In contrast, contents of DTAI or other alkylamides in the extracts used in the midazolam studies [11, 12] were not specified.</td>
    </tr>
    <tr>
      <th>455</th>
      <td>ultraviolet absorption spectra<br>retention times</td>
      <td></td>
      <td>Peaks were assigned by a comparison of retention times and ultraviolet absorption spectra.</td>
    </tr>
    <tr>
      <th>1324</th>
      <td>placebo<br>double-blind<br>MenoAct851 formulation</td>
      <td></td>
      <td>The selected volunteers were randomized to placebo (inert substitute for a treatment or intervention) or MenoAct851 formulation (500 mg BID for 14 days in double-blind fashion) groups.</td>
    </tr>
    <tr>
      <th>552</th>
      <td>atrial fibrillation</td>
      <td></td>
      <td>(2006b) included 7 patients with atrial fibrillation, whereas Ansell et al.</td>
    </tr>
    <tr>
      <th>25</th>
      <td>pharmacodynamic<br>pharmacokinetic<br>pharmacogenomic data</td>
      <td></td>
      <td>The case described herein demonstrates the importance of considering the pharmacokinetic and pharmacodynamic effects of cannabis and an individual’s pharmacogenomic (PGx) data when evaluating a patient’s medication regimen for therapeutic response and/or adverse drug events.</td>
    </tr>
    <tr>
      <th>152</th>
      <td>pharmacokinetic level</td>
      <td></td>
      <td>At present, our current studies at the pharmacokinetic level may not be able to explain this problem strongly.</td>
    </tr>
    <tr>
      <th>174</th>
      <td>P-gp</td>
      <td></td>
      <td>IC Next, we determined the inhibition of P-gp by the extract of L. pumila and the constituents by using the two widely used probes calcein-AM and digoxin (Rautio et al., 2006).</td>
    </tr>
    <tr>
      <th>343</th>
      <td>curve fitting</td>
      <td></td>
      <td>All curve fitting was carried out using Prism 8.0.2 (GraphPad Software, San Diego, CA).</td>
    </tr>
    <tr>
      <th>1479</th>
      <td>precursor-product ion transitions</td>
      <td></td>
      <td>The precursor-product ion transitions of CIP and ofloxacin (internal standard) were 332.1→288.1 and 362.2→318.1, respectively.</td>
    </tr>
    <tr>
      <th>794</th>
      <td>warfarin</td>
      <td></td>
      <td>She had no history of warfarin use, but warfarin was detected in her blood serum analysis.</td>
    </tr>
    <tr>
      <th>274</th>
      <td>total RNA</td>
      <td></td>
      <td>The concentration of total RNA was determined by Nano Vue Plus (GE healthcare Korea, Seoul, Korea).</td>
    </tr>
    <tr>
      <th>43</th>
      <td>inhibitory neurotransmitter levels<br>dopamine levels</td>
      <td>dopamine levels</td>
      <td>When CB1Rs on presynaptic neurons are activated, inhibitory neurotransmitter levels are reduced and dopamine levels increase [5,24,25].</td>
    </tr>
    <tr>
      <th>1642</th>
      <td>2C9<br>CY3A4</td>
      <td></td>
      <td>Curcuminoids have been shown to inhibit CY3A4 and 2C9 in vitro [230].</td>
    </tr>
    <tr>
      <th>1451</th>
      <td>TAM resistance<br>cell growth<br>apoptosis<br>cell viability</td>
      <td>cell growth<br>cell viability</td>
      <td>In a study involving TAM-resistant cell line MCF-7 tam-R, while 10 Evn-50 is an ethyl acetate extract of Vitex negundo L. When used in combination with TAM to treat TAM-resistant MCF-7/TAM-R cells, it significantly reduces cell viability, inhibits cell growth, induces apoptosis, and reverses TAM resistance of MCF-7/TAM-R cells (Hu et al., 2012).</td>
    </tr>
    <tr>
      <th>782</th>
      <td>herb</td>
      <td></td>
      <td>An herb was defined as a product or an extract originating from a single botanical source.</td>
    </tr>
    <tr>
      <th>253</th>
      <td>adverse events</td>
      <td></td>
      <td>All the adverse events were mild in intensity and resolved without any treatment.</td>
    </tr>
    <tr>
      <th>737</th>
      <td>darunavir concentrations</td>
      <td></td>
      <td>Thus, at the approved dosage of darunavir-ritonavir, darunavir concentrations at the end of the dosing interval remain well above the concentration needed to inhibit replication of HIV strains (20; V. Sekar, S. Spinosa-Guzman, E. Lefebvre, and R. Hoetelmans, presented at the 16th International AIDS Conference, 2006).</td>
    </tr>
    <tr>
      <th>702</th>
      <td>hesperidin<br>terpenoids (limonene and linalool)<br>polymethoxylated flavonoids (PMF)<br>cytoprotective effects</td>
      <td></td>
      <td>Citrus Sinensis (L.) Osbeck from Rutaceae family mainly contains hesperidin, polymethoxylated flavonoids (PMF), and terpenoids (limonene and linalool), and these phenolic bioactive compounds indicate considerable cytoprotective effects against OS [18].</td>
    </tr>
    <tr>
      <th>451</th>
      <td>CYP enzymes<br>CYP substrates<br>pharmacokinetics</td>
      <td></td>
      <td>Moreover, age-related changes have been observed in the pharmacokinetics of several CYP substrates,[28–30] as well as certain CYP enzymes,[29,30] thus the question remains as to whether such effects may extend to botanical supplements and their effect on drug metabolism in the elderly.</td>
    </tr>
    <tr>
      <th>78</th>
      <td>intermediary metabolites<br>TDI effects</td>
      <td></td>
      <td>The TDI effects of these herbals is felt when patients chronically use them because sufficient intermediary metabolites may be generated and this can be deleterious to consumers concomitantly taking conventional medications, as stated earlier.</td>
    </tr>
    <tr>
      <th>1460</th>
      <td>protein expression levels<br>transcription activity</td>
      <td>protein expression levels</td>
      <td>Studies have shown that just the monitoring of protein expression levels is insufficient in understanding transcription activity in vitro (Gordân et al., 2009).</td>
    </tr>
    <tr>
      <th>441</th>
      <td>AAP dosage<br>GGT</td>
      <td></td>
      <td>AAP at 1000 once a day or 1000 mg × 4 times a day was administered in the presence or absence of GGT (7680 mg) daily.</td>
    </tr>
    <tr>
      <th>1495</th>
      <td>extremely</td>
      <td></td>
      <td>The scale was anchored at each end with the labels “not at all” (0 mm) and “extremely” (100 mm).</td>
    </tr>
    <tr>
      <th>594</th>
      <td>conflict of interests</td>
      <td></td>
      <td>The authors declare that there is no conflict of interests regarding the publication of this paper.</td>
    </tr>
    <tr>
      <th>54</th>
      <td>pharmacogenomics studies<br>HDIs<br>important herb products<br>clinic study</td>
      <td></td>
      <td>In the following, we reviewed pharmacogenomics studies, mainly from clinic study, on some important herb products that have been reported to have HDIs.</td>
    </tr>
    <tr>
      <th>44</th>
      <td>COMT Met/Met</td>
      <td></td>
      <td>Interestingly, the patient’s PGx results (Table 1) reported a genotype for COMT Met/Met, therefore higher levels of dopamine in his synapses would be expected.</td>
    </tr>
    <tr>
      <th>315</th>
      <td>qi<br>yang<br>blood<br>yin</td>
      <td></td>
      <td>When the bias of medicine is greater than that of food, it will inevitably affect the balance of qi, blood, yin and yang of the human body (Jia et al., 2021).</td>
    </tr>
    <tr>
      <th>1200</th>
      <td>Schisandra lignans</td>
      <td>CYP</td>
      <td>Another limitation of the current study is the reliance on the assumption that Schisandra lignans are solely responsible for the interactions with CYP substrates.</td>
    </tr>
    <tr>
      <th>1050</th>
      <td>Viscum album extracts<br>breast cancer patients<br>other types of cancer</td>
      <td></td>
      <td>Clinical studies have reported on the benefits of Viscum album extracts (VAE) not only in breast cancer patients but also for other types of cancer [10–13].</td>
    </tr>
    <tr>
      <th>1352</th>
      <td>adverse events</td>
      <td></td>
      <td>All subjects completed the study and no adverse events related to either of the herbal medicines or warfarin were reported.</td>
    </tr>
    <tr>
      <th>931</th>
      <td>over the counter medications<br>prescription medications</td>
      <td></td>
      <td>Subjects were also asked to abstain from taking prescription and over the counter medications for 2 weeks before and during the study period.</td>
    </tr>
    <tr>
      <th>894</th>
      <td>Banderol<br>Samento</td>
      <td></td>
      <td>IC In conclusion, Samento and Banderol exhibit a completely different in vitro profile as perpetrators in herb–drug interactions.</td>
    </tr>
    <tr>
      <th>330</th>
      <td>CAW-R61J<br>C. asiatica<br>Plant Material</td>
      <td></td>
      <td>C. asiatica Plant Material and Preparation of CAW-R61J.</td>
    </tr>
    <tr>
      <th>1259</th>
      <td>toxicity profile</td>
      <td></td>
      <td>There was no difference in the toxicity profile of hormone therapy with ginkgo biloba use in women with early stage breast cancer.</td>
    </tr>
    <tr>
      <th>293</th>
      <td>precision<br>accuracy</td>
      <td></td>
      <td>These data indicated that the accuracy and precision of the method were satisfactory.</td>
    </tr>
    <tr>
      <th>172</th>
      <td>alkyl phenols<br>triterpene glycosides</td>
      <td></td>
      <td>The two major classes of compounds isolated from the roots of KF are alkyl phenols and triterpene glycosides (saponins) as reported earlier (Ali and Khan, 2011).</td>
    </tr>
    <tr>
      <th>548</th>
      <td>CL/F<br>CL/Fs<br>fu<br>AUC</td>
      <td>Cmax<br>Cmax, maximum concentration<br>F, bioavailability<br>CL/F, apparent clearance<br>AUC<br>CL, clearance<br>t1/2<br>CL/F<br>tmax, time to Cmax<br>AUC, area under the plasma concentration–time curve<br>tmax</td>
      <td>Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin  tmax (h)\t1.4 (1.1–1.6)\t1.9 (1.1–2.7)\t1.3 (1.1–1.6)\tNA\tNA  Cmax (μg mL−1)\t1.8 (1.7–1.9)\t1.7 (1.5–2.0)\t1.9 (1.5–2.2)\t0.94 (0.67–1.29)\t1.06 (0.77–1.47)  t1/2 (h)\t38.6 (35.7–41.5)\t34.9 (31.0–38.8)\t41.2 (35.1–47.3)\t0.94 (0.79–1.12)\t0.99 (0.83–1.18)  AUC (μg mL−1 h)\t60.3 (54.5–66.1)\t63.0 (57.3–68.8)\t65.5 (55.3–75.6)\t1.04 (0.94–1.67)\t1.06 (0.95–1.19)  CL/F (mL h−1)\t213 (193–232)\t204 (183–224)\t202 (175–229)\t0.89 (0.80–0.99)\t1.05 (0.94–1.17)  Fraction unbound (fu)\t0.010 (0.007–0.013)\t0.010 (0.007–0.014)\t0.011 (0.008–0.014)\t1.00 (0.75–1.25)\t1.12 (0.39–1.84)  \t \t \t \t \t  R-warfarin  tmax (h)\t1.4 (1.1–1.6)\t1.9 (1.1–2.7)\t1.8 (0.7–2.9)\tNA\tNA  Cmax (μg mL−1)\t1.8 (1.7–2.0)\t1.7 (1.5–1.9)\t1.9 (1.5–2.2)\t0.90 (0.67–1.21)\t1.02 (0.8–1.4)  t1/2 (h)\t55.6 (46.2–65.0)\t47.7 (41.5–53.9)\t52.6 (47.4–57.9)\t0.93 (0.80–1.08)\t0.98 (0.84–1.14)  AUC (μg mL−1 h)\t108.7 (90.0–127.3)\t105.8 (91.7–119.9)\t105.0 (96.3–113.7)\t1.0 (0.9–1.1)\t0.99 (0.87–1.13)  CL/F (mL h−1)\t123 (106–140)\t124 (109–139)\t121 (112–131)\t0.87 (0.75–0.99)\t0.96 (0.84–1.11)  Fraction unbound (fu)\t0.006 (0.004–0.007)\t0.005 (0.004–0.007)\t0.006 (0.004–0.007)\t0.95 (0.72–1.18)\t1.04 (0.80–1.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration–time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax.</td>
    </tr>
    <tr>
      <th>572</th>
      <td>CYP 2E1<br>CYP 1A2<br>CYP 2D6<br>CYP 3A4/5</td>
      <td></td>
      <td>Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined.</td>
    </tr>
    <tr>
      <th>47</th>
      <td>Katie Meyer</td>
      <td></td>
      <td>The authors want to thank Katie Meyer for her assistance.</td>
    </tr>
    <tr>
      <th>1054</th>
      <td>dextrorphan-d<br>HLMs<br>β-estradiol</td>
      <td></td>
      <td>(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), β-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA).</td>
    </tr>
    <tr>
      <th>1349</th>
      <td>CYP2C9*2<br>CYP2C9*1<br>CYP2C9*3</td>
      <td></td>
      <td>CYP2C9 and VKORC1 genotyping  The CYP2C9*1,*2 and *3 polymorphisms of CYP2C9 were detected by polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) analysis.</td>
    </tr>
    <tr>
      <th>735</th>
      <td>Polycystic ovary syndrome (PCOS)</td>
      <td></td>
      <td>Polycystic ovary syndrome (PCOS) patients’ flow diagram.</td>
    </tr>
    <tr>
      <th>1164</th>
      <td>conflict of interests</td>
      <td></td>
      <td>Go to: Conflict of interests  There is no conflict of interests.</td>
    </tr>
    <tr>
      <th>1161</th>
      <td>concomitantly taking warfarin<br>daily Gouqizi dose<br>prosthetic heart values</td>
      <td></td>
      <td>However, a daily Gouqizi dose of 6 g (dosing recommended by Chinese Pharmacopoeia) for 3 days did not enhance the effects of warfarin in three patients with prosthetic heart values who were concomitantly taking warfarin.</td>
    </tr>
    <tr>
      <th>1234</th>
      <td>Gegen</td>
      <td></td>
      <td>Taken together with the results of the current study, it seems clear that these effects could be attributed to the Gegen present in DFG.</td>
    </tr>
    <tr>
      <th>746</th>
      <td>confidence intervals<br>pharmacokinetic parameters<br>natural log transformed<br>treatment as a fixed effect<br>analysis of variance model</td>
      <td></td>
      <td>Pharmacokinetic parameters were natural log transformed before analysis, and confidence intervals for means (and for the difference between two means) were constructed on the natural log scale based on an analysis of variance model with treatment as a fixed effect.</td>
    </tr>
  </tbody>
</table>

</body>
</html>
